1. BRONCHIAL ASTHMA AND OTHER CHRONIC OBSTRUCTIVE PULMONARY DISEASES {#ppul24373-sec-0010}
====================================================================

A‐22. The Effect of Vitamin D Administration on Vitamin D Status and Respiratory Morbidity in Premature Infants {#ppul24373-sec-0020}
===============================================================================================================

[*Golan Tripto I*.]{.ul} ^1^, Bistritzer J.^2^, Loewenthal N.^2^, Dizitzer Y.^3^, Goldbart A.^1^

^1^ *Pediatric Pulmonary Unit, Soroka University Medical Center ‐ Beer‐ Sheva, Israel;* ^2^Department of Pediatrics, Soroka university Medical Center ‐ Beer‐Sheva, Israel; ^3^Clinical Research Center, Soroka University Medical Center ‐ Beer‐ Sheva, Israel

**Objective:** To assess whether increasing the daily intake of vitamin D will improve serum vitamin D levels and serve as primary prevention for respiratory morbidity in late premature infants.

**Methods:** A randomized double‐blinded clinical trial, including preterm infants born at 32 + 6 to 36 + 6 weeks\' gestation, between May 2015 and January 2017. The control group received 400 IU of cholecalciferol daily compared to 800 IU daily in the intervention group. We measured the levels of 25 (OH) vitamin D at birth (cord blood), 6 months and 12 months, and followed the respiratory morbidity in both groups.

**Results:** Fifty subjects were recruited during the study period: 25 subjects in each group. The median 25 (OH) vitamin D levels in the control group vs. the intervention group were: 26.5 vs. 34 nmol/L (p‐value 0.271) at birth, 99 vs. 75.5 nmol/L (p‐ value 0.008) at 6 months and 72.5 vs. 75 nmol/L (p‐value 0.95) at 12 months of age. Regarding respiratory morbidity, the intervention group, which had significantly lower vitamin D levels, had 3.5 vs. 1.9 (p‐ value 0.073) respiratory diseases during the follow‐up year. Both groups had similar rates of Emergency department visits for respiratory symptoms and number of relievers consumed.

**Conclusion:** Doubling the daily intake of vitamin D in the first year of life does not increase its serum levels when compared to the control group. We found a reversed association between serum vitamin D levels and the number of respiratory diseases in premature infants during the first year of life.

A‐33. Pulmonary Function Evaluation in Pediatric Patients with Primary Immunodeficiency Complicated by Bronchiectasis {#ppul24373-sec-0030}
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Lai S. H., Wong K. S., Chiu C. Y., [*Chiu C. C*.]{.ul}

Division of Pediatric Pulmonology, Chang Gung Memorial Hospital ‐ Taoyuan, Taiwan

**Background:** Primary immunodeficiency (PID) accompanied with recurrent respiratory infection is thought to have a devastating effect on pulmonary function. The major aim of this study was to investigate the relationships between chest computed tomography (CT) scan morphology of bronchiectasis, clinical severity of dyspnea, and deterioration of pulmonary function parameters.

**Methods:** Children diagnosed with PID in a tertiary pediatric referred center in northern Taiwan were enrolled and retrospectively reviewed. Demographic and clinical data including age, sex, age at diagnosis of PID, follow‐up period, chest CT images (modified Reiff scores), pulmonary function test (PFT) parameters, quality of life questionnaires (mMRC dyspnea scale) were collected and analyzed. Spearman's correlation was used for correlation between continuous variables. All statistical analyses were performed using SPSS software (version 20.0; NY, USA).

**Results:** A total of 19 children with PID were enrolled. Among the latter, 13 patients were diagnosed as having bronchiectasis based on chest CT scans. Modified Reiff scores of chest CT scans were negatively correlated with FEV1 (% predicted) (Spearman r = --0.74, *P* = 0.009, n = 11) and FEV1/FVC ratio (Spearman r = --0.71, *P* = 0.014, n = 11). A significant negative correlation was found between the mMRC dyspnea scale and FEV1 (% predicted) (Spearman r = --0.69, *P* = 0.041, n = 9) and FVC (% predicted) (Spearman r = --0.78, *P* = 0.014, n = 9). In contrast, the mMRC dyspnea scale was positively correlated with RV (% predicted) (Spearman r = 0.85, *P* = 0.016, n = 7) and RV/TLC (Spearman r = 0.86, *P* = 0.014, n = 7). Furthermore, duration of the follow‐up period was found to be significantly negatively associated with FVC (% predicted) (Spearman r = --0.67, *P* = 0.013, n = 13).

**Conclusions:** In pediatric patients with primary immunodeficiency, chest CT scan appears to be a good tool for not only the diagnosis of bronchiectasis, but also the degree of pulmonary function impairment. A further analysis reveals that the quality of life impairments of thse patients could be particularly due to the airflow obstruction and air trapping related to bronchiectasis.

A‐39. Characteristics of Breath Sound in Infants with Risk Factors for Asthma Development {#ppul24373-sec-0040}
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**Objective:** Early diagnosis and intervention of bronchial asthma in children are important, although no clinical method for objectively evaluating bronchial reactions in infants and young children are available. Breath sound parameters have been suggested as biomarkers of the airway narrowing in children. Using a commercially available breath sound analyzer, the characteristics of airway condition were investigated in infants with risk factors for asthma development.

**Methods:** A total of 443 infants (mean age, 9.9 months; range, 3‐24 months) were included in the present study. The breath sound parameters of the frequency limiting 99% of the power spectrum (F99), the roll‐off from 600‐1200 Hz (Slope) and spectrum curve indices, the total area under the curve of the dBm data (A3/AT) and the ratio of power and frequency at 50% and 75% of the highest frequency of the power spectrum (RPF75 and RPF50), were evaluated. Using an ATS‐DLD based original Japanese questionnaire, we examined the characteristics of airway conditions of infants.

**Results:** Altogether, 283 infants who had no history of acute respiratory infection were analyzed. The RPF75, RPF50, Slope and F99 in infants with positive results of allergy and atopic dermatitis were significantly more increased than those in the infants with a negative result.

**Conclusions:** Our results show that the breath sounds of infants with risk factors of asthma development reveal residual airway changes, even in a healthy state. Breath sound analysis may be useful for assessing the airways of infants for asthma development.

A‐47. Correlation of BMI with Clinical Presentation and Duration of Hospitalization among Filipino Children Admitted with the Diagnosis of Asthma {#ppul24373-sec-0050}
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[*Pontigon M*.]{.ul}

Pediatrics, Quezon City General Hospital ‐ Quezon City, Philippines

**Introduction:** Obesity and asthma are common disorders, and the prevalence of both has increased in recent decades. This study aims to recognize the correlation between body mass index (BMI) with clinical presentation and duration of hospitalization in children and adolescents diagnosed with asthma and admitted in a tertiary government hospital.

**General Objective:** To determine the correlation of BMI with the number of symptoms (clinical presentation) and duration of hospitalization among children aged 5 to 18 years old admitted with a diagnosis of asthma.

**Design:** Cross‐sectional analysis.

**Subjects:** Patients 5 to 18 years old admitted with a diagnosis of asthma from June 2015 to March 2016. Those with comorbidities of pneumonia, cardiac disease, tuberculosis and demise were excluded.

**Methodology:** Weight and height were measured upon admission and plotted on the appropriate Center for Disease and Control (CDC) BMI‐for‐age growth chart for all included patients. Subjects were classified according to their Body Mass Index as Obese, Overweight, Normal/Healthy weight and Underweight. Symptoms and signs related to asthma were recorded upon admission. Date of discharge was determined from medical records and duration of hospitalization (days) was computed.

**Statistical analysis:** SPSS version 10 for Windows was used. Descriptive statistics were generated for all variables. For nominal data, frequencies and percentages were computed. For numerical data, mean ± SD was generated. Point and interval estimates of the odds ratio were also computed. Analysis of the different variables was performed using ANOVA, the Chi‐square test and Pearson correlation analysis.

**Results:** A total of 148 patients were included, with a mean age of 9.25 years and equal sex distribution. The majority had a healthy weight 56 (37.8%). Among the symptoms studied, there was a significantly higher proportion (*P* value \< 0.001) of subjects with shortness of breath among the obese and underweight groups. A higher proportion of subjects (*P* value \< 0.001) with higher number of asthma symptoms were noted among the obese and underweight groups. Significantly positive correlation coefficients of 0.415 (*P* value \< 0.0001) between BMI and number of symptoms and 0.654 (*P* value \< 0.0001) between BMI and duration of hospitalization were also noted.

**Conclusion:** The results of this study showed that there was a significant correlation between BMI and days of hospitalization and the number of symptoms. A positive correlation was noted in which with increasing BMI, the hospitalization days and the number of symptoms also increased and vice versa. A significantly higher proportion of obese, overweight and underweight children with asthma presented with shortness of breath.

**Keywords:** Body Mass Index, Obesity, Underweight, and Asthma.
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**Introduction:** Protracted bacterial bronchitis (PBB) is characterized by an isolated chronic wet or productive cough without signs of another cause, and which usually responds to 2 weeks of an appropriate oral antibiotic covering the common bacteria of the respiratory tract such as *Haemophilus influenzae* or *Streptococcus pneumoniae*. Management of patients who fail to respond to the initial treatment and present a PBB‐extended or a recurrent PBB, potentially associated with the development of bronchiectasis, remains controversial.

**Aim:** The purpose of our study was to evaluate the efficiency and tolerance of a long duration treatment with low doses of azithromycin in the PBB‐extended.

**Methods:** A register was established that included all patients aged between 0 and 16 years who underwent a bronchoscopy at the Queen Fabiola Children\'s University Hospital between January 2012 and December 2017 for chronic cough and who were treated by low dose azithromycin for a minimum of 3 months for a PBB‐extended.

**Results:** The response rate in our cohort was higher than 80 % after a median treatment duration of 6 months. Less than 30% of the patients experienced a recurrence of PBB within 6 months after stopping the treatment and no side effects were recorded. Multiple hospitalizations for respiratory infections appeared to be the only factor associated with treatment failure.

**Conclusions:** Our study suggests that azithromycin may be an effective and better tolerated alternative to prolonged classic antibiotic therapy in the treatment of the PBB‐extended, along with the necessity to confirm our results with a randomized protocol.

A‐57. Prevalence of Childhood Asthma in Ulaanbaatar, Mongolia in 2009 {#ppul24373-sec-0070}
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**Background:** Bronchial asthma is a common but important chronic disease in children throughout the world. To take measures against the prevalence of childhood asthma, many researchers have surveyed the actual statuses of childhood asthma in developed countries; however, in most Asia‐Pacific developing countries including Mongolia, such surveys have never been sufficiently conducted To date. We have thought that this survey, though performed in 2009, will provide important and meaningful information even now in taking measures to prevent prevailing bronchial asthma in children in Mongolia or the countries under similar statuses.

**Methods:** The asthma prevalence and patient background information in Mongolian children aged 6 to 7 living in Ulaanbaatar were examined using a written questionnaire modified for their parents from that prepared by the International Study of Asthma and Allergies in Childhood (ISAAC).

**Results:** The estimated prevalence of asthma in Mongolian children was 20.9%. The following 3 risk factors were found to be related to asthma: (1) having allergic rhinitis symptoms, (2) mothers\' smoking, and (3) history of severe respiratory infection before 1‐year‐old.

**Conclusions:** The asthma prevalence in Mongolian children was higher than that in the world and Asia Pacific countries reported by ISAAC. The higher prevalence was probably attributable to household smoking (especially mothers) in draft‐free houses designed for the cold area as well as severe air‐pollution due to rapid industrialization and urbanization in Mongolia. Smoking prohibition in the mother (including family members) and a reduction of exposure to air pollutants are urgently needed to prevent developing childhood asthma.

A‐69. Clinical Characteristics and Risk Factors of the Wheezing and Asthma Phenotype in Children Under 5 Years Old {#ppul24373-sec-0080}
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[*Dung N. T*.]{.ul} ^1^, Thuan B. K.^2^

^1^Pediatric Department, Bachmai Hospital ‐ Hanoi, Vietnam; ^2^Vinh Medical University ‐ Hanoi, Vietnam

**Background:** Asthma in children under 5 years old is difficult to diagnose. The clinical presentation of asthma varies with age, and there are no tests that can diagnose asthma with certainty in young children. Thus, the clinician is left to try to define different asthma phenotypes based on clinical characteristics.

**Patient and methods:** Diagnosis of asthma and definition of clinical phenotypes based on patient history, diagnostic work‐up, and treatment responses following the PRACTAL 2008 and GINA 2014 guidelines.

**Results:** There were 309 children under 5 years old to be diagnosed and classified according to asthma clinical phenotype. Of these, there were 218 males and 91 females, with a male/female ratio of 2.39/1. There were 184 children under 2 years of age (59.5%) and 125 children over 2 years of age (40.5%). There were 197 children classified as virus‐induced asthma (63.8%), 1 child as exercise‐induced asthma (0.3%) and 111 children as allergic asthma (35.9%). A specific allergic trigger could be identified in 5 children with allergic asthma. Virus‐induced asthma was more common in children under 2 years of age (67.5%) while allergic asthma was more common in children fromtwo to 5 years of age (49.0%) (OR= 2.44 (1.47‐4.06; *P* = 0.000). Allergic asthma was more common in males (79.3%) and virus‐induced asthma more common in females (34.5%) (OR= 2.02 (1.13‐3.61); *P* = 0.010). There were no statistically significant differences for family history with regard to allergies and an increase of eosinophils in virus‐induced and allergic phenotype. Fever and crepitation were more common in virus‐induced asthma than allergic asthma. Other clinical signs and symptoms did not differ between the 2 groups of virus asthma and allergic asthma. The percentage of hospitalized children from 5 or more times/year was 42.3% in the allergic asthma group, higher than the 24.4% in virus asthma with a statistically significant difference (OR = 2.28 (1.35 to 3.87; *P* = 0.001). The percentage of children who missed school because of asthma from 19 days or more/year was 45.9% in the allergic asthma group and higher than 22.8% in the virus‐induced asthma group with a statistically significant difference (OR = 2.87 (1.69 to 4.89); *P* = 0.001). The percentage of children with parental leave from work to care for asthma from 22 days or more / year was 69.4% and higher than 52.8% in the virus‐induced asthma with a statistically significant difference (OR = 2.03 (1.20 to 3.41): *P* = 0.004).

**Conclusions:** Viral asthma is common in children under 2 years old while allergic asthma is common in children fromtwo to 5 years old with a history of allergic diseases. Fever and crepitation are common in viral asthma. Allergic asthma affects the quality of life of children more than viral asthma.

**Keywords:** asthma phenotype; viral asthma; allergic asthma.
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The KAPARD Work Group on Asthma Medication Compliance.

**Background:** Compliance is a major component of successful medical treatment. However, noncompliance remains a barrier to effective delivery of healthcare worldwide.

**Methods:** Twenty healthcare facilities (secondary or tertiary hospitals) belonging to the Korean Academy of Pediatric Allergy and Respiratory Diseases (KAPARD) participated. Questionnaires were given to patients currently receiving treatment in the form of inhaled or oral or transdermal patch for mild to moderate asthma.

**Results:** A total of 1838 patients responded to the questionnaire. Mean age was 5.98 ± 3.79 years (range, 0‐18 years). With help from their caregivers, the percentage of patients that answered "taking as prescribed" was 38.04% for inhalant users, 50.09% for oral medication users, and 67.42% for transdermal users. Transdermal patch users had significantly greater compliance when compared to the other two groups (*P* \< 0.001). 34.15% of inhalant users, 70.33% of oral medication users, and 93.00% of transdermal patch users felt that their medication delivery system was "Easy" or "Very easy" to use (*P* \< 0.001). "Method of administration" was deemed to be the most difficult part of the treatment regimen to follow, and 76.7% of patients preferred once‐daily administration (ie, "Frequency of administration").

**Conclusions:** Asthma medication compliance in young children was found to be better in the transdermal patch group. This may be due to requiring fewer doses and easy to follow instructions. From a compliance point of view, the transdermal patch seems more useful for long‐term asthma control in children compared to oral or inhaled medicine.

**Keywords:** Multicenter; KAPARD; Asthma Medication; Compliance.
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Asthma is one of the most common chronic inflammatory diseases. People with asthma have sensitive airways which react to triggers causing mucosa swelling and airway narrowing. The incidence of asthma is increasing every year. There is increasingly more research for asthma therapy of which probiotics is one of them. Probiotics are microorganism which can provide health benefits to the host, regulate microbial balance in the intestine, control the immune microenvironment and alleviate the condition of allergy and inflammation.

In this study, we used *Dermatophagoides pteronyssinus* (Der p) to induce female BALB/c mice allergic reaction. The mice received intraperitoneal Der p sensitization on day 1 to day 3 and intranasal Der p sensitization on day 14, 17, 21, 24, and 27. This animal asthma model had been established. In addition, the Der p‐sensitized mice were randomly assigned to two groups. One was fed LGG (*Lactobacillus rhamnosus* GG) on days 1 to 14 to test the prophylactic effect on asthma; the other group was fed on days 14 to 27 to test the treatment effect on asthma. The normal control group consisted of non‐sensitized mice who received normal saline rather than Der p.

According to the results, LGG treatment group, whether before or after Der p‐sensitization, can suppress airway inflammation and airway hyperresponsiveness, decrease IgE and Th2 cytokines (such as IL‐4, IL‐5 and IL‐13) and raise IFN‐γ and TGF‐β.

In conclusion, oral LGG can prevent and treat Der p‐sensitized airway inflammatory reaction. Therefore, oral LGG may have a role in allergic airway disease prevention and treatment.

**Keywords:** asthma, *Lactobacillus rhamnosus* GG (LGG), probiotics, airway hyperresponsiveness, IFN.
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**Background:** Few studies have examined the relationship between dyspnea perception and eosinophilic airway inflammation in asthmatic children.

**Objective:** We tested the hypothesis that eosinophilic airway inflammation is associated with poor perception of airway obstruction.

**Methods:** Two hundred seventeen asthmatic children (median age, 10.7years) were evaluated using the acetylcholine chloride (Ach) challenge test. FENO was examined before the Ach challenge test. The BHR was assessed as the provocative concentration of Ach causing a 20% decrease in forced expiratory volume in 1 second (FEV1) (PC20). Perception of dyspnea was scored using a modified Borg scale after each dose of Ach. The dyspnea threshold was defined as the point at which the Borg scale score became higher than 0. We evaluated the dyspnea perception score at a 20% decrease in FEV1 relative to baseline (PS20) and % drop in FEV1 at the dyspnea threshold (% drop FEV1‐Th).

**Results:** PS20 was negatively correlated with FENO (r = ‐0.198, *P* = 0.004) and positively with PC20 (r = 0.37, *P* \< 0 0.001). The % drop in FEV1‐Th was negatively correlated with PC20 (r = ‐0.39, *P* \< 0 0.001), but not with FENO.

**Conclusions:** Eosinophilic airway inflammation is able to induce relative insensitivity to dyspnea in asthmatic children with moderate airway constriction. This may consequently lead to the undertreatment of asthma.

A‐107. Characteristics of Acute Severe Exacerbations of Asthma in Children in the Intensive Care Unit, Children Hospital 1 {#ppul24373-sec-0120}
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**Objective:** To determine the characteristics of the epidermiology, clinical, paraclinical and treatment of acute severe exacerbations of asthma in the intensive care unit, Children Hospital N01 from 01/03/2008 to 30/4/2015.

**Methods:** Case series

**Results:** There were 69 cases of acute severe exacerbations of asthma in this study. The near‐fatal group accounted for 19%. The 12 months to 5 years age group accounted for 58%. Female/male ≈ 1.2/1. Sixty‐one percent of children were from Hồ Chí Minh City. Admission to ICU increased recently. Dyspnea was the chief complaint, accounting for 88%. Cough, wheezing, dyspnea were essential symptoms. Fiftly‐one percent had a history of asthma. Preventer medication ownership was recorded in 34% of cases. The rate of impaired consciousness was 59.4%. 27% had a pH \< 7.3% and 33% had a PaCO2 \> 40 mm Hg. Chest X‐rays showed hyperinflation, infiltrates and atelectasis. Time of treatment was 7 days (6,11), days in ICU was 2 days (2, 4). Ten children were intubated, 43.5% received NCPAP; 72.6% of children older than 1 year were given MgSO4, 65% children were given diaphyllin, 20% children were given salbutamol and 6% children were given adrenaline subcutaneously. All intubated patients received pressure control ventilation. Inspiratory pressure was 14 to 16 cmH2O to achieve tidal volume of approximately 6ml/kg, mean PEEP was 7 cmH2O, FiO2 was approximately 80% and I/E was 1/2 ‐ 1/3. Intubated patients spent longer days in hospital and days in ICU.

**Conclusions:** Appropriate treatment at first is crucial to lower the number of children to be intubated. Mechanical ventilation still remains the last recourse in the treatment of near fatal exacerbations of asthma after MgSO4, diaphyllin and salbutamol.
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**Aim:** To know the relationship between serum‐specific immunoglobulin E (IgE) to peanut and Brazil nut among atopic diseases in southern Taiwan.

**Method:** Sera of individuals with suspected atopic diseases were collected for the measurement of serum‐specific IgE (FEIA ImmunoCAP, Thermo Fisher Scientific) to peanuts, cashew nuts, Brazil nuts, almonds and coconuts. Cases with possible sensitization to these nuts (serum‐specific IgE ≧ 0.35 kU/L) were selected and their clinical relationships with physician‐diagnosed atopic dermatitis and asthma were analyzed.

**Results:** Compared with the non‐sensitization group, people with peanut/tree nut sensitization had a higher prevalence of atopic dermatitis, but no such difference was noted in the prevalence of allergic rhinitis. In the situation of asthma, people with sensitization to peanuts and Brazil nuts, but not other nuts, had a higher prevalence of asthma than those without sensitization to any nut (*P* \< 0.001 and *P* \< 0.05, respectively). Binary logistic regression analysis also showed positive associations between peanut (OR: 1.164, *P* value = 0.017) and Brazil nut (OR: 1.304, *P* value = 0.055) sensitization and asthma. The associations between peanut and Brazil nut sensitization and asthma were independent of the prevalence of other atopic diseases.

**Conclusion:** Those with allergic reactions to nuts have higher rates of asthma although sensitization to specific food allergens such as peanuts and Brazil nuts may predispose individuals to asthma in Southern Taiwan.
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**Background:** Asthma is the most common chronic disease in childhood, and invasive pneumococcal disease (IPD) is a leading cause of global morbidity and mortality. Current guidelines recommend supplementary vaccination with pneumococcal polysaccharide vaccine (PPSV23) in asthma only for patients treated with prolonged high‐dose oral corticosteroids. Here we evaluated the risk of IPD among children with asthma after the introduction of pneumococcal conjugate vaccines (PCV).

**Methods:** We searched four electronic databases and included all observational studies of IPD or pneumonia in populations receiving PCV that reported data for children with asthma and healthy controls. Primary outcomes were occurrence of IPD and pneumonia. Secondary outcomes included mortality, hospital admissions, hospital length of stay, intensive care unit admission, respiratory support, costs, and additional medication use.

**Results:** Four studies met the inclusion criteria; three retrospective cohorts (\~26 million person‐years) and one case‐control study (n =3,294 children) qualified for the meta‐analysis. Children with asthma had \~90% higher risk of IPD than healthy controls (OR= 1.90, 95% CI= 1.63‐2.11, I2 = 1.7%). Pneumonia was also more frequent among children with asthma than among controls, and one study reported that pneumonia‐associated costs increased with asthma severity.

**Conclusions:** After introduction of PCV, children with asthma continue to have a higher risk of IPD than children without asthma. Further research is needed to assess the need for supplemental PPSV23 vaccination in asthmatic children, regardless of of their use of oral steroids.
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**Background:** A recent genome‐wide association study reported rs6967330 of CDHR3 encoding for human rhinovirus‐C (HRV‐C) receptor to be a novel risk factor for recurrent severe asthma exacerbations in Caucasian preschoolers. However, there is limited data on its importance in Asian populations. The relevance of CDHR3 to childhood lung functions is also unknown. This cross‐sectional study investigated the associations between CDHR3 and wheezing illnesses and lung function of preschool children in Hong Kong.

**Methods:** Chinese children younger than 6 years of age were recruited from randomly selected nurseries and kindergartens throughout Hong Kong. The demographic, early‐life exposures and allergy phenotypes of these preschool children were recorded by validated and modified ISAAC questionnaire. These children underwent incentive spirometry to measure their forced expiratory indices. Their buccal swabs were collected for DNA extraction and tagging single‐nucleotide polymorphisms (SNPs) of CDHR3 were determined by TaqMan genotyping assays. Genotypic and haplotypic associations between these SNPs and wheezing and lung function traits were analyzed by multivariable regression and R‐package haplo.stats 1.7.7, respectively.

**Results:** The mean (SD) age of a total of 1341 children was 4.7 (1.0) years. Forty‐one percent of them had domestic exposure to cigarette smoking, whereas 17% and 11% had wheeze ever and current wheeze respectively. Current wheeze was associated with rs6967330 and rs140154310 of CDHR3, with the respective odds ratios (ORs) being 1.63 and 2.20. These two SNPs were also associated with frequency of wheezing illnesses over the past 12 months, with ORs being 1.57 (*P* = 0.034) for rs6967330 and 2.14 (*P* = 0.024) for rs140154310. Current wheeze was also associated with the 3‐locus GAC haplotype of CDHR3 (OR, 1.54 and *P* = 0.048). Two CDHR3, SNPs rs408223 and rs140154310 were associated with FEV0.5, FVC and FEV0.5/FVC, and the GGG haplotype was associated with FEV0.5.

**Conclusions:** CDHR3 is a candidate gene for wheezing illnesses and forced expiratory indices in Chinese preschool children, which supports the importance of HRV‐C infection in altering the susceptibility for early‐life wheezing. Our findings need to be replicated in prospective studies.

**Funding:** Direct Grant for Research (4054367) of CUHK and Health and Medical Research Fund (17161332).
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**Background:** Poor adherence leads to poor asthma control. Objective monitoring of adherence, however, is often difficult. A simple questionnaire to identify poor adherence and factors that hinder adherence may be useful in clinical practice.

**Methods:** A 53‐item working questionnaire was developed based on concepts obtained through semi‐structured interviews of adolescents with asthma who were treated with inhaled corticosteroids (ICS). The questionnaire was then administered to adolescents (9‐15 years old) with asthma on ICS at multiple hospitals and clinics in Japan. Adherence to ICS medication was separately evaluated by "confidential" questions to ask frequency of "forgetting to take medicine" by nonmedical study staff. The best model to predict adherence was formed by multivariate logistic analysis. Validation of the model was performed using answers to the questions from a separate group of ICS‐treated asthma patients of the same age.

**Results:** Responses from 445 adolescents were used as development data set and those from separate 275 adolescents were used as validation data set. A 6‐item logistic model was selected from the development data set. It showed good statistical fit and well discriminated poor adherence with AUC at 0.814 and 0.759 in development and validation datasets, respectively. Probability of adherence was calculated as propensity score in the logistic regression model and named as the Pediatric Asthma Adherence Questionnaire (PAAQ) score. The PAAQ scores for the physicians' ratings of adherence differed significantly in the hypothetical direction.

**Conclusion:** The PAAQ may be a useful tool to evaluate adherence in adolescents with ICS‐treated asthma.

A‐208. Effect of Long‐term Inhaled Corticosteroid Therapy on Adrenal Suppression Growth and Bone Health in Children with Asthma {#ppul24373-sec-0170}
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**Introduction and Objectives:** Possible adrenal suppression and effects on bone metabolism and growth are concerns of long‐term use of inhaled corticosteroids (ICS) in children. Describing the effect of ICS on the above and Vitamin D levels in children with asthma compared to a control group of asthmatic children who were not on ICS was the primary objective. Effect of the dose and duration of ICS on the above parameters were assessed in the cases as a secondary objective.

**Method:** This was a comparative descriptive cross‐sectional study conducted at the University pediatric unit, Lady Ridgeway Hospital from September 2017 to June 2018. Seventy children agedthree to 9 years diagnosed as having asthma on inhaled corticosteroid therapy for more than 6 months were included as cases. Children who were on oral steroids for exacerbations a week Before the study, asthma with other chronic illnesses and children over 9 years old to avoid the confounding effects of pubertal growth acceleration seen at this age, were excluded. Comparison group consisted of 70 age‐matched children with asthma who were not on ICS.

Heights were assessed according to their Mid Parental Heights (MPH). Serum calcium, alkaline phosphatase and vitamin D levels were assayed in both groups. Low dose short Synacthen test was performed on cases and serum cortisol at 0, 30, 60 minutes of the test was performed to assess HPA axis function. Peak cortisol level \> 500nmol/l at 30 minutes was considered to have passed the test and exclude adrenal suppression. The average daily dose of ICS was categorized as low, medium and high according to published literature.

**Results:** Both the associations between long‐term ICS and growth (chi square value = 0.785, *P* = 0.376) and calcium levels (*P* = 0.88) were not statistically significant. A significant association was found between long‐term inhaled corticosteroid therapy and ALP level (*P* \< 0.01) although the interquartile ranges of serum ALP in both groups were within the normal range for the age.

There was no statistically significant difference in vitamin D levels in both groups (*P* = 0.886), although Vitamin D levels were deficient in 34% of cases and 41% of controls (\< 50 nmol/l). Interestingly suppressed cortisol levels were seen in 24% of cases. Cumulative doses of ICS in 70 cases were low, medium and high in 41%, 41% and 17% of children respectively.

A significant association was found between the dose of inhaled corticosteroid therapy and adrenal suppression (chi square value= 29.80, *P* \< 0.001) and the duration of corticosteroid therapy and adrenal suppression (chi square value= 12.291, *P* \< 0.01).

**Conclusion:** ICS had no impact on the growth and bone profiles in children. However, 25% of children who were on long‐term ICS showed adrenal suppression which was significantly associated with the dose and duration of therapy.
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Pediatrics, University of Jordan ‐ Amman, Jordan

**Objective:** Asthma is caused by complex interactions of genetic and environmental factors. Vitamin D deficiency is being linked to an array of immunologically based diseases, one of which is asthma. The aim of this study is to assess the level of serum vitamin D in children with bronchial asthma and to correlate it with the severity of the condition. Additionally, we aim to determine whether vitamin D deficiency is associated with atopy and allergen sensitization in children with bronchial asthma.

**Methods:** This study included 98 children with bronchial asthma, aged between 4 and 14 years. Serum 25‐hydroxy vitamin‐D levels were determined. Severity of asthma was determined according to the Global Initiative for Asthma (GINA) assessment and the Asthma Control Test (ACT). Skin prick testing for inhaled allergen sensitization was also performed.

**Results:** Our results showed a high prevalence of vitamin D deficiency among asthmatic children. Vitamin D levels were deficient in 41.8% of asthmatic children and insufficient in 34.7%. Only 23.5% had sufficient vitamin D levels. The severity of asthma symptoms showed a significant correlation with vitamin D deficiency. Additionally, children with vitamin D deficiency tended to use more systemic steroids than those with normal vitamin D levels. However, there was no association between vitamin D deficiency and atopy in asthmatic children.

**Conclusion:** Our study clearly demonstrates the importance of verifying vitamin D levels in children with bronchial asthma. This could be a target for modifying treatment modalities and determining new risk factors for asthma development and severity in pediatrics.

A‐221. Drug Use and Quality of Life in Asthmatic Children 1 Year before and after Admittance in an Outpatient Pediatric Asthma Clinic {#ppul24373-sec-0190}
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**Purpose of the study:** To compare quality of life and drug use in asthmatic children before and after their attendance in a specialized asthma clinic.

**Background:** Asthma is the most common chronic condition during childhood. Despite this, asthma is often both overdiagnosed and underdiagnosed resulting in fragmented therapy, deterioration in quality of life as well as increased direct and indirect costs. Since 2014, and due to the financial crisis, the Greek state has introduced e‐prescription as a tool for better control of pharmaceutical prescription and pharmaceutical expenditure. This platform, in which almost all Greek citizens are registered, provides the possibility of a documented assessment of the patient\'s medication use and allows estimations of direct pharmaceutical costs.

**Materials and Methods**: Forty‐six asthmatic children 7 to 14 years old, classified as step 3 or 4 according to GINA guidelines 2018.

Antibiotic, antihistamine and nasal steroid use as well as quality of life (QoL) were measured in asthmatic children admitted to an outpatient pediatric asthma clinic of a tertiary care pediatric hospital, 1 year before and 1 year after.

Quality of life (QoL) was measured with the DISABKIDS Questionnaire, which is a validated questionnaire, completed both by children and their parents. The measures used for the study were the DISABKIDS chronic generic measure (DCGM‐37) and the DISABKIDS Condition‐specific module for asthma. The DISABKIDS chronic generic module (DCGM‐ 37) consists of 37 rating‐scaled items assigned to six dimensions: Independence, Emotion, Social inclusion, Social exclusion, Limitation, and Treatment. These six dimensions can be combined to produce a general score for HRQoL. The condition‐specific asthma questionnaire (DISABKIDS Asthma Module -- 17 questions) consists of two domains: the impact domain, concerning limitations and symptoms, and the worry domain, concerning worries related to asthma. In the study, both DISABKIDS self‐report versions (child version) and proxy versions (completed by one of their parents) were used.

**Results:** Total antibiotic use appeared to have decreased 1 year after follow‐up in a specialized asthma clinic. Both the overall use (p 0.08) and the use of amoxycillin / clavulanate (p 0.01) were statistically significant. The use of amoxycillin, cephalosporins and macrolides was also found to be reduced. A statistically significant reduction was also found in the use of antihistamines (p 0.048). In terms of quality of life, a statistically significant improvement was found in the worry domain of asthma both in children (p 0.012) and their parents (p 0.013) as well as in the impact domain for parents (p 0.05).

**Conclusions:** Antibiotic, antihistamine and nasal steroid use in asthmatic children in need of step 3 or 4 treatment according to GINA guidelines is significantly reduced after attending an asthma clinic. Quality of life is improving.

2. ALLERGIC BRONCHOPULMONARY DISORDERS (EXCLUDING BRONCHIAL ASTHMA) {#ppul24373-sec-0200}
===================================================================

B‐133. Cut‐off Values of Diagnostic Criteria for Allergic Bronchopulmonary Aspergillosis in Asthmatic Children {#ppul24373-sec-0210}
==============================================================================================================

[*Jat K. R*.]{.ul}, Kumari J., Lodha R., Mukherjee A., Saini S., Kumar A., Kabra S. K.

Pediatrics, All India Institute of Medical Sciences ‐ New Delhi, India

**Introduction:** Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity lung disease occurring primarily in patients with asthma and cystic fibrosis. The diagnostic criteria for ABPA have been evolving, although the latter are for adults. There are no separate diagnostic criteria for children. The objective of our study was to evaluate cut‐off values of total IgE, *Aspergillus*‐specific IgE, *Aspergillus*‐specific IgG, and eosinophil count in differentiating ABPA in asthmatic children.

**Methods:** In this prospective cross sectional study, we enrolled consecutive children between 5 to 15 years of age with poorly controlled asthma (partly controlled and uncontrolled as per GINA guidelines) between July 2016 to March 2018. We excluded children with cystic fibrosis. The enrolled children were investigated for ABPA that included total IgE, *Aspergillus*‐specific IgE, *Aspergillus*‐specific IgG, skin prick test for *Aspergillus*, serum precipitins, absolute eosinophil count (AEC), chest X‐ray, and chest CT (in selected patients). ABPA was diagnosed as per recent criteria: if both of the following criteria were fulfilled: (1) total IgE \>  1000 IU/ml and positive skin prick test (SPT) to *Aspergillus* or *Aspergillus*‐specific IgE \> 0.35 kUA/L; (2) at least of two of following three: presence of precipitating antibody or *Aspergillus*‐specific IgG \> 27 mg/L; chest radiology suggestive of ABPA; and total eosinophil count \> 500 cells/mm3. Data were analyzed using STATA 12.0. We used the receiver operating characteristic (ROC) curve along with area under the curve (AUC) to determine the utility of various parameters to differentiate children with ABPA from those without. To determine best cut‐offs, Youden's index was used (sensitivity +  specificity ‐1).

**Results:** We included 106 asthmatic children (male: female 72:34) with mean (SD) age of 10.2±2.6 years. The prevalence of ABPA was 12/106 (11.3%; 95% CI, 5.2%, 17.5%). Among baseline characteristics including spirometry of included children, only the presence of brownish sputum was greater in ABPA children. Among diagnostic criteria, all were significantly different between children with ABPA and without ABPA except *Aspergillus‐*specific IgG and positive SPT. The AUC (95% CI) of ROCs are shown in Figure 1. The difference between AUC of total IgE and *Aspergillus‐*specific IgE vs. *Aspergillus‐*specific IgG was significant. The sensitivity and specificity of total IgE (\>1000 IU/ml), *Aspergillus‐*specific IgE (\> 0.35 kUA/L), AEC (\> 500/ mm3) and *Aspergillus‐*specific IgG (\> 27 mg/L) cut‐offs as defined by diagnostic criteria was 100% and 65.9%, 75.0% and 79.8%, 91.7% and 57.0%, and 27.3% and 87.5% respectively.

The best cut‐off values as per Youde's index of total IgE, *Aspergillus‐*specific IgE, AEC, and *Aspergillus‐*specific IgG were 1806 IU/ml, 0.63 kUA/L, 786/mm3, and 16.8 mg/L, respectively with corresponding sensitivities and specificities of 75% and 76.6%; 75.0% and 88.3%; 83.3% and 74.2%; and 63.4% and 71.5%, respectively.

**Conclusions:** *Aspergillus‐*specific IgE levels had the best discriminative value followed by total IgE, AEC, and *Aspergillus‐*specific IgG for ABPA in asthmatic children. The currently proposed cut‐off values may not be appropriate for children.

Reflections and concrete proposals for action: There is need to develop childhood‐specific diagnostic criteria for ABPA.

3. BRONCHOPULMONARY AND PLEURAL INFECTIONS (INCLUDING TUBERCULOSIS) {#ppul24373-sec-0220}
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**Background:** Various modalities of Noninvasive respiratory support are used for infants and young children who are hospitalized to the intensive care unit with acute bronchiolitis. High Flow Nasal Cannula (HFNC) is one of the new modalities of delivering high concentration oxygen therapy and has been widely used in the last decade.

**Methods:** This is a one‐year retrospective study that was conducted in our pediatric intensive care unit (PICU) comparing the intervention failure rate of three different Noninvasive respiratory support modalities (bi‐level positive airway pressure (BIPAP), continuous positive airway pressure (CPAP) and HFNC) for infants and young children between the ages of 1 month and 2 years admitted with the diagnosis of bronchiolitis. A sample size of 137 patients was collected with a median age of 2 months. Children who required HFNC were older (mean 4.5 months) than children who required BIPAP (2.7 months) while the mean age for children who required CPAP was (2.8 months).

**Results:** HFNC carried a higher failure rate in comparison with the other two respiratory support modalities (50.6% for HFNC n39/77 vs. Zero % for CPAP n0/10% and 8% for BIPAP n4/50, *P* \< 0.01). Among the 39 patients who failed HFNC, (90%) were successfully shifted to BIPAP and weaned off later, while the other 4 were intubated and needed mechanical ventilation. On the other hand, all 4 patients who failed BIPAP were intubated and mechanically ventilated. No difference was found between the three groups in terms of gender or the causative virus. No respiratory complications or mortality was reported in the three groups. In the BIPAP group, oxygen requirement was significantly reduced at 24 hours from the start of the intervention and afterward in comparison with the HFNC group (*P* \< 0.01 ‐ 0.02), although not statistically significant with the CPAP group. No difference was observed in length of PICU stay or hospital stay between the three groups. We did not observe any association between causative virus(es) and the number of ER or pulmonology clinic visits for wheezing or recurrent bronchodilator use after discharge from the hospital.

**Conclusions:** This study highlights the superiority of BIPAP and CPAP over HFNC for acute bronchiolitis patients in PICU. Further prospective randomized trials are recommended to confirm this finding.
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**Objective:** To study human coronavirus (HCOVS) infections in children with community‐acquired pneumonia (CAP) in Zhejiang．

**Methods:** From November 2014 to November 2016, the nasopharyngeal aspirations (NPAS) or throat swabs from children diagnosed with CAP were collected from the Children's Hospital, Zhejiang University School of Medicine. Respiratory specimens were screened for 18 respiratory viruses, including HCOVS (OC43，229E，NL63 and HKU1) by Luminex Liquid Chip Technology．In addition, the epidemiological characteristics, severe pneumonia and complications of children infected with HCOVS were analyzed.

**Results:** A total of 404 cases of CAP children with NPAS or pharyngeal swabs were collected. The total virus detection rate was 52.23% (211/404), while the HCOVS detection rate was 0.5% (2/404). One case was HCOV‐Oc43, and the other was Hcov‐Hku1. Neither of the two children was infected with HCOVS alone, and enteroviruses and rhinoviruses were detected in both cases. The age of onset of HCOV‐positive children in both cases was less than 1 year old, and both cases were severe pneumonia.

**Conclusion:** HCOVS infections are rare in children with CAP in Zhejiang. HCOV S infections can cause severe pneumonia.

C‐130. ARDS in Children with Ventilator‐Associated Pneumonia at Children\'s Hospital Number 1 {#ppul24373-sec-0250}
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[*Le P. T*.]{.ul}, Phung N. T. N.
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**Background:** Ventilator‐associated pneumonia has the highest mortality rate among nosocomial infections. The Pediatric Acute Lung Injury Consensus Conference Group issued new recommendations regarding PARDS (Pediatric Acute Respiratory Distress Syndrome) in 2015. This study describes the characteristics of PARDS in children with ventilator‐associated pneumonia (VAP) in our hospital.

**Aim:** To investigate the features of ARDS in ventilator‐associated pneumonia in pediatric patients from the Intensive Care Unit -- Children\'s Hospital Number 1 from August 2015 to May 2016.

**Study design:** Descriptive, prospective study. (Prospective cross‐sectional study)

**Results:** Sputum specimens from 33 pediatric subjects were collected to determine microorganism agents. The positive rate with culture was 18.2%. The rate of positive PCR samples was 60.6%. For early‐onset VAP, the pathogens consisted of Gram‐positive bacteria (predominantly *Streptococcus pneumoniae*) and atypical bacteria with proportions of 60% and 40%, respectively, while in late‐onset VAP, the bacterial etiology profiling was Gram‐negative bacteria 39.1%, Gram‐positive bacteria 30.4% and atypical 30.5%. All of the children were on pressure control invasive ventilation. Children with mild ARDS accounted for 63%, moderate ARDS 24% and severe ARDS 13%. The mortality rate from this study was 15%.

**Conclusion:** In our study, all of the children were on pressure control ventilation; most had mild or moderate ARDS; there were 13% children with severe ARDS. The mortality rate from this study was 15%.

**Keywords:** ventilator associated pneumonia (VAP), Acute Respiratory Distress Syndrome (ARDS), bacterial pathogen, pediatric.
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We performed real life observations on the etiology of the different viral or bacterial nasopharyngeal infections in children with acute (acute bronchitis and bronchiolitis) and chronic cough (asthma or chronic wet cough) outside of winter epidemic conditions.

**Material and methods:** For a period of 6 months (April‐October 2018), we collected nasopharyngeal and deep throat swabs from 74 children (36 females and 38 males, aged 1.5 -- 11.9 years) divided in 4 groups as follows: 24 children with bronchial asthma (BA), 20 with chronic wet cough (CWC), 24 with bronchiolitis and bronchitis (AB), and 10 healthy children (HC) as a control. All children with BA and CWC were tested during acute exacerbation. The children taking antibiotics Before obtaining the samples, as well as those with X‐ray changes corresponding to pneumonia were excluded. The children with CWC, AB and HC were without any personal or family history for asthma. From the obtained samples, specific microbiological agent detection was performed by culture examination. Additionally, PCR and/or serology for adenovirus, *Bordetella pertussis* and *B. para‐pertussis*, human metapneumovirus (hMPV), influenza virus A and B, adenovirus, rhinovirus (RV), parainfluenza virus, Mycoplasma pneumonia, bocavirus and respiratory syncytial virus (RSV) were performed.

**Results:** None of the children had positive result for Bordetella, Mycoplasma and influenza or parainfluenza virus, perhaps due to excluded cases with pneumonia and the season in which the samples were obtained. In the HC, we did not identify viral pathogens or any bacterial colonization in the throat samples. In 20% of the nasal swabs, *Staphylococcus aureus* was cultured. In 33% of the patients from the AB group, we found only viruses -- RSV, RV and hMPV, while in 25%, we found combined infection with virus and bacteria. Isolated bacteria consisted mainly of *Moraxella catarrhalis* while *Streptococcus pneumoniae* had an equal prevalence of 33% of the children in this group. Only one child had *Staphylococcus aureus*, found in the nose but not in the throat swab. In the BA group, we found virus infection only in 25%, predominantly adenovirus, followed by RV and RSV. In 56% of the cases, *Streptococcus pneumoniae* was confirmed in the throat swabs vs. only 33% for isolated *Moraxella catarrhalis*. There were no other bacteria isolated in the BA group. In the CWC group, we found only in 10% of viral infections mainly hMPV, followed by adenovirus and RV. Fifty percent had isolated *Streptococcus pneumoniae* while the remaining 40% had polymicrobial etiology including *S. aureus, H. influenzae, S. pyogenes, E. aerogenes*.

**Conclusion:** The \"wait and see\" strategy is not advisable for children with CWC since only 10% have isolated viruses and 40% have polymicrobial flora found; thus antibiotics should be given for these children as soon as possible. Outside winter epidemic seasons, *M. catarrhalis* and *S. pneumoniae* (non vaccine serotypes) are still the most prevalent bacteria while RV, RSV and adenoviruses are the predominant viral cough triggers.

**Acknowledgements:** This study was supported by a grant from the Medical University of Sofia (Council of Medical Science, project no. 7770/2017, grant no. 106/2018).
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We analyzed the current etiological profile of pneumonia in children after introduction of the pneumococcal vaccine in Bulgaria.

**Material and methods:** For a period of 3 years (December 2015 ‐ November 2018), we collected the clinical and laboratory data of 285 children (150 females and 135 males, aged 1 -- 17.9 years) which had been hospitalized for pneumonia (confirmed by X‐ray and clinical presentation). We specifically looked for immunization status and co‐morbidities. The laboratory data included -- CRP, full blood count, sputum culture examination, PCR and/or serology for respiratory viruses, Chlamydia and *Mycoplasma*.

**Results:** 105 children had been taking antibiotics Before hospitalization while the remaining 180 patients were antibiotic naïve. In 44.9% of the cases, we could not prove etiological agent, while bacteria were confirmed in 41.6% and viruses in 16.2% (in 4.6%, we found combined virus and bacteria), and fungi were found in 2.5%. When dividing the cases according to prior antibiotic use, the distribution was: 38.8%, 48.3%, 15% and 2.2% for antibiotic naïve vs. 55.23%, 28.5%, 18.9% and 2.8% for the others respectively (*P* = 0.002). When looking at the bacterial isolates and prior antibiotic use, we did not find any significant difference regarding *Mycoplasma pneumoniae* isolation (*P* = 0.36) although there was one for *Streptococcus pneumoniae* (*P* = 0.015), mainly due to the standard guidelines to GPs to start with penicillin antibiotic for pneumonia. As expected *Mycoplasma* was isolated in older children, while *Streptococcus* was mainly isolated in younger patients. Mean age for children with bacterial pneumonia was 6.54 years, for those with viral pneumonia 4.34 years., for combined (viral+bacterial) 3.08 years. and for fungal pneumonia 10.42 years (*P* = 0.000). The values for CRP were lower in cases with *Mycoplasma* and in cases with non‐compact infiltrate changes on X‐rays (*P* = 0.002 and *P* = 0.000). Almost 2/3 of the children have been immunized with pneumococcal vaccine (66%). The immunized patients had higher numbers of viral and lower numbers of bacterial isolates − 25.7% and 37.23% vs. non‐immunized patients − 4.12% and 48.45%, respectively (*P* = 0.002). There was no difference in *Streptococcus pneumoniae* isolation and vaccination status, but there was a major drop in *Mycoplasma* isolates in vaccinated patients (6.9% vs. 32.98%, *P* = 0.000). For the patients with asthma only, we could not identify the microorganism in 14%, while in 48.5% and 51.2%, we found viruses and bacteria, respectively (co‐infection was found in 23.26%). In 50% of children without asthma, we did not isolate the etiological agent and there was co‐infection only in one case, while viral pneumonia and bacterial pneumonia was confirmed in 10.6% and 39.3% respectively (*P* = 0.008). All children but 3 were discharged healthy for mean 6.54 days in hospital stay. The mentioned 3 patients had severe complications and required surgical intervention.

**Conclusion:** In the future, we could expect more viral pneumonia with increasing vaccination coverage and maybe we should reevaluate our treatment guidelines.

**Acknowledgements:** This study was supported by a grant from the Medical University of Sofia (Council of Medical Science, project no. 7771/2017, grant no. 107/2018).
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**Objective:** To compare the need for pediatric critical care in a tertiary children's hospital with a diagnosis of community‐acquired pneumonia (CAP) or hospital‐acquired pneumonia (HAP). Furthermore, we conducted a pilot study to evaluate the possible medical biomarkers which are associated with longer pediatric intensive care unit stay.

**Methods:** An observational, retrospective cohort analysis was conducted in children who were admitted to our tertiary children's hospital with a diagnosis of CAP or HAP. Patient demographics, clinical characteristics, and comorbidity were collected between January 2012 and December 2013. The following prospective pilot study was conducted in children who were admitted to our pediatric intensive care unit (PICU) due to pneumonia progression. We evaluated the clinical profiles and medical biomarkers. The primary endpoint was the duration of PICU stay with associated predicting factors.

**Results:** A total of 548 patients with 598 episodes of pneumonia (310 males; 288 females) requiring admission to our children's hospital were included. The mean age at admission was 59.6 ± 1.95 months and the average length of stay was 11.4 ± 0.70 days. 530 episodes were identified as CAP and the other 68 episodes were HAP. Patients with CAP had significantly shorter lengths of hospital stay and duration of ICU stay than those with HAP (8.2±10.5 vs. 36.5±31.5 days, *P* \< 0.001; 2±6.9 vs. 10±18 days, *P* \< 0.001). The most common co‐morbidities in CAP were neurological diseases and atopy history. Among the CAP patients, 90 episodes (17%) led to ICU admission during treatment course with the most common comorbidities being neurological diseases. However, in HAP patients, cardiovascular diseases were the most common co‐morbidities as well as those (38.2 %) who required PICU care. The overall mortality rate was 3.8%, with the mortality rate being significantly higher in the HAP group (*P* \< 0.001).

The pilot study included 8 children with the diagnosis of pneumonia in PICU from Jan 2015 to Dec 2015. Neither progressive ARDS mobility nor mortality occurred. The mean age at diagnosis was 37.5 ± 30.4 months. The average number of days of PICU stay was 6.9 ± 4.7 days. The median duration of hospital stay was 14 days. Patients were divided into two groups: PICU stay more than 7 days and less than 7days. The values of pro‐BNP, AaDO2, platelets, CRP and CI in patients with PICU stay more than 7 days showed a significant difference with those less than 7 days in the initial PICU admission (*P* \< 0.05). However, the values of thoracic fluid content (TFC) or even TFC corrected by cardiac output were not significantly different between the two groups. The levels of sputum 8‐isoprostane and urinary 8OHdG revealed a trend of decreasing level after disease relief.

**Conclusions:** In this study, we found that (1) HAP resulted in significantly longer lengths of hospital stay and PICU stay than CAP. The possible risk factors for the need of critical care are associated neurological disease in CAP and heart disease in HAP; (2) the possible biomarkers of pro‐BNP, platelet, CRP, CI, 8‐isoprostane and 8OHdG may predict the duration of PICU stay in our pilot study. These results not only help further our understanding of the risk of pneumonia in children who require critical care but also provide chances for better intensive respiratory care.
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**Background:** Pneumonia is a leading cause of respiratory morbidity and mortality in children younger than 5 years of age.^1^ The incidence of severe cases of Community‐Acquired Pneumonia (CAP) in low‐and middle‐income countries is still high.^2^ Although severe CAP can be diagnosed by clinical features and chest X‐ray, it could be useful to measure biomarkers to predict the outcome.

The aim of the study was to determine the association between C‐Reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR), Leukocyte Count (LC), and Neutrophil‐to‐Lymphocyte Ratios (NLR) with outcome of children hospitalized with severe CAP.

**Methods:** Ninety children aged between \> 28 days to \< 5 years hospitalized with diagnosis of severe CAP in the Pediatric Department of West Nusa Tenggara Province General Hospital from January to October 2018 were enrolled. Data on demographic and clinical characteristics, and laboratory examination were recorded. All subjects were treated in accordance with the hospital CAP protocol and prospectively monitored until discharged.

**Results:** Out of 90 subjects, 68% were ages \< 1 year, 59% male, 87% passive smoke exposure, 56% lived in crowded environment, 62% came from low family income, 97% showed infiltrate on chest X‐ray 81% with comorbidity and Fe deficiency anemia was the most common (64%). C‐reactive Protein, ESR, LC, and NLR were not significantly associated with hospital length of stay and duration of oxygen consumption (*P* \> 0.05). After adjustment for CRP, LC, NLR, and age, ESR was found associated with mortality, with every increase in one log of ESR decreasing the log odds of death about 3.3 (*P* = 0.043).

**Conclusion:** Higher ESR was associated with lower risk of death. However, none of the biomarkers were associated with hospital length of stay or duration of oxygen consumption.

**Keywords:** Community‐Acquired Pneumonia, outcome, children, biomarker.
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**Background:** Viral bronchiolitis is one of the leading causes for hospitalization of infants and respiratory syncytial virus (RSV) is associated with the majority of these cases. IFN‐γ is an essential cytokine in the viral cell‐mediated immune response and suppresses the production of Th2‐type cytokines. The present study assessed IFN‐γ expression in RSV infection and whether this profile was influenced by the infants' atopic status, family history of asthma and recurrent wheezing.

**Methods:** Twenty‐seven infants (21 boys and 6 girls), aged 4 to 23 months (average 13 months), hospitalized at the Pediatric Department of the Alexandrovska University Hospital with first or recurrent episode of bronchial obstruction were enrolled in this study.

Detailed history, physical examination, blood sample and nasopharyngeal aspirate (NPA) collection were performed. The viral etiology of the respiratory tract infections was determined using polymerase chain reaction (PCR) and the concentration of IFN‐γ in NPA by ELISA kits.

**Results:** The mean NPA levels of IFN‐γ in RSV (+) infants -- 4.3 (0‐30.1) pg/ml was lower than RSV (‐) infants -- 14.43(0‐49) pg/ml, (*P* = 0.12). A gender difference in IFN‐γ was detected with significant higher values in girls (OR, 1.95; \[CI\] 0.85--4.26; *P* = 0.05). The cytokine ratio did not differ between infants with or without atopic status and family history of asthma. Moderate‐to‐severe bronchiolitis in 7 cases (20%) was associated with lower IFN‐γ level (OR, 0.8; \[CI\] 0.64--1.13; *P* = 0.06), none of them required mechanical ventilation. Decreased IFN‐γ production correlated with the recurrent episodes of wheezing (*P* = 0.05).

**Conclusions:** Our study proves that RSV infection is associated with decreased IFN‐γ responses and their correlation with severity and recurrence of wheezing were the main outcome measures.
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**Abbreviations:** CHW: The Children's Hospital Westmead; CDF: Chest drain and fibrinolytics; VATS: Video‐assisted thoracoscopic surgery; PCV: Pneumococcal conjugate vaccine; PCR: polymerase chain reaction; IQR: interquartile range; PICU: Pediatric Intensive Care Unit; MSSA: Methicillin‐sensitive *Staphylococcus aureus*; MRSA; Methicillin‐resistant *Staphylococcus aureus*; MDR: multidrug resistant.

**Background:** Hospitalization rates for pediatric empyema have increased in the US, UK and Australia despite declining rates of hospital admission for community‐acquired pneumonia. Several RCTs comparing primary interventions (CDF vs. VATS) have shown no difference in clinical outcomes.

**Objectives:** This retrospective cohort study included admitted patients requiring intervention for empyema. Across 2011--2018, admission rates to hospital and intensive care were analyzed for trends in incidence and disease severity. Outcomes were compared between primary CDF and VATS. We compared associations with treatment failure and reintervention following primary CDF.

**Results:** One hundred and ninety‐five patients were included, 176 with primary CDF and 18 with VATS. Rates of hospital and ICU admission increased during the study. We report a difference in chest drain duration (‐68h, 95%CI 14.6h--121.4h, p = 0.01), postoperative length of stay (‐3.9d (95% CI 0.14--7.66, p = 0.05) and reintervention rate (6% vs. 28%, p = 0.04) in favor of VATS. Reintervention following primary CDF was associated with ICU admission (41% vs. 22%, OR 2.4 95% CI 1.2--4.9, p = 0.01), bronchopleural fistula (20% vs. 9%, OR 2.7 95% CI 1.1--6.9, p = 0.04) and persistent fever post‐intervention (10d vs. 5d, p \<0.0001).

**Conclusion**: Rates of empyema needing intervention increased with increasing rates of ICU admission. There were significant differences in clinical outcomes between CDF and VATS, favoring VATS. Reintervention following primary CDF was associated with persisting fever, bronchopleural fistula and ICU admission. Future research to determine how to best select patients for primary VATS is needed to reduce the need for reintervention following primary CDF.
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**Purpose:** Classification and management of congenital cystic lung disease (CCLD) remain unestablished. This study aims to establish the novel classification and management guideline for CCLD.

**Materials and Methods:** In the nationwide survey conducted by the Japan Study Group of Chest Surgery, 874 CCLD patients were identified and involved in the primary study. Of the latter, 428 patients born between 1992 through 2012 and treated at the 10 high‐volume centers (194 prenatally and 234 postnatally diagnosed) were furthermore reviewed with pathological and statistical analysis. Based on these results and the systematic literature review, a revised classification and a treatment guideline for CCLD were drafted.

**Results:** The present classification divides CCLDs into 5 major subtypes according to the embryological background; 1) pulmonary airway malformations including congenital pulmonary airway malformation (CPAM), 2) lung bud malformations including intra‐ and extra‐lobar bronchopulmonary sequestration, 3) foregut malformations including bronchiogenic cyst, 4) bronchial atresia (BA), and 5) the others. Pathological analysis indicated that 37.5% of the BA cases showed CPAM type 2‐like lesions such as microcystic maldevelopment and parenchymal maldevelopment of the pulmonary hyperplasia that should be distinguished from CPAM. Among the patients who were previously diagnosed to have intralobar bronchopulmonary sequestration, a cohort of patients who showed bronchi facing in the opposite direction of the accessory lung bud in the resected lung were excluded from the lung bud malformations. Thus, the eligibility of each subtype was clarified, and the hybrid or combined lesions of the different subtypes were actively excluded in the present classification. In the survey, casually 10%‐15% of the prenatally diagnosed patients seemed to carry a high risk for critical perinatal features such as fatal hydrops and neonatal respiratory distress. The fetal lung lesion volume ratio was significantly higher among these symptomatic patients compared to the asymptomatic patients (2.04±1.71 vs. 0.98±0.50, *P* \< 0.00071). CPAM appeared to be more strongly associated with these critical features compared to other subtypes, when the eligibility of CPAM was properly assessed. Among the asymptomatic neonatal patients, 56.3% developed infectious symptoms before the age of 2 years. The prenatally diagnosed patients acquired significantly higher %VC when operated earlier than those diagnosed postnatally (98.3±11.9 vs. 81.7±9.7, *P* \< 0.0222). Persistent cystic lesion in the lung required further surgical intervention in 4 patients, whereas carcinogenesis was not observed in the series.

**Conclusions:** Based on these observations and the systematic literature review, fetal MRI assessment, an early surgery during the infantile period and avoidance of pneumonectomy were recommended especially in the patients with CPAM in the present guideline.
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**Background:** Laryngomalacia (LM) is the most common cause of stridor and dyspnea in newborn infants. The aim of this study is to determine whether LM types are related to clinical course and which factors are related to higher risk for severe forms of LM.

**Methods:** A retrospective study of pediatric cases in a tertiary referral center was performed from January 2014 to June 2018. Electronic charts were reviewed for patients diagnosed as having LM and a total 201 patients were included.

**Results:** LM occurred predominantly in males (n = 140, 69.7%). The median age at the time of diagnosis was 3.1 months. Type I was the most common morphological type (n = 140, 69.7%), followed by type II (n = 90, 44.8%) and type III (n = 47, 23.4%). The proportions of combined types of LM and synchronous airway lesion were 35.8% (n = 72) and 34.3% (n = 69), respectively. The severity of LM was classified as mild (n = 111), moderate (n = 47), and severe (n = 43). Factors with significant differences according to the severity of LM included inpatient consult, LM type III, combined types of LM, synchronous airway lesion, previous endotracheal intubation, previous surgery, neurological impairment, congenital heart disease, and syndrome/genetic disorders. Among these factors, significant determinants that influence LM severity were finally selected---inpatient consult (odds ratio \[OR\] 3.08, 95% confidential interval \[CI\] 1.57--3.11, *P* = 0.001), neurological impairment (OR, 3.21, 95% CI, 1.43--7.33, *P* = 0.005), LM type III (OR, 2.15, 95% CI, 1.06--4.39, *P* = 0.034), combined types of LM (OR, 3.08, 95% CI, 1.65--5.80, *P* \< 0.001), and synchronous airway lesion (OR, 2.06, 95% CI, 1.08--3.94, *P* = 0.029).

**Conclusions**: In children with LM, it is important to identify its severity. Risk factors for LM severity may be useful for clinicians in establishing management strategies and providing appropriate education for the caregivers.
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**Background:** High‐flow nasal cannula (HFNC) had been shown to have similar efficacy and safety compared to nasal continuous positive airway pressure (nCPAP) as post‐extubation or early noninvasive support for respiratory distress among infants ≥ 28 weeks\' gestational age in a randomized, controlled trial. However, the comparison of gas exchange efficiency and lung protective effect among high amplitude bubble continuous positive airway pressure (BCPAP) and high flow CPAP (mimicking HFNC) treated rats with acute lung injury (ALI) had not been investigated.

**Objectives:** To test the hypothesis that high amplitude BCPAP support after acute lung injury may have different effects on gas exchange efficiency and lung injury protection compared to high flow CPAP (mimicking HFNC) support in rats with ALI.

**Methods:** After normal saline lavage lung injury, all rats initially received high tidal volume mechanical ventilation (9 ml/kg) for 30 minutes, then were randomly divided into three groups: high amplitude BCPAP group using the bubble technique with 135 degrees of expiratory limb (n = 8); standard BCPAP group using the bubble technique with 0 degree of expiratory limb (n = 4); and high flow CPAP (mimicking HFNC) group using the high flow technique (2 L/min, n = 8). All groups were killed 2.5 hours after BCPAP or high flow CPAP (mimicking HFNC) support. Arterial blood gases, respiratory rate, peak inspiratory pressure (PIP) and mean airway pressure (MAP) of rat lung during respiratory support, wet‐to‐dry lung weight ratio, lung homogenate and/or bronchoalveolar lavage fluid tumor necrosis factor‐α, macrophage inflammatory protein‐2, interleukin‐6 and total protein levels were measured and compared among groups after study completion.

**Results:** The high amplitude BCPAP group exhibited a significantly higher PaO2, lower PaCO2 and significantly lower alveolar protein, PIP, MAP, wet‐to‐dry lung weight ratio and cytokine level compared to high flow CPAP (mimicking HFNC) group. High amplitude BCPAP group also exhibited a lower cytokine level compared to the standard BCPAP group. No difference in gas exchange efficiency was observed between the two BCPAP groups.

**Conclusion:** High amplitude BCPAP support decreases lung inflammation, increases gas exchange efficiency and lung compliance compared to high flow CPAP (mimicking HFNC) support in rats with ALI, and may have a better lung protective effect than standard BCPAP.

**Keywords:** bubble continuous positive airway pressure, high‐flow nasal cannula, respiratory support, acute lung injury.
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**Background:** Chylothorax is a condition in which chylous fluid accumulates into the pleural space. The etiologies of chylothorax are various and traumatic or postoperative chylothorax is common. Nontraumatic chylothorax in children is rare and more difficult to treat than traumatic chylothorax. In some cases, they are refractory to conventional treatment, leading to severe morbidity and mortality. Thus, the purpose of this study is to analyze the clinical features of chylothorax in pediatric patients in our hospital and seek appropriate therapeutic management.

**Methods:** A retrospective review was performed in 63 patients with chylothorax from January 2000 to December 2018 in the Children's Hospital of Seoul National University. Traumatic or postoperative chylothorax was excluded. A total of20 patients with nontraumatic chylothorax were included in our study. Etiology, treatment, and outcome of chylothorax were analyzed.

**Results:** Nontraumatic chylothorax was diagnosed in 20 patients. Male patients (14/20 = 70%) were more frequently affected than female (6/20 = 30%) patients. Eighteen patients were diagnosed before 1 year of age (90%), only two patients were diagnosed after 1 year of age (6 years old, 12 years old respectively). The most common cause of spontaneous chylothorax was idiopathic factors, constituting 45.5% (13), three cases were related to high central venous pressure due to venous thrombosis and recurrent sepsis, 2 cases were related to Down syndrome, 1 case was Noonan syndrome, and the remaining case was Gorham stout syndrome. Seventeen patients needed a respiratory support device, 6 of the latter received low flow oxygen supplementation, 11 patients received ventilator support. Dietary modification (NPO or MCT base feeding), conventional medication (somatostatin or octreotide), sirolimus, surgical management were administrated to our patients. In the neonate and infant group, three patients who were related to venous thrombosis died because of recurrent septic shock before chylothorax management was administered. Fifteen patients received a dietary modification (NPO or MCT base feeding) and nine patients improved by conservative management. One patient died due to heart failure before medical treatment. Somatostatin or octreotide was used in 5 patients who failed dietary modification, but only one patient improved with octreotide. Among the somatostatin or octreotide failure group, 4 patients received surgical management (pleurodesis or thoracic duct ligation). Three of these patients improved, although one patient died after thoracic duct ligation operation because of post‐op ARDS. Two patients who were diagnosed after 1‐year of age were refractory to nutritional modification and conventional medication such as somatostatin or octreotide. However, lymphatic intervention and surgical treatment were not suitable for these two patients. Considering that their underlying disorder consisted of Noonan syndrome and Gorham stout syndrome, we used sirolimus to treat the refractory chylothorax. After administration of sirolimus, their chylothorax improved compared to before.

**Conclusions:** Most of the nontraumatic spontaneous chylothorax in pediatric patients occur in newborns and the most common cause of chylothorax in the neonatal and infantile period is idiopathic. On the other hand, nontraumatic chylothorax in childhood is rare and tends more to be accompanied by the underlying syndrome. Moreover, the treatment failure rate is higher in the childhood group. In such cases, sirolimus which is an mTOR inhibitor, can be beneficial to patients who tend to be refractory and cannot be treated with lymphatic intervention or operation.
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**Introduction:** Abnormal lung sounds, especially such as stridor, rhonchi and wheeze, are caused by a narrowed airway. As a nature of children, their airways are narrow, and easily collapsed in various diseases. So we must pay attention when diagnosing children with abnormal lung sounds. Nevertheless, pediatricians often make mistakes in misdiagnosing congenital tracheal stenosis as laryngomalacia or asthma without considering the importance of these symptoms, because these are frequently encountered in daily practice, and most of the patients improve as they grow. It is a serious problem to have the diagnosis of tracheal stenosis delayed because of the pediatrician's confident way of thinking.

**Objective:** To determine the frequency of congenital tracheal stenosis among patients who presented with continuous abnormal sounds on auscultation such as stridor, rhonchi and wheeze in our outpatient department.

**Methods:** We carried out a retrospective study in which we analyzed clinical history, diagnosis and management of 226 patients who had presented with abnormal continuous lung sounds to our institute between October 2008 and October 2018. Abnormal lung sounds were defined as persisting for more than 3 weeks or having been repeated more than once. Diagnoses were made by clinical symptoms and chest X‐ray. Paranasal sinuses and neck X‐rays were taken when physicians judged them necessary. CT scans were performed when tracheal stenosis was suspected, as well as flexible laryngoscopy for almost all of the patients with stridor to confirm whether they had laryngomalacia or not.

**Results:** A total of 226 patients (male: female= 153: 73) were included. The most common symptom was stridor in 104 patients, followed by wheeze/rhonchi in 62 patients, and biphasic abnormal sounds in 58 patients. In 2 patients, classification was impossible from their medical charts. Seventy patients were diagnosed as laryngomalacia, 25 patients with asthma, 18 patients with protracted bacterial bronchitis, and 16 patients with sinobronchitis.

Eleven patients (4.8%) were diagnosed as congenital tracheal stenosis, all of whom were male. Two of them had vascular ring and one had pulmonary artery sling. Patients with Down syndrome, 22q11.2 deletion syndrome, and preterm low birth weight infants were included. All patients with congenital tracheal stenosis presented with biphasic abnormal sounds. The median age at diagnosis was 12 months (1 month to 5 years). The median delay between the onset of symptoms and diagnosis was 7 months (1 to 48 months). Seven of 11 cases were repeatedly treated as asthma before diagnosis. All patients were carefully managed especially to prevent respiratory tract infections after diagnosis, and only one patient needed mechanical ventilation for a short period when he suffered from bronchitis. Surgery for vascular rings was performed in 1 of 2 patients. None had undergone tracheoplasty.

**Discussion:** Congenital tracheal stenosis is not a rare disease among patients with abnormal lung sounds. Prolonged and recurrent respiratory complaints in infancy or childhood should alert the pediatricians to the possibility of tracheal stenosis.
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**Purpose:** Specific genetic causes for childhood interstitial lung disease (chILD) in immunocompetent patients have been identified within the past decade. However, little is known about the pathogenesis of many forms of chILD, and treatment approach has not been standardized. A national survey was carried out by the Japanese Society of Pediatric Pulmonology (JSPP) To identify the histopathology and response to current treatment, especially hydroxychloroquine, which is contraindicated for children younger than 6 years old in Japan.

**Methods:** A questionnaire was sent to pediatricians who registered a chILD patient to the JSPP. We conducted the survey over a period of 9 years, between 2010 and 2018. Children (0‐15 years) were included in the survey with persistent hypoxemia (PaO2 less than 60 torr or SpO2 less than 90%) for more than 2 weeks, diffuse infiltrates on CT scanning, and elevated serum markers such as KL‐6, Sp‐A, or Sp‐D. Immunodeficiency and other diseases which present with similar symptoms to chILD were excluded. The questionnaire included information on the patients' clinical symptoms, family history, pathological histology, clinical genetic findings, treatments and clinical outcomes. Informed consent was obtained by all patients' guardians before participating in the survey.

**Results:** Twenty‐six cases were identified, including 15 males and 11 females. Age of onset was between 0 months and 8 years. Fourteen (53%) cases presented in the first year of life. Lung biopsy was performed in 11 (42%) cases. Five cases showed changes of nonspecific interstitial pneumonia (NSIP), 1 case with desquamative interstitial pneumonia (DIP), 1 case with cryptogenic organizing pneumonia (COP), 1 case with usual interstitial pneumonia (UIP), 1 case with acute lung injury (ALI), and 2 cases untagged. Genetic testing was performed in 21 (80%) cases. Mutation in Sp‐C gene (SFTPC) was detected in 8 cases, ATP binding cassette subfamily A member 3 (ABCA3) in 1 case, NK2 homeobox 1 (NKX2‐1) in 1 case, coatomer associated protein subunit alpha (COPα) in 1 case, and no mutation was detected in 10 cases. In the first half of the study period, only 5 out of 16 (31%) cases were diagnosed with genetic testing without lung biopsy, which increased to 8 out of 10 (80%) cases in the latter half. Prednisolone was used in 24 (92%) cases and hydroxychloroquine in 20 (76%) cases with no onset of retinopathy. Conventional treatment with prednisolone or hydroxychloroquine, monotherapy or in combination, resulted in a good response in 17 (65%) cases. Three (11%) children died despite all therapies. In addition, it turned out that 1 case was diagnosed as juvenile idiopathic arthritis 4 years after registration.

**Conclusions:** This is the first nationwide prospective study regarding chILD in Japan. The histopathology in this study is similar to that reported previously. There is increasing emphasis on genetic studies in the diagnosis of chILD as it can help avoid unnecessary lung biopsy. Corticosteroid and hydroxychloroquine were the main therapeutic agents in our study. Hydroxychloroquine therapy was tolerated in many cases, with no significant side effects.
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**Background:** Bronchiolitis obliterans syndrome (BOS) is a life‐threatening respiratory complication of allogeneic hematopoietic cell transplantion. Even though the lung function test is crucial in the diagnosis and monitoring of BOS, there is little information on the association of the change in lung function with prognosis in children with BOS.

**Methods:** Twenty three children aged 11.8±4.9 years with BOS after allogeneic hematopoietic cell transplantation were enrolled, and their clinical data were reviewed retrospectively. All subjects repeated the pulmonary function test at an interval of 1 month after occurrence of BOS.

**Results:** Among 23 subjects with BOS, 6 (25.0%) subjects expired due to respiratory failure, 4 (17.4%) subjects underwent lung transplantation, and 16 (69.6%) subjects needed O2 therapy. The mean value of FEV1% predicted at the diagnosis of BOS was 37.0±13.0%, and it rose after 12 months (47.0±24.9%). FEV1 % predicted at diagnosis of BOS tended to be lower in subjects with oxygen therapy (34.7±12.2) than in subjects without oxygen therapy (45.8±11.1), \[YJ1\] although there was no statistical significance. The changes in FEV1 % predicted at 3 months after BOS diagnosis were significantly lower in the subjects with oxygen therapy (‐19.4±24.3%) than in subjects without oxygen therapy (8.6±21.9%). However, there was no significant difference in the change over 3 months of FEV1% predicted values between the two groups at 6, 9, and 12 months. In addition, the group with a negative slope of FEV1% predicted change during the first 3 months had a higher likelihood of O2 therapy, compared to the group with a positive slope of FEV1 change during the period (HR of 3.57, *P* = 0.059).

**Conclusion:** The change in FEV1 during the first 3 months after BOS was significantly different between the subjects with and without oxygen therapy. These results suggest active intervention strategy is needed during the first 3 months after BOS To improve the prognosis.
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**Background:** Lung transplantation is the final treatment modality for end‐stage lung disease and the survival rate has recently improved. Korea is a latecomer in lung transplantation, but the number of cases is gradually increasing since the first lung transplantation in a child was performed in 2011.

**Methods:** We retrospectively evaluated the outcomes and survival rate of children between the ages of 0 and 18 years who received a lung transplant at the Asan Medical Center between August 2011 and December 2018. A total of 14 children underwent lung transplantation.

**Results:** The mean age of the lung transplant recipients was 11.1±5.2 years (1.7‐18.6 years), and 7 were male and 7 were female among the 14 children. Nine children underwent bilateral whole lung transplantation, 4 underwent bilateral lobar lung transplantation, 1 underwent right lobar lung and left whole lung transplantation, and there was one patient who received heart‐lung transplantation. The reasons for lung transplantation were bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation (HSCT) (5 of 14 patients, 35.7%), chemotherapy induced lung injury (2 of 14, 22.0%), cystic fibrosis (2 of 14, 14.3%), primary pulmonary hypertension (1 of 14, 7.1%), interstitial lung disease after HSCT (1 of 14, 7.1%), lung injury induced by humidifier disinfectant (1 of 14, 7.1%), bronchopulmonary dysplasia (1 of 14, 7.1%), and pulmonary alveolar proteinosis (1 of 14, 7.1%). Most patients received intensive care (9 of 14, 64.3%) including extracorporeal life support (6 of 14, 42.9%) before lung transplantation. Among the 14 children, only 2 patients died (14.3%), 1 patient died of fungal infection and 1 patient died of postoperative bleeding. The mean observation period was 2.0±2.4 years. The one‐year survival rate was 87.5% (7/8). Among the complications after lung transplantation, there were 3 cases of changing the immunosuppressants due to adverse drug reactions, and 2 cases of diaphragm palsy. In addition, polyneuropathy, fungal infection, postoperative bleeding, right pulmonary vein stenosis and sepsis each occurred in one case.

**Conclusion:** In Korea, pulmonary complication after HSCT was the main cause of lung transplantation, unlike other countries. Although the follow‐up period is not sufficient to evaluate late outcome of lung transplantation, early outcome of lung transplantation in Korea was comparable to the results from the International Society for Heart and Lung Transplantation. Lung transplantation can be an accepted treatment option for end stage lung disease in Korean children.
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**Introduction:** Non‐cystic fibrosis bronchiectasis is a major contributor to the chronic respiratory morbidity in both developed and developing countries. Failure to expectorate mucus resulting in progressive airway damage is the hallmark of bronchiectasis which stresses the importance of airway clearance as the key step in its management. Multiple airway clearance techniques have been introduced although research in children is limited. Pre‐medication with Hypertonic Saline (HS) nebulizations before airway clearance is an established method in managing bronchiectasis in cystic fibrosis (CF) and non‐CF bronchiectasis in adults. This study is aimed to assess the effectiveness of HS nebulizations Before physiotherapy over conventional physiotherapy in children with non‐CF bronchiectasis.

**Objectives:** Primarily to compare the change in FEV1 from pretreatment phase to posttreatment phase between the two groups.

Secondarily to compare improvements in FVC, FEV1/FVC ratio, PEFR, MEF25‐75 and the frequency of exacerbations between the two groups.

**Design and Methods:** Ethical clearance, clinical trial registration (SLCTR/ 2018/010) and parental and assent consents were obtained Before the study. This was an RCT conducted at the Lady Ridgeway Hospital for children, Colombo from February to December 2018. All children aged 5 to 15 years diagnosed to have non‐cystic fibrosis bronchiectasis were included. CF was excluded with two negative sweat tests. Chronic colonization of *Pseudomonas*, children who do not comply with physiotherapy, follow‐up plan or spirometry, and presence of typical extra pulmonary features of CF were excluded.

Computer‐generated variable blocked randomization was performed for the two groups after a baseline spirometry. The test arm received 200 µg of inhaled salbutamol followed by hypertonic saline nebulizations Before chest physiotherapy twice daily for 8 weeks. Control arm received all except HS nebulization. Parents were adequately trained on the usage of inhaled medication, home nebulizations and technique of chest physiotherapy. Spirometric parameters and number of exacerbations after 8 weeks of therapy were documented. Data was processed with Microsoft Excel, independent t test and the Mann‐Whitney U test where statistical significance was taken as p value less than 0.05.

**Results:** Sixty‐five children were primarily enrolled. (34 in HS group, 31 in conventional group). Mean ages of HS and conventional arms were 9.6 years. (SD 3.4) and 8.8 years. (SD 3.5) respectively. Percentage of predicted FEV1 of the HS and conventional arms were 61 (23) and 63(25) respectively. The mean improvement in predicted FEV1 was significantly higher (*P* = 0.002) in the HS arm 15.5(3.7) than conventional arm 4.5(8.9). The HS group showed a higher mean improvement in predicted FVC 18(5.9) compared to (*P* \< 0.012) the conventional group 7.1 (5.7) and significant growth (*P* = 0.001) of PEFR was demonstrated in HS 15.3(7.4) compared the conventional group 5.2(6.2). Mean improvement in predicted MEF 25 to 75 was significantly higher (*P* \< 0.001) in test arm compared to the control arm, however FEV1/FVC ratio was comparable. Number of exacerbations were comparatively lower (*P* = 0.005) in the test arm 0.3(0.51) than the control arm 1.5(0.76).

**Conclusions:** Hypertonic saline nebulization is an effective strategy to improve airway clearance as it improves dynamic lung volume including FEV1 and FVC and improves PEFR and MEF75‐25 significantly.
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**Objective:** To investigate the short‐term outcome in extremely preterm infants who underwent the automated control of inspired oxygen concentration with CPAP.

**Method:** We performed a retrospective cohort study of extremely preterm infants born before 28 weeks of gestational age in our NICU. Study subjects were divided into two groups: AUTO group who underwent the automated control of inspired oxygen concentration (AUTO) with CPAP, and MANUAL group who underwent manual control of inspired oxygen concentration (MANUAL) with CPAP before introduction of AUTO in our NICU. We retrospectively investigated the patient characteristics and short‐term outcome related to the respiratory system (reintubation rate, duration of CPAP, introduction rate of home oxygen therapy) and retinopathy of prematurity (incidence, stage, and therapy rate). the Mann‐Whitney U test and Chi‐squared test were used for statistical analysis, and logistic regression was used for multivariable analysis.

**Result:** A total of 47 infants were eligible for this study. There were 25 and 22 infants in the AUTO group and MANUAL groups, respectively. In the AUTO and MANUAL groups, the median (range) of their gestational age in weeks was 25.1 (23.3‐27.9) and 25.5 (23.7‐27.9, *P* = 0.25), birth weight in grams was 690 (461‐990) and 789 (442‐1178, *P* = 0.02), the rate of maternal steroid administration was 73% and 36% (*P* = 0.01), age at study entry in days was 2 (54‐48) and 31 (2‐67, *P* = 0.31). Reintubation rate was 56% and 50% (*P* = 0.68), duration of CPAP (day) was 28 (6‐62) and 26 (3‐38, *P* = 0.29), and introduction rate of home oxygen therapy was 20% and 27% (*P* = 0.56). The incidence of total retinopathy of prematurity (ROP) was 64% and 77% (*P* = 0.32), the incidence of ROP over stage Ⅱ was 24% and 59% (*P* = 0.02), and therapy rate for ROP was 8% and 14% (*P* = 0.53) in each group. There was a statistically significant association between the decreasing risk of ROP over stage Ⅱ and use of AUTO by multivariable analysis adjusted for confounding factors (odds ratio: 0.22 \[95% CI: 0.06‐0.76\], *P* = 0.02).

**Discussion:** In this study, the incidence of ROP over stage Ⅱ was significantly decreased in extremely preterm infants who underwent AUTO with CPAP. It is suggested that exposure to the excessive oxygen levels and the fluctuation of oxygenation are related to the incidence of ROP. Large studies indicate the strict SpO2 target range. But in fact, the manual control of inspired oxygen concentration during respiratory support is not sufficient for the maintenance of SpO2 within the latter. AUTO can maintain SpO2 within the target range compared to the manual control of inspired oxygen concentration. AUTO has the potential to prevent ROP by decreasing the exposure to excessive oxygen levels and the fluctuation of oxygenation. Several limitations should be considered in our study. This was a retrospective, single‐centered, non‐randomized study; a further multi‐centered prospective study is needed.

**Conclusion:** The automated control of inspired oxygen concentration might help to reduce the severity of ROP in extremely preterm infants.
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**Introduction:** The lung function of children born as very low birthweight (VLBW) prematures was examined in several studies. Since their pulmonary function is decreased, lower respiratory tract infections in this population may have a more severe clinical course. In our study, in addition to lung function measurement, we also wanted to see whether there is a connection between mental abilities and pulmonary function.

**Methods:** Before the examination, a license was obtained from the ethical committee of the University of Szeged. The parents of each participant signed a written consent. We examined 52 children (age: 7.3 ± 1.2 years, mean ± standard deviation) who were treated during their neonatal age in our NICU as VLBW prematures. For the lung function tests, a Piston PDD‐301s spirometer was applied. The results of the patients were compared to the ERS/ATS statement conformed database of the spirometer, in accordance with their weight, height and age and were expressed as a percent of the expected value. On the same day, the patients performed a Raven progressive matrix test. Four patients could not produce an evaluable pulmonary function test. We compared the lung function tests of the 21 patients with the best cognitive function test performers (Group 1, Raven 1‐2 = 75 ‐\> 95 percentile) with the 16 worst performers (Group 2, Raven 4‐5, in one case 7 = 10‐50 percentile and \< 5 percentile in one case). Patients who fulfilled the criteria of bronchopulmonary dysplasia (BPD: need of supplemental oxygen for ≥ 28 days; 18 cases) were compared to patients without BPD (28 cases). Groups were compared with Student unpaired t‐test.

**Results:** In the examined population, we found the following percentage values: FEV1 90.8 ± 17.3%, FVC 86.5 ± 23.2%, FEF25‐75% 79.7 ± 25.4%, MEF50% 85.7 ± 27.3%. There was no significant difference whether between the lung function test parameters or between the age and body size values or of the two groups. When we compared patients with and without BPD, there were lower, albeit not significantly different values regarding the expired volumes in favor of the non‐BPD cases (FEV1, FVC), while there were significantly lower expiratory flows in the case of the patients with BPD. There was no significant difference between the Raven test results of the BPD and non‐BPD patients.

**Conclusions:** We could also detect in our smaller population that VLBW patients at the age of 6 to 8 years have lung function test values in the lower normal region of the reference range. This may raise the presumption of the higher susceptibility of these children to respiratory tract diseases also in the later decades of life. BPD patients have lower pulmonary function test results than non‐BPD patients. On the other hand, we could not find any connection between low Raven test performance and lung function results.
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**Background:** Esophageal atresia (EA) and/or tracheoesophageal fistula (TEF) is one of the rare congenital anomalies occurring in 1 out of 3,000‐5,000 births. There has been improvement in the survival of these infants during recent decades. The diagnosis of TEF with EA is commonly made during the first 24 hours after birth. Preoperative flexible endoscopy (FE) is not yet routinely included in the diagnostic and postoperative assessment. This study aimed to evaluate the predictive factors that affected patients' prognosis and the role of flexible endoscopy application in managing infants with EA and/or TEF in a tertiary medical center.

**Methods:** We enrolled patients who were admitted into our hospital due to suspected EA and/or TEF and accepted an FE examination for one or more times between Jan. 2000 and Dec. 2017. All associated medical and surgical records were retrospectively reviewed. The analyzed data included basic characteristics, diagnosis, age of surgical repair, associated anomaly, timing of FE before and after surgical repair, and mortality. Factors related to patient's mortality were analyzed.

**Results:** A total of 33 patients were enrolled, including 28 (84.8 %) cases referred from other hospitals. Their mean birth weight was 2448 ± 603 gm, including 19 (57.6%) low‐birth‐weight infants, 17 (51.5%) cases with cardiac anomalies, 12 (36.4%) cases aged \> 90 days, and 12 (36.4%) cases underwent FE before reconstruction. The most common classification of enrolled cases was type C (84.8%). Additional other airway anomalies were found in 23 (69.7%) cases, including tracheomalacia, bronchostenosis, lung hypoplasia, and laryngeal cleft. One case underwent nasal‐tracheo‐fistula‐gastric catheter insertion before surgery. The mean age of receiving surgical reconstruction was 5 ± 7 days. The most common postsurgical complication was anastomotic stenosis (25, 75.8%) that required laser therapy (9, 27.3%), balloon dilatation (17, 51.5%), or stent implantation (2, 6.1%). Gastroesophageal reflux was also commonly found in 21 (63.6%) cases. The overall 2‐year survival rate was 72.7% (27/33). Significant factors related to 1‐year mortality were post‐reconstruction referral (*P* = 0.004), age of reconstruction \> 7 days (*P* \< 0.001), and cardiovascular surgery requirement (*P* = 0.032).

**Conclusions:** In infants with EA and/or TEF, FE is feasible for the early identification of associated airway and esophageal anomaly, as well as postoperative diagnosis and therapeutic interventions. Post‐reconstruction referral, age of reconstruction \> 7 days, and cardiovascular surgery requirement were significantly related to 1‐year mortality of infants with EA and/or TEF.
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**Background:** Patent ductus arteriosus (PDA) is a common cardiovascular complication among premature infants and may be responsible for prematurity‐related complications. Surgical ligation is considered when medical treatment has either failed or was contraindicated. Transcatheter occlusion, which was established in term infants, has recently been applied to premature population. Previous reports stated that the complication and success rates were not statistically different between the transcatheter technique and surgical ligation. In this study, our aim was to compare the oxygenation status and oxygen dependence between these two techniques.

**Method:** We performed a retrospective study of infants born with birth body weight less than 1800gm and admitted to the National Cheng Kung University Hospital from September 2014 to June 2018. Infants with hemodynamically significant PDA and were either contraindicated to or had failed medical therapy were included. We identified 30 patients and divided the latter into the transcatheter group (Group A, N = 13) and surgical ligation group (Group B, N = 17). The basic demographic data, FiO2 change, pulmonary score, intubation days, ventilator‐dependent days, oxygen‐dependent days and mortality within 1 year were evaluated.

**Results:** The birth body weight, gestational age, post‐menstrual age on procedure day, body weight on procedure day, pulmonary score and FiO2 before procedure were not different between these two groups. The range of body weight on procedure day was from 478 to 1602gm in group A and from 551 to 1646gm in group B. The overall mortality within 1 year was similar (*P* = 0.360). The overall incidence of chronic lung disease was not significantly different (2/10 vs. 8/16, *P* = 0.218). When comparing the FiO2 change before and 5 days after the procedure, the transcatheter closure group had a significant improvement in FiO2 compared with the surgical ligation group on post‐procedural day1 (‐9.23±23.12 vs. 5.82±14.80, *P* = 0.039), day3 (‐10.58±23.25 vs. 5.88±12.47, *P* = 0.020) and day5 (‐15.08±27.208 vs. 3.41±10.869, *P* = 0.043). The oxygen‐dependent days (*P* = 0.053) were not significantly different. In subgroup analysis, very low birth weight (VLBW) infants also had more FiO2 reduction in the first 5 days after procedure (*P* = 0.044). Compared with the surgical ligation group, the decline in pulmonary score was significantly greater in the transcatheter group (‐0.50±0.7 vs. 0.08±0.29, *P* = 0.018).

**Conclusion:** Compared with surgical ligation, transcatheter occlusion of PDA can reduce FiO2 during post procedure day 1 to day 5 for infants with BBW\< 1800gm. The decline in pulmonary score is greater in the transcatheter group. There is a trend of less oxygen‐dependent days in the transcatheter treatment group. Further study is necessary to confirm the effect on lung functions.
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**Introduction:** Congenital pulmonary airway malformations (CPAM) are rare disorders of which the incidence is not precisely known. This malformation might threaten the fetus, but it can also disappear spontaneously, or neonates can be asymptomatic with the malformation. According to previous studies, CPAM may increase the risk for lung infections and lung malignancies, which is also the argument used when treating asymptomatic CPAM‐patients with surgery.

Purpose of the study: The purpose of the present study was to investigate whether there are differences between the treatment protocols between Nordic countries.

**Material and methods:** A questionnaire was sent to 16 Nordic centers dealing with pre‐ and postnatal management of patients with congenital lung malformation. This questionnaire was aimed to collect information on pre‐ and postnatal treatment protocols in the centers involved.

**Results:** The treatment protocols of this malformation vary largely in Nordic centers. Prenatal ultrasound was the primary examination in all centers. Magnetic Resonance Imaging (MRI) was used routinely as next prenatal examination in four centers for every CPAM‐patient with persistent finding in ultrasound during whole pregnancy (4 of 11). Five centers (5 of 11) used MRI if needed for differential diagnosis. Various prenatal interventions were used in cases of fetal hydrops caused by CPAM. Shunting macrocystic lesion was used in 4 out of 11 centers, maternal cortisone in 9 out of 11. Over half of the centers (7/11) consulted and co‐operated with centers that performed fetal surgery and 3 out of 11 did consider ex utero intrapartum (EXIT) surgery.

Postnatally surgery was performed in every center (100%) for symptomatic CPAM‐patients. One center (14%) did not remove CPAM but instead performed follow‐up on asymptomatic patients. Two centers (29%) performed mini‐invasive surgery. The number of postoperative controls varied fromone to three visits. As immediate postoperative complication, two centers (29%) reported prolonged air leak, which sometimes required reoperation. In our survey, we also asked if there was morbidity among the patients who were chosen for follow‐up only. Two centers (29%) reported sequelae, one center reported infections and one center had removed pulmonary neoplasm, which had originated from CPAM.

**Conclusion:** According to the present study, treatment protocols vary both for prenatal and postnatal management between the centers. To be able to optimize the management of CPAM, evidence‐based treatment protocols are needed.
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**Background:** High‐flow nasal cannulas (HFNCs) are shown to transmit a continuous positive distending pressure to the infant's upper airway. A strong association reportedly exists between the pharyngeal pressure, measured as a substitute for the continuous positive airway pressure, and flow rate of HFNC. However, the influence of the differences in the devices and the cannulas used for HFNC on pharyngeal pressure has not been well verified. This study aimed to assess the pharyngeal pressure exerted by two commonly used HFNC devices: Optiflow junior and Precision flow in preterm infants.

**Method:** Pharyngeal pressure was measured in 12 preterm infants receiving respiratory support with HFNC using the Optiflow junior or Precision flow at the neonatal intensive care unit of the Kurashiki Central Hospital and the Kakogawa Central City Hospital from 2016 to 2017. The flow rate gradually increased from 1 L/kg/min to 4 L/kg/min (maximal flow rate of 8 L/min), and the pharyngeal pressure was measured over 1 minute at each flow rate in a resting state with active mouth closure. The mean pharyngeal pressure value for 1 minute was defined as the pharyngeal pressure at that flow rate.

**Result:** The median gestational age of the subjects was 28 weeks (range 24--29 weeks), and the median birth weight was 959 g (range 438--1602 g). At the time of measurement, the median corrected gestational age was 34.8 weeks (range 31.0--36.9), and the median weight was 1290 g (range 953--1932 g). Eight infants used the Optiflow junior: four used premature size cannula (tip OD2.4 mm), and the remaining four used neonatal size cannula (tip OD 2.8 mm). Four infants used Precision flow: three used single prong cannula (tip OD1.9 mm), and the remaining infant used double prong, infant cannula (tip OD1.9 mm). Pharyngeal pressure tended to rise to flow rate dependence with any type of cannula. In patients managed with the Optiflow junior, the mean pharyngeal pressure at the flow rates of 1, 2, 3, and 4 L/kg/min for premature size cannula were 2.3, 3.0, 3.1, and 3.6 cmH2O, respectively, and for neonatal size cannula were 0.5, 1.9, 3.0, and 3.7 cmH2O, respectively. In patients managed with Precision flow, the mean pharyngeal pressure for each cannula at flow rates of 1, 2, 3, and 4 L/kg/min for single prong cannula were 1.8, 3.9, 4.7, and 5.0 cmH2O, respectively, and for double prong, infant size cannula were 2.6, 5.7, 6.0, and 7.0 cmH2O, respectively.

**Conclusion:** When using the same flow rate, the pharyngeal pressure provided by each device and cannula was different in the preterm infants. With Optiflow junior, the maximum pharyngeal pressure provided by any cannula was \< 4 cmH2O; however, with Precision flow, it was ≧ 7 cmH2O. The structure of the dedicated circuit of each device and the outer diameter of the tip of the cannula may have affected the pharyngeal pressure.
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**Background:** Cystic fibrosis (CF) is an inherited multisystem disorder which causes exocrine pancreatic insufficiency in early life and severe chronic lung disease in children. While being the most common life‐limiting recessive genetic trait among Caucasian populations, frequency of CF is reported to be approximately 1 in 350,000 live births in Japan, making the clinical features unclear and causing delays in diagnosis. The purpose of this study was to describe the clinical features of CF cases in Japan.

**Methods:** We conducted a complete literature review of CF case reports in Japan between 1994 and 2015. Patients who did not meet the domestic diagnostic criteria or the report which did not contain sufficient data were excluded from the study. We investigated clinical features of 53 patients described in 44 case reports, including one patient of our own.

**Results:** Among the 53 patients, 27 were male and 26 were female. 45 were Japanese and 7 had a foreign nationality. Four cases had consanguineous‐marriage parents. The mean birth week was 37.6 weeks (±3.6 weeks) and the average birth weight was 2,843g (±701g). The median age of diagnosis was 2.1 years (0 to 43 years). At the time of diagnosis, the mean weight and height were ‐3.0 ± 2.0 SD and ‐2.0 ± 0.9 SD, respectively. The most common symptom seen at the time of diagnosis was meconium ileus during the neonatal period (100%), failure to thrive during infancy (63%), and chronic respiratory symptoms among older generations (97%). Other features frequently seen were airway colonization by *Pseudomonas aeruginosa* (85%), airway colonization by *Staphylococcus aureus* (33%), hyponatremia or hypochloridemia (31%), and alkalosis (27%). A few cases had renin‐angiotensin‐aldosterone system activation, fecal ileus, insulin‐dependent diabetes mellitus. Six cases required continuous home oxygen therapy, 2 of which eventually underwent lung transplantation. Liver transplantation was performed in one of 6 cases with liver cirrhosis. Responsible gene mutation, cystic fibrosis transmembrane conductance regulator (CFTR) mutation, was identified in 32 cases. Among 50 abnormal alleles, 36 alleles were identified in previous reports, but 14 alleles had never been described.

**Conclusion:** Classic symptoms of CF are often seen in Japan because of the delay in diagnosis. The delay contributes to the poor weight gain of the patients at the moment of presentation. While clinical characteristics were similar to those of Caucasian populations, genotypes were somewhat different from other populations. Some patients had a completely new mutation whose pathogenesis is not proven. This might suggest difficulty of genetic diagnosis which is commonly done in other countries as a screening test in the early stage of one's life. CF should be kept in mind as a differential diagnosis for children with meconium ileus, poor weight gain, or chronic respiratory problems To diagnose early in Japan.
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**Background:** The impact of separating the adult from pediatric patients on *P. aeruginosa* detection in the respiratory cultures of patients was examined at the University of Minnesota CF Center.

**Methods:** This study was a retrospective review using data recorded in the University of Minnesota CF Database between 1995 and 2010. Respiratory culture results obtained during routine CF clinic encounters of two cohorts of pediatric and adult CF patients (pre‐ and post‐separation) were analyzed for presence of *P. aeruginosa*.

**Results:** The odds of a pediatric patient having *P. aeruginosa* were significantly less if the first culture was obtained after separation of pediatric and adult clinics. Being diagnosed by newborn screening or introduction of inhaled tobramycin did not affect this outcome. This reduction in *P. aeruginosa* was not detected in the adult cohort.

**Conclusions:** Separation of pediatric and adult CF clinics has contributed to a decrease in *P. aeruginosa* prevalence in pediatric patients.
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We live in a decade of rapidly changing and ever increasing methods for both diagnosis and treatment of children and adults with CF. In particular, the development and implementation of the so‐called intestinal organoid ("mini gut") methodology has since 10 years shown to enable personalized functional diagnosis of the basic defect in the surface cells of CF patients, also discriminating between the more severe and milder function abnormalities (related to the different mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). And probably even more important, this enables the investigation of individual applicability of and responses to all the recently developed new medications, the so‐called CFTR modulator therapy. This has made possible the important change from symptomatic treatment to preventive treatment leading to prevailed lung function and increased survival of CF patients. In this lecture, all of these important developments will be shortly addressed. At the end, the audience will be updated in conformity with 2019 standards!

F‐158. Agreement between Two Concomitant Sweat Conductivity Tests {#ppul24373-sec-0540}
=================================================================

[*Camargos P*.]{.ul} ^1^, Nolasco D.^2^, Sader O.^1^, Bedran R. M.^1^, Alvim C. G.^1^, Alves Junior J. V.^3^, Pereira F. H.^3^

^1^Pediatric Pulmonology Unit, University Hospital, Federal University of Minas Gerais ‐ Belo Horizonte, Brazil; ^2^Diagnosis Support Action and Research Center, Medical School, Federal University of Minas Gerais ‐ Belo Horizonte, Brazil; ^3^Center for Newborn Screening and Genetic Diagnosis (NUPAD), Medical School ‐ Federal University of Minas Gerais, Brazil

**Background:** Even though it is considered as a screening test, sweat conductivity (SC) analysis seems to be an alternative diagnostic method to the coulometric quantitative test (CQT) for the diagnosis of Cystic Fibrosis (CF). It is widely accepted that coulometry requires specialized technicians, in addition to being performed only in referral centers. On the other hand, SC sweat analysis is a semi‐automated procedure, simpler and faster than the conventional CQT. Specially in poor‐resource settings, it allows the decentralization of the diagnostic network and, consequently, a wider accessibility to CF diagnosis. To date, there are no studies comparing two concomitant conductivity tests performed in the same patient.

**Objective:** to assess the agreement between two sweat conductivity results performed concomitantly in young infants.

**Methods:** This was a prospective, cross‐sectional study in which two sweat samples were obtained from the two arms among 100 consecutive patients, using the Wescor Macroduct collection system (Wescor, USA). Conductivity analysis was performed through the Sweat Conductivity Analyzer (Wescor, USA). To test the intra‐individual variability, the Cohen\'s kappa coefficient was applied. Statistical analyses were performed through SPSS version 18.0 (SPSS Inc., USA). Conductivity tests were classified according to the reference values recommended by the manufacturer, i.e., positive (above 80 mmol/L), borderline (60‐80 mmol/L), and negative (less than 60 mmol/L).

**Results:** The age of the participants ranged from 23 to 89 days, with a mean age of 48.5 days of life; 55% of them were boys. Nine out of the 100 recruited infants had a positive SC test, i.e., values greater than 80 mmol/L in both tests. There was no disagreement between the two conductivity tests in the same patient. Cohen's Kappa index value was equal to 1.0 (Standard Error of Kappa = 0.000), showing a perfect agreement between values obtained in both tests. The number of agreements expected by chance was 83.6, i.e., 83.6% of the observations.

**Conclusion:** Since the strength of agreement was perfect, it reveals a high reliability of SC. Apart from its role as a screening test, it seems that it has a place as a diagnostic tool in CF.

**Funding:** Supported by a Grant (number 486201/2013‐9, to PC) from the Brazilian Council for Scientific and Technological Development.
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**Background:** Multiple Breath inert gas Washout (MBW) is a sensitive method to identify ventilation inhomogeneity in the peripheral airways of the lungs. Newborn screening (NBS) for cystic fibrosis (CF) is increasingly used and a tool for monitoring pulmonary disease at an early age is needed. We aimed to assess the feasibility and value of MBW as a clinical monitoring tool after decision to implement MBW in early infancy as a routine method.

**Method:** All CF children diagnosed since NBS implementation in May 2016 were selected for MBW measurements at their routine outpatient visits. Infant MBW training sessions were conducted by experts. Within possibilities, MBW measurements (at least 2 acceptable runs) were obtained within 3 months of age and every 3 (±1) months for 1 year. All children were sedated with dexmedetomidine and standardized MBW measurements were performed using the Exhalyzer D 3.2.1 system with sulfur hexaflouride (SF6) as tracer gas.

**Results:** Thirteen infants with mean age (range) 10.5 months (1 -- 19 months) were included. At initial MBW measurement, the mean LCI (range) was 7.33 (6.19 ‐ 9.98). The CF infants were mainly below the upper limit of normal (ULN) LCI 7.72 (based on unpublished data on healthy infants). Three CF infants presented with an LCI above the ULN. We scheduled 43 MBW measurements, 39 of which were successfully obtained in sufficiently sedated children during routine outpatient visits. Three tests were cancelled due to clinical signs of lung infections and one due to insufficient sedation. All cancelled tests were rescheduled and performed within 2 to 4 weeks. MBW measurements were technically safe as no adverse events were observed. Criteria for technical acceptability was met in 39/39 (100%) tests. The time required for an acceptable test differed with a mean time (range) 15 minutes (7 -- 58). Two test occasions were not performed within the timeframe of 3 ±1 months, while all other tests were conducted within the scheduled timeframe during the 1‐year implementation period.

**Conclusion:** Our results indicate that longitudinal SF6 MBW is feasible for lung function testing in infants with CF from 3 months of age. Our experience showed that successful measurement required expert training of operators. Furthermore, our study demonstrated that intranasal Dexdor® is an effective and safe sedative for infant lung function testing. Value as a clinical monitoring tool awaits many more longitudinal measurements.

F‐212. Lung Ultrasound and Computed Tomography in Cystic Fibrosis Children ‐ A Comparative Study {#ppul24373-sec-0560}
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[*Ciuca I. M*.]{.ul} ^1^, Pop L. L.^1^, Moise L. M.^2^

^1^Pediatric Department, University of Medicine and Pharmacy Victor Babes ‐ Timisoara, Romania; ^2^Anatomy and Radiology Department, University of Medicine and Pharmacy Victor Babes ‐ Timisoara, Romania

**Background:** Because of frequent exacerbations and pulmonary deterioration in cystic fibrosis (CF), the radiological exposure to chest X‐ray and CT scan is frequent in patients with CF, with subsequent potential secondary effect, although also required. Lung ultrasound is, currently, a useful method of evaluation in multiples diseases such as: pneumonia, pleural effusion, interstitial syndrome or pulmonary fibrosis; therefore, the use of LUS in CF would be of interest Aim of the study: Evaluation of thoracic ultrasound utility in CF exacerbations.

**Methods:** Fifty CF patients were included in the study and monitored for 2 years of age. Lung ultrasound was performed every 3 months, at clinical and biological evaluation. CT scan was performed during exacerbations and for stable patients, every 2 years timetable (aged over 8 years). Ultrasound was performed using a linear high frequency 8 to 12 MHz probe, using a score based on specific artifacts which quantified the presence of consolidation, interstitial syndrome, saccular bronchiectasis and pleural effusion. CT was interpreted using the Bhalla scoring system, independently of the LUS score. Pearson\'s correlation was used for the evaluation of the relationship between LUS score and CT.

**Results:** Median CT Bhalla score was 14.3 + ‐4.5, and the average LUS score = 5.13 + ‐2, consistent for moderate morphological lung injury. A good correlation was found in patients with increased LUS (\> 4) and CT score, R= 0.75, *P* \< 0.001. There was no reliable correlation between the lung ultrasound score and CT, therefore, validation of the LUS‐CF score (R= 0.37, *P* = 0.26) was impossible with the currently identified artifacts. For patients in acute exacerbations, alveolar‐interstitial syndrome described by multiple B‐line artifacts and the presence of lake signs quantifying cystic bronchiectasis were accurately identified by LUS and confirmed by CT.

**Conclusion:** Lung ultrasound might be considered for detection of extensive lung changes in children with CF; but would not be recommended for incipient structural alterations, such as small bronchiectasis and air trapping. LUS could be used for fast and safe assessment in CF pulmonary exacerbations.

F‐220. Diagnostic Value of Sputum Cultures in Children under 2 Years of Age with Cystic Fibrosis and Other Chronic Productive Lung Diseases {#ppul24373-sec-0570}
===========================================================================================================================================

Bar‐On O.^1^ *,* Zaks‐Hoffer G.^2^, Mussaffi H.^1^, Scheuerman O.^2^, Mei‐Zahav M.^11^, [*Prais D*.]{.ul} ^1^, Stafler P.^1^, Steuer G.^1^, Levine H.^1^, Blau H.^1^

^1^Graub CF Center, Pulmonary Institute, Schneider Children\'s Medical Center of Israel ‐ Petach Tikva, Israel; ^2^Pediatrics Dept. B, Schneider Children\'s Medical Center of Israel ‐ Petach Tikva, Israel

**Background:** Airway infection and ensuing inflammation may be important in infants with non‐CF Chronic Productive Lung Disease (CPLD). As for Cystic Fibrosis (CF), prompt detection of specific pathogens could enable directed treatment and slow pulmonary deterioration. However, acquisition of sputum from the very young is challenging, as they do not expectorate. Bronchoalveolar lavage is invasive and therefore not used frequently. We routinely collect sputum for bacterial cultures from non‐expectorating infants with chronic lung disease and a productive cough in the clinic setting. Airway clearance by an experienced physiotherapist and oropharyngeal suction promotes coughing of pooled secretions to above the larynx for acquisition of sputum ('deep suction'). In non‐productive infants or when culture results are negative, salbutamol and 4.5% hypertonic saline inhalation is delivered before physiotherapy and suction ('induced sputum').

**Aims:** 1. To describe bacterial culture results achieved by deep suction or induced sputum in infants under 2 years of age. 2. To compare bacterial cultures in CF and non‐CF CPLD during routine clinic visits versus pulmonary exacerbations.

**Methods:** Medical records were retrospectively reviewed for infants aged 0 to 2 years with CF or CPLD, who had at least 2 sputum cultures and were treated at the Schneider Children's Medical Center Pulmonary Institute between 2010‐2016. Collected data included microbiological culture results, clinical status, and antibiotic treatment.

**Results:** Ninety‐eight infants (16 with CF) were evaluated. A total of 534 cultures were acquired, 201 from CF infants (12 (2‐23), median (range) per infant), and 333 from non‐CF CPLD infants (3 (2‐21), median (range) per infant). Age at first culture was 3.8 (1‐19.5) months for CF and 10.4 (0.5‐22) months for CPLD. Three hundred ad sixty‐one cultures (68%) were positive for any bacteria. Of all positive cultures, 171 (47%) were acquired during pulmonary exacerbations, and 194 (53%) during routine follow‐up. *Pseudomonas aeruginosa* was positive at least once in 46% of patients (56% CF and 44% non‐CF CPLD, *P* = 0.42). More infants with CF compared to CPLD had positive cultures for *Staphylococcus aureus* (75% vs. 34%, *P* = 0.004), *Klebsiella oxytoca* (31% vs. 7%, *P* = 0.016) and *Pseudomonas species* (31% CF and 4% CPLD infants, *P* = 0.003). One CF and 7 CPLD infants had ESBL‐resistant bacteria. No MRSA or multi‐resistant *Pseudomonas* were identified. Chronic *P. aeruginosa* (Leeds' criteria) was rare: 0/16 CF and 6/82 CPLD, mostly following prolonged hospitalization. In neither group was there a correlation between culture results and pulmonary exacerbations versus routine visits.

**Conclusions:** Airway infection is common in infants with CF and CPLD. Bacterial flora appeared to differ between these patient groups, perhaps confounded by more frequent cultures in CF patients. *Staphylococcus aureus* was more common in CF infants and may be an early marker for this disease. Interestingly, *Pseudomonas aeruginosa* was common in both CF and CPLD but chronic infection was rare and bacteria were not multi‐resistant. Prompt diagnosis and aggressive treatment when required may have decreased chronic carriage and may improve clinical outcome. Our findings are retrospective and a prospective study is warranted.
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**Renoux M. C.,** **[*Guiomard C*.]{.ul}**

Pediatric Pulmonology, University Hospital of Montpellier ‐ Montpellier, France

**Objective:** 22q11.2 deletion syndrome (22q11.2 DS) is characterized by a large variety of clinical presentation and many degrees of severity. Respiratory disorders are not part of the classic description of the disease, yet they are often a secondary manifestation of the various known disorders. Asthma and atopy are also described in this population, as well as respiratory tract disorders. The objective of this study was to identify the various respiratory disorders presented by a cohort of children with 22q11DS.

**Methods:** We conducted a retrospective descriptive study at the University Hospital of Montpellier between 30/08/2000 and 30/08/2018. We collected the various respiratory disorders presented during the follow‐up of these children.

**Results:** One hundred and two files were examined and 76 patients were included in our study. Asthma concerned 26 patients in our cohort (34%) which is more frequent than in our general population (9% in Occitania region, France). It was significantly related with atopy (*P* \< 0.01). Respiratory tract disorders were identified in 10 patients (13%). The most common were: tracheomalacia and laryngomalacia. Lower respiratory infections were found in 18 patients (24%) and were significantly related to lymphopenia (*P* \< 0.05) and swallowing disorders (*P* \< 0.05).

**Conclusion:** Respiratory disorders (such as asthma and atopy) should be considered and screened during follow‐up of children with 22q11DS.

G‐129. Long Term Follow‐Up of Lung Function Testing in a Pediatric Cohort of Patients with Bronchiolitis Obliterans Syndrome after Stem Cell Transplantation {#ppul24373-sec-0600}
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[*Jerkic S. P*.]{.ul} ^1^ *,* Walther S.^1^, Pommerening H.^1^, Jarisch A.^2^, Rettinger E.^2^, Soerenson J.^2^, Schubert R.^1^, Bader P.^2^, Zielen S.^1^

^1^Department of Allergy, Pulmonology und Cystic Fibrosis, Children's Hospital, Goethe‐University ‐ Frankfurt am Main, Germany; ^2^Department of Stem Cell Transplantation and Immunology, Children\'s University Hospital ‐ Frankfurt am Main, Germany

**Background:** Bronchiolitis Obliterans Syndrome (BOS) after allogeneic hematopoietic stem cell transplantation (SCT) is a progressive, chronic lung disease in which a persistent inflammation leads to obstruction of the small airways. The incidence of BOS rises globally due to steady increases in utilization of SCT. However, the history of lung function in patients with BOS after SCT is poorly characterized although understanding the course of lung function in these patients is necessary for prompt clinical recognition and treatment. The objective of this study is to describe the long‐term follow‐up of lung function parameters in patients with BOS post SCT.

**Methods:** A retrospective cohort of 10 patients with BOS aged 3.4 to 12.3 years (median 6.4) at the time of the SCT were included. Lung function parameters were investigated over a period of 1.0 to 13.5 years (median 3.54). In total, 213 available lung function tests were evaluated and longitudinal changes in lung function parameters were analyzed.

**Results:** There were three variations of progression noted. Three out of 10 patients developed a significant progressive deterioration of their BOS despite steroid pulses and maximal conservative therapy with FAM (Fluticason, Montelukast, Azithromycin). Two patients died, one patient received a lung transplant. Four out of 10 patients developed a chronic progression with severe but stable lung function impairment showing a combined restrictive and obstructive pattern and hyperinflation (FVC \< 60%, FEV1 \< 50%, FVC/FEV1 \< 70 and RV/TLC \> 150%). Three out of 10 patients presented with typical signs of BOS on computed tomography (CT) such as bronchial wall thickening and mosaic pattern of perfusion, and in broncho‐alveolar lavage (BAL) with neutrophils \> 70%, and responded well to steroid pulses. Their lung function parameters improved to normal values during the course of the disease.

**Conclusion:** Our results indicate that BOS leads towards a progressive, chronic lung disease and is related to an increased overall mortality and morbidity. Important elements of treatment involve early and accurate detection, as well as specific and individualized therapeutic concepts to optimize the long‐term outcomes in SCT survivors with BOS.

G‐193. Impact of HIV and Antiretroviral Drug Exposure on Lung Growth and Function over 2 Years in an African Birth Cohort {#ppul24373-sec-0610}
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^1^Department of Paediatrics and Child Health, MRC Unit on Child and Adolescent Health, University of Cape Town ‐ Cape Town, South Africa; ^2^Paediatrics and Child Health, University of Cape Town ‐ Cape Town, South Africa; ^3^Telethon Kids Institute, School of Physiotherapy and Exercise Science, Curtin University, and Centre for Child Health Research, University of Western Australia ‐ Perth, Australia

**Background:** HIV‐exposed uninfected (HEU) infants have poorer health outcomes compared to HIV‐unexposed (HU) infants, including increased risk for respiratory disease. Previously we found that lung function soon after birth was altered in HEU infants, but the longer‐term impacts of HIV and/or antiretroviral (ARV) drug exposure on lung function are not known.

**Objectives:** We aimed to assess the impact of HIV and ARV exposure on lung growth and function over the first 2 years of life.

**Methods:** Infants enrolled antenatally in the Drakenstein Child Health study between 2012‐2015 had lung function measured using tidal breathing and multiple breath washout at 6 weeks and 2 years. Maternal HIV diagnosis was established during pregnancy using routine testing and HIV‐infected women received ARV therapy as per Western Cape Prevention of Mother To Child Transmission guidelines at the time; CD4 counts were collected. Infants were tested for HIV using PCR and antibody testing. The association between HIV and ARV exposure and lung function during 2 years was assessed using linear regression, adjusted for BMI for age Z‐score, sex, ethnicity, socioeconomic status (SES) quartile at enrolment and pre‐ and postnatal smoke exposure (based on urine cotinine).

**Results:** A total of 1036 infants had at least one lung function measurement and were followed over 2 years, 226 (22%) were HEU; 535 (52%) male, 560 (54%) black African ancestry, 330 (33%) mothers smoked during pregnancy, 775 (71%) household tobacco smoke exposure. Nine hundred and ten (88%) infants had lung function tested at 6 weeks and 743 (72%) children at 2 years. The majority of HEU infants were black African (93% vs. 43% HU, *P* \< 0.001), HEU infants had less household smoke exposure (69% vs. 81%, *P* = 0.01), lower SES (*P* = 0.001) and had higher BMI z‐score at 2 years (*P* = 0.001) compared to HU; other demographics were similar.

At 6 weeks, HEU infants had higher tidal volume compared to HU (1.1mL, CI, 0.02; 2.2, *P* = 0.045). Amongst the HEU infants, those whose mothers had triple therapy ARVs had lower expiratory flow ratios, tPTEF/tE, compared to those whose mothers had zidovudine (AZT) only (‐0.26, CI ‐0.4; ‐0.1, *P* \< 0.001). At 2 years, tidal volume differences were no longer seen, but HEU infants had a higher lung clearance index compared to HU (0.12, CI, 0.02; 0.23, *P* = 0.019). Low antenatal maternal CD4 count was associated with an average 6.5mL lower tidal volume at 2 years compared to infants whose mothers had CD4 counts\> 500 cells/ mm3 (CI, 1.0, 12.1; *P* = 0.02).

**Conclusion:** HIV exposure affects lung function at birth and is associated with mild lung function impairment at 2 years of age. More severe maternal immune compromise contributes to lower lung function. The impact of ARVs on lung growth warrants further investigation. Ongoing surveillance of respiratory health is important in HEU.

**Funding:** The Wellcome Trust (204755/Z/16/Z and 203525/Z/16/Z), Bill and Melinda Gates Foundation (1017641), South African MRC
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**Background:** Pectus excavatum results in compression of the heart and may compromise cardiac function. The changes in cardiac volumes of the ventricles and systolic function in children after Nuss operation have been less reported. Echocardiography is noninvasive and can provide images to evaluate the volumes and systolic function of the ventricles.

**Methods:** Between 2014 and 2018, a total of 14 (12 male, 2 female) patients, age 12.2 + /‐ 4.8 years, height 145.4 + /‐ 29.2 cm, weight 35.9 + /‐ 13.7 kg with pectus excavatum underwent echocardiography before and after chest wall correction with the Nuss procedure. The volume ratios of the right to left ventricles and the systolic functions of the left ventricle were calculated by transthoracic echocardiography.

**Results:** The volume ratios of the ventricles increased from 0.39 + /‐ 0.13 to 0.52 + /‐ 0.26, p‐value 0.04. The ejection fraction of the left ventricle increased from 74% + /‐ 6.4% to 76.2% + /‐ 7.1%, p‐value 0.39.

**Conclusions:** Cardiac volumes of both ventricles increased significantly and the ejection fraction of the left ventricle maintained within normal ranges after the Nuss operation for pectus excavatum in children.
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**Background:** Recently, we experienced a *Mycoplasma pneumoniae* (MP) infection pandemic and an increase in the rate of Macrolide‐resistant (MR) isolates in Japan.

**Objective:** It is necessary to understand the recent aspects of MP infections among Japanese children.

**Material and Methods:** We enrolled children with suspected MP infections who visited 85 institutions throughout Japan since March 2008 in whom samples were collected. Informed consent was obtained from the parents of the patients. MR isolates were defined by sequencing of domain V of the 23s rRNA gene of MP. Furthermore, we also examined the MICs of 7 antimicrobial agents for the isolates and the distribution trend of MP P1genes.

**Results:** From 2008 to 2017, a total of 1702 MP isolates were obtained. The annual number of isolates reached its peak (598) in 2012 and increased in 2015 and 2016 again. The overall detection rate of MR isolates was 69.3%. The annual rate of the latter reached its peak (81.8%) in 2012. It has since decreased to 8% in 2018. Almost all MR isolates had the A2063G point mutation. There was no isolate resistant to quinolone and tetracycline agents. Furthermore, the detection rate of type 1 of MP P1genes was approximately 50% in the outbreak of 2015‐2016, whereas it was more than 90% in the outbreak of 2011‐2012.

**Conclusion:** In these 10 years, outbreaks of MP infections have occurred twice in Japan. However, there were differences in the rate of MR isolates and the distribution of MP P1genes among the isolates between the two outbreaks. The annual MR rate of MP infections reached its peak (81.8%) in 2012 and thereafter it has been decreasing to 8% in 2018.

I‐32. Effect of Multi‐Ethnicity and Ancestry on Prevalence of Allergic Disease {#ppul24373-sec-0660}
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*[Kim JT.]{.ul}*, Kim HS.
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**Background/purpose:** Differences exist among racial and ethnic groups in the prevalence and severity of allergic diseases. However, influence of population admixing on allergic disease has not been studied. We examined the effect of population admixing on the occurrence of allergic disease.

**Methods:** We reviewed the data of 68,043 adolescents who participated in the 11th Korea Youth Risk Behavior Web‐based Survey, which provides a sample that is representative of the entire Korean middle school and high school student population. Multi‐ethnic status was determined by using parental country of birth and prevalence of asthma, allergic rhinitis (AR), and atopic dermatitis (AD) was determined by questionnaire.

**Results:** Multi‐ethnic adolescents accounted for approximately 0.9% of the total adolescents. Prevalence of asthma was significantly higher in the multi‐ethnic group compared to the non multi‐ethnic group while that of AR and AD was significantly higher in the non multi‐ethnic group compared to the multi‐ethnic group. Parental region of country at birth showed a significant difference in prevalence of allergic disease. Univariate analysis found that urbanity, perceived economic status (PES), parental region of country at birth, and environmental tobacco smoke (ETS) showed a significant odds ratio (OR) in asthma, AR and AD. Body mass index (BMI) showed a significant OR in asthma and AD. After adjusting for urbanity, PES, BMI and ETS, multiethnicity showed a significantly lower OR in AR and AD.

**Conclusion:** Population admixing appears to have a significant effect on the prevalence of allergic disease. Further study will be needed to clarify the effect of population admixing on prevalence of allergic disease.

I‐51. Chronic Wet Cough in Aboriginal Children: When Is a Cough Not Just a Cough? {#ppul24373-sec-0670}
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**Background:** Chronic wet cough, which is prevalent in Indigenous children, is the most common symptom of bronchiectasis and its precursors. Early recognition of chronic wet cough leading to prompt and appropriate treatment may potentially prevent progression to bronchiectasis. Therefore, timely health seeking for chronic wet cough by families, and its effective management by health practitioners is potentially important to prevent development of bronchiectasis.

**Purpose:** To identify the barriers to and enablers for timely health seeking for chronic wet cough by families, and optimal management by health practitioners, for chronic wet cough in Aboriginal children.

**Method:** A qualitative study was conducted in two communities (one remote town and one very remote community) in the Kimberley region of northern, Western Australia, of which 43% of the population is Aboriginal. Data were gathered through individual semi‐structured in‐depth interviews and focus groups to ascertain: 1.Aboriginal family knowledge and beliefs about chronic wet cough in children and to identify the barriers and enablers to seeking health care.2.Health practitioner knowledge of chronic wet cough and chronic lung disease in Aboriginal children and to identify barriers and enablers to effective management.

**Results:** Forty Aboriginal family members participated. The three key barriers identified were: (i) 'Cough normalization' i.e. 70% of participants considered chronic cough as normal (with 53% of participants' previous interactions with doctors informing participants' understanding of chronic cough), (ii) lack of health literacy information and (iii) a sense of disempowerment (belief that no medical action would be taken and inability to challenge doctors). The key enabler described was the provision of culturally appropriate health literacy information. All participants reported that they would seek help for chronic wet cough once they were informed that it could signify underlying disease. Furthermore, families suggested that improved health practitioner knowledge of chronic wet cough would facilitate health seeking by parents.

Thirty‐seven health practitioners participated. Key barriers to optimal management of chronic wet cough were: (i) limited training in assessment and management of chronic wet cough, (ii) normalization of cough in children by health practitioners, and (iii) prioritization of acute presentations and competing better known chronic conditions. Key enablers were (i) improving practitioners' knowledge and expertise in managing chronic wet cough, (ii) easy access to clear clinical practice guidelines, (iii) improving health practitioners' cultural competence when working with Aboriginal families, and (iv) health system changes to facilitate longitudinal patient care.

**Conclusion:** Knowledge about chronic wet cough and its implications is not widely appreciated amongst families and health practitioners in remote Western Australia. Culturally appropriate health information for families, training for health practitioners, easy to access clinical practice guidelines and a health service model for effective longitudinal patient care is needed to improve early detection and effective management of chronic wet cough. These measures have the potential to prevent bronchiectasis in Aboriginal children.

**Reflections:** Results may potentially apply to other settings. There is a need to study knowledge about chronic wet cough in other populations, particularly indigenous communities and their health practitioners.

I‐58. Epidemiological Trends of Children Requiring ICU Care in Taiwan: A Retrospective Population‐Based Analysis {#ppul24373-sec-0680}
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**Background:** More than 99.5% of people living in Taiwan are covered by a national health insurance. Children younger than 18 years account for 20\~25% of the general population, but the birth rate of newborns has gradually been getting lower during the past decade. Analysis on the changing patterns of children requiring intensive care is important for future children's medical policy plan. This study aimed to investigate the epidemiology of children treated in intensive care units (ICUs) in Taiwan from 2000 to 2013.

**Method:** Systematic random samples from the Taiwan's National Health Insurance Research Database were analyzed. Using the 5% inpatient data claims during 2000 to 2013, children with records of ICU hospitalization were enrolled and divided into different age groups. The related age, diagnosis, cost, seasonality, and mortality rate were analyzed and compared to adults.

**Result:** A total of 16,727 (1,195 ± 117 cases/month) children having ICU records were enrolled, including 9,628 (57.6%) boys and 7,099(42.4%) girls. Among them, infants (0‐11 months old) were the highest population (60.2%), and their most common diagnoses were neonatal respiratory problems, preterm birth/low birth weight, and jaundice. Small children (1‐5 years old, 19.6%) and bigger kids (6‐11 years old, 8.4%) had similar disease patterns, and congenital cardiac/vascular anomaly, respiratory failure/insufficiency, and pneumonia were common diagnoses. Adolescents (12‐17 years old, 11.1%) had a markedly higher diagnostic rate in traumatic cranial hemorrhage than the other age groups. The top ICU hospitalization season was summer. The ICU mortality rate of children was around 4%‐6% and had a decreasing trend. From 2000 to 2013, the children's ICU hospitalization rate significantly declined; however, the adults' ICU hospitalization rate obviously increased. As a result, the ratios of children's ICU care significantly declined from 14.6% to 6.9%.

**Conclusions:** Children's ICU care needs in Taiwan gradually declined from 2000 to 2013. Infants are the largest population to have ICU care. Preterm births, neonatal respiratory or congenital cardiovascular diseases accounted for top ICU diagnoses, although traumatic brain injury rose in adolescents. Upgrading children's ICU care by targeting diseases of different age groups is important in any nation with an aging population.
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**Rationale:** The air quality and pollution in the air is completely dependent on the surroundings one lives in. Capturing ourselves indoor during the high level of pollution also needs to be readdressed since indoor air is usually dirtier than the air outdoors, due to trapping of air contaminants inside. Allergic Children are most vulnerable as they are most likely to stay indoors for longer durations. This study aimed to evaluate the change in allergic symptoms in allergic children by using an air purifier.

**Methods:** Forty‐five allergic children were recruited from the Hanyang University Guri Hospital Pediatric Allergy Clinic (18 children with atopic dermatitis, 18 with allergic rhinitis, 9 with asthma). A Samsung air purifier was set up in the subject's family room and operated with filter‐on for 28 days as acting day and filter‐off for 28 days as control with an average 14 hours/d (8--24 hours/d) since September 2018. Allergic symptom scores were self‐checked on a smart cellular phone by the subject\'s parents as Atopic dermatitis: SCORAD; allergic rhinitis: total 4 nasal symptom score (T4NSS); Asthma: Asthma symptom score (ASS). At same period, the level of the PM10, PM2.5, pollens and NO2, SO2, O3 were measured and recorded daily for air quality.

**Results:** The mean improved rate for SCORAD was 15.16%, T4NSS was 28.86%, ASS was 50.7% at the filter‐on phase of the air purifier phase than at the filter‐off phase. There was no significant correlation between allergic symptom scores and the level of air pollutants and pollens in this period although showed a lag‐effect trend between them.

**Conclusion:** Allergic symptom scores were improved by using a mechanical air purifier set up in the home of allergic children.
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**Background:** Urbanization is an important cause for asthma increase, and some may be attributed to increased outdoor air pollution. Although many studies have identified the individual effect of single pollutants, they often mask the health effect of the mixture overall. In the real world, dynamic changes in air pollutants and meteorological factors always coexist simultaneously. Thus, a comprehensive study was carried out to study the influence of air pollution and meteorological factors on asthma acute exacerbation (AE).

**Material and method**: The Emergency department visit for asthma AE data (ICD 9 code 493.xx) were collected from the claims data of 1 million subjects randomly selected from 23 million insurants registered from 2005 to 2013 in Taiwan from the National Health Insurance Research Database. Complete monitoring data for the air pollutants (SO2, NO2, O3, CO, PM2.5 and PM10) and meteorological factors (relative humidity, rainfall, and daily average temperature) were collected from 74 Environmental Protection Agency monitoring stations of the Taiwanese government. In the present study, each ER visit for asthma AE was defined as case day. In bidirectional control samplings, the same weekdays 1, 2 or 3 weeks before and after ER visit for asthma were defined as the control days. Multiple correlation coefficients (R) (multiple regression analysis) were used to explain how much of the variance in the ED visits could be explained by a given set of air pollutants.

**Result:** As the study cases were divided as male and female, a 1 ug/m3 increase in the 48‐h averages of PM2.5 and a 1℃ increase in temperature were associated with asthma ER visit \[OR= 1.004 (95%CI, 1.000--1.008) and 0.986 (95%CI, 0.979--0.994) respectively\] for male patients. A 1 ppb increase in the 48‐h averages of O3 and a 1℃ increase in temperature were associated with asthma ER visit \[OR= 1.003 (95%CI, 1.000--1.007) and 0.985 (95%CI, 0.976--0.993) respectively\] for female patients. As the study cases were divided according to their age, increase in temperature was a protective factor for asthma ER visit with a 1℃ increase in temperature associated with OR= 0.981 (95%CI, 0.971--0.991) and 0.985 (95%CI, 0.975--0.994) for the pediatric group and young adult group, respectively. Each 1 ug/m3 increase in the 48‐h averages of PM2.5 was associated with asthma ER visit for patients older than 65 years old (OR= 1.008 (95%CI, 1.003--1.014).

**Conclusion:** In Taiwan, asthma AE is closely related to low temperature and indicated air pollution. There is an obvious bias if only a single air pollutant is being considered and neglects the influence of meteorological factors in studying the effects of the environment on asthma. With the result of this study, we can predict asthma exacerbation precisely according to individual age, gender and local air pollution/ meteorological conditions. In days with high risk for asthma exacerbation, patients with asthma should avoid/decrease outdoor activity, dress warmly and maintain inhaled corticosteroid therapy.
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With the increasing numbers of children with home‐ventilators in the community, the quantification of proficiency to evaluate the skill of endotracheal suctioning has attracted much attention to provide safe and efficient care. The purpose of This study is to identify criterion values to evaluate the proficiency of endotracheal suctioning skills between expert nurses and nursing students, using a motion capture system. Twelve expert nurses from two institutions and twelve nursing students from a university were recruited in This study. The maximum anteflexion angle, the path length and fixation time of dorsum manus were measured by a motion capture system (Perception Neuron, Noitom, USA) during endotracheal suctioning on a simulator. After measuring their performance, participants were questioned using the Japanese version of the National Aeronautics and Space Administration Task Lord Index (NASA‐TLX). Permission from the ethical committee was obtained before commencing This study (17‐81‐1). A total of 21 valid data from 11 nurses and 10 nursing students were obtained. The mean completion times of expert nurses and students were 84.15\[s\] and 115.30\[s\], respectively. As a result of independent t‐test, a significant difference was found between the two groups (*P* = 0.00028). The average of anteflexion angle of nurses was 29±8.05\[deg\] and the students' was 34±10.68\[deg\] without significant difference (*P* = 0.153). As for the total path length of dorsum manus, there was a significant difference in their left hands (*P* = 0.01), but no statistical significance was found in their right hands (*P* \> 0.05). The fixation time of dorsum manus were 327.2\[s\] for nurses and 59.66\[s\] for students in their right hands, and 24.2\[s\] and 39.85\[s\] in their left hands. In NASA‐TLX scores, there were significant differences regarding time pressure (*P* = 0.004), anxiety (*P* = 0.02), stress (*P* = 0.028), and satisfaction of their performance (*P* = 0.007).

However, while the path length of the right dorsum manus was not statistically significant, there was a significant difference in completion time between the two groups. The reason considered was that their left hand was their nondominant hand, while their dominant hand needed to be kept clean to touch an asepstic suction catheter. Therefore, novice participants were unfamiliar with manipulating suctioning equipment with their left hand, which appeared as a difference in their proficiency. Their fixation time of right hands occupied approximately 50% of their average completion time, whereas the percentage of fixation time within the completion time was about 40% for the nurse group. Given the fact that the NASA‐TLX score revealed that the student group was time‐pressured and unsatisfied about their performance, the prolonged fixation time might play an important role in cognitive activity for them. In conclusion, we identified three possible criterion values: the performance time, the path length of the left dorsum menus, and fixation time of the dorsum menus in both hands, to measure the proficiency of endotracheal suctioning skills. Further study is required to determine the sufficient level of proficiency to provide safe endotracheal suctioning, including accuracy, avoidance of patient pain, hygienic manipulation of the catheter, and location of equipment to prevent adverse events in endotracheal suctioning.
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Endotracheal suctioning is recently provided not only in hospitals but also in community settings. The provision places for such invasive procedure have expanded, including special‐need schools in particular. It is easily imagined that endotracheal suctioning is a stressful health‐maintaining technique for family caregivers or school teachers until acquiring its high‐risk characteristics. This study, therefore, aims to compare the learning outcome in the 2D/3D Computer Graphic (3D CG) animation as one of the training methods of endotracheal suctioning skill. Thirteen experienced nurses from three institutions and twelve nursing students from a university participated in This study. These participants were asked to watch a 2D video of an experienced nurse performing endotracheal suctioning on a training simulator, or 3D CG animation which is able to enlarge areas of interest (AOIs) and rotate virtual camera angles as a visual stimulus. The position of the participants' heads was fixed on a head holder in front of the display. Simultaneously, their eye movement was tracked by a head‐mounted eye‐mark recorder (EMR‐9, NAC Image technology Inc., Japan) with a world camera (62\[deg\] horizontal angle of view) and binocular cameras. The sampling rate was 60\[Hz\]. Obtained data were analyzed by EMR‐dFactory (version 2.7.0, NAC Image technology Inc., Japan). The gaze fixation was defined as less than 2\[deg\] within 100\[ms\]. Afterwards, impression regarding watching the digital content to learn the procedure of a nursing skill was assessed by an original self‐reported questionnaire. Excluding the data of Ns.5 and St.1, in whom the estrangement with other measurement results was remarkable, data from 12 nurses and 10 nursing students were analyzed. After the eye‐mark was computed, analysis for frequency distribution of fixation point movement velocity was conducted. Contrary to the previous study which concluded that the novice group tended to be unimodal, bimodality of eye trajectory velocity with two peaks at 0 to 29 \[deg/s\] and 75 \[deg/s\] was found in all of the four groups. An independent t‐test revealed no significant differences in the two nurse groups who watched 2D video or 3D CG. There was no significant difference in the two student groups who watched 2D video or 3D CG. From post‐performance questionnaire responses, benefits of 3D CG were reported that the function of a virtual camera improved the accessibility to AOIs by screen transition, whereas operation was difficult, so they could not realize the effect of learning. Advantages of 2D video was described that it is easy to concentrate because the device was familiar, while there was a negative impression that it was hard to observe AOIs compared to 3D CG. There was no significant difference between the groups who watched 2D video or 3D CG animation in the frequency distribution of fixation point movement speed analysis. However, considering the unignorable potential of 3D CG animation as a training tool, we concluded that defining visual criteria for assessing learning outcome of digital contents requires more research in the future.
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The aim of this study is to compare the level of endotracheal suctioning proficiency between experts and novices, using an eye‐mark recorder.

A head‐mounted eye‐tracking device (Pupil, Pupil Lab, USA) was used to capture eye movement of the participants. Twelve experienced nurses from three healthcare facilities who had more than 3 years of experiences of suctioning, and twelve nursing students from a university who had no experience of providing suctioning for real patients, participated in a simulation scenario of a patient with endotracheal intubation. We utilized cephalothorax realia with a simulated upper respiratory tract from mouth, nose, to a tracheal bifurcation, which did not represent any biological/pathological reactions of the human body. While the participants performed endotracheal suctioning, their completion time, gaze fixation frequency and gaze fixation duration were measured, followed by the percentage of fixation duration against the completion time, and the frequency distribution of fixation point movement velocity was calculated. The sampling rate was 60\[Hz\]. The gaze fixation was defined as less than 2\[deg\] within 100\[ms\]. After performing endotracheal suctioning, the participants were asked to fulfill a Japanese version of the National Aeronautics and Space Administration Task Lord Index (NASA‐TLX) survey. Data were analyzed by MATLAB (2014a, USA), SPSS(version 22.0, USA), and Microsoft Excel (Home and Business 2016, USA). Approval from the ethical committee was obtained before commencing This study (17‐81‐2).

Average completion times in the nurse group and the student group were 88.2\[s\] and 112.3\[s\]. As a result of independent t‐test, there was a significant difference (*P* = 0.006) between the two groups. The values for gaze fixation frequency were 63.6(right) and 67.3(left) for the nurse group, and 88.8(right) and 83.4(left) for the student group (*P* = 0.004(right), *P* = 0.04(left)). Gaze fixation duration of the nurse group was 55.4\[s\](right) and 54.4\[s\](left), and 80.7\[s\](right) and 08.5\[s\](left) for the student group, with significant differences between the two groups (*P* = 0.03(right), 0.03(left)). Percentages of fixation duration against the completion time were 62.8%(right), 61.6%(left) in the nurse group, and 71.9%(right) and 71.7%(left) in the student group. The graph of frequency distribution of fixation point movement velocity was unimodal with a peak at 0 to 29 \[deg/s\] in both groups, which was constrative of the characteristics of expert nurses' bimodal eye movement speed in our previous study. As for the result of NASA‐TLX, there was no significant difference between the two groups.

The completion time, gaze fixation frequency, gaze fixation duration could be referable visual quantitative criteria for skill assessment of endotracheal suctioning. There were no significant differences in percentages of fixation duration against the completion time and analysis of frequency distribution of fixation point movement velocity; however, factors which differentiate the results from the previous study have to be confirmed. Given the fact that the NASA‐TLX did not vary depending on the participants\' clinical experience, the workload might have been equally high in the unfamiliar environment of a laboratory.Further studies will be required to determine the sufficient level of proficiency to provide safe endotracheal suctioning before putting it into practice in pediatric patients in the future.
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The diagnostic search of prolonged and chronic cough in children presents difficulties, because there are many different respiratory and extrapulmonary diseases as its causes.

**Aim:** to determine the clinical structure and causes of prolonged and chronic cough in children.

**Patients and methods:** 272 children aged from 2 to 17 years with prolonged (fromfour to 8 weeks) (n = 109) and chronic cough (more than 8 weeks) (n = 163) were examined. Catamnesis lasted from 6 to 18 months. The control group included 60 healthy children. All patients underwent history and examination, as well as surveys of parents and/or patients with specially designed questionnaire, including the score of the main characteristics of cough (dry/wet, frequency, intensity and others). According to indications, the following were taken: chest X‐rays, consultations with specialists, in‐depth examination in a specialized hospital or diagnostic center. Statistical analysis was carried out with the help of a package of computer programs «Microsoft Excel 2010» , «Statistica v. 10.0 » . The examined children with prolonged and chronic cough, along with acute respiratory tract infections (ARTI) (in 45%), had a high frequency (in 43%) of occurrence of allergic respiratory diseases (ARD) (allergic rhinitis, bronchial asthma) (*P* \> 0,05). Bronchial asthma (BA) including its cough variant was diagnosed in 29% and in 8% respectively of children with prolonged and chronic cough. The frequency of occurrence of BA increased with patient age. Other, rarer causes of prolonged and chronic cough (chronic bronchitis; whooping cough; psychogenic, neurogenic cough; gastroesophageal reflux disease; foreign body airway obstruction) were found in 12% of our patients. In clinical structure of the prolonged cough (fromfour to 8 weeks), ARTI prevailed (upper ARTI or exacerbation of the chronic upper respiratory tract infections in 25% and lower ARTI in 40%) in contrast to chronic cough (more than 8 weeks), during which the frequency of allergic genesis of the disease increased (allergic rhinitis in 18% and BA in 34%). Our research proved that a longer cough (regardless of of its genesis) was found in patients with negative predisposing factors and their combination: passive smoking; unfavorable environmental conditions; recurrent respiratory tract infections (*P* \< 0.05). Prolonged and chronic cough was further promoted by previously delayed diagnosis of the disease, insufficient treatment, late consultation with a doctor (*P* \< 0.05). Furthermore, there were more frequently observed recurrent episodes of prolonged or chronic cough in the examined children with the presence of comorbid disease (chronic upper respiratory tract pathology of the infectious/allergic genesis) in contrast to patients without comorbidity (*P* \< 0,05). Thus, the multifactorial causes of prolonged and chronic cough in children necessitate the development and introduction of informative diagnostic algorithms into clinical practice. This will help reduce the time of diagnostic search, enable early start of treatment and preventive measures and improve prognosis and quality of life of patients.
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**Background**: The Global Youth Tobacco Survey 2014 in Indonesia showed that 57.3% of students are exposed to environmental tobacco smoke, which causes inflammation of respiratory tracts and a decrease in lung function. Urinary cotinine can be used as a biomarker for cigarette smoke exposure.

**Objectives**: To examine the effects of environmental tobacco smoke exposure on urinary cotinine level and lung function test in children.

**Methods**: Subjects were students aged 11 to 16 years‐old in Jakarta. Data were obtained from questionnaire, spirometry and urinary cotinine test using ELISA method.

**Results**: There were 92 subjects, consisting of 46 in the case group and 46 in the control group. Urinary cotinine level \> 10 ng/ml was found in 37.0% of the case group and 4.3% of the control group; *P* = 0.000; OR= 8.50 (CI, 95% 2.08‐34.71). There were significant differences between urinary cotinine level with number of smokers (*P* = 0.027) and number of cigarettes per day (*P* = 0.037). No association was found between cigarette smoke exposure and lung function test. There was a significant difference in school absenteeism between the case group and control group; *P* = 0.004; OR= 6.00 (CI, 95% 1.42‐25.33).

**Conclusions**: Children exposed to environmental tobacco smoke have higher urinary cotinine levels than nonexposed children. Factors such as number of smokers and number of cigarettes per day may affect urinary cotinine levels.

**Keywords:** children; cigarette smoke exposure; urinary cotinine level; lung function test.
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Early‐life environmental exposures may impact on lung growth and function. This study longitudinally investigated the impact of indoor air pollution (IAP) and environmental tobacco smoke (ETS) exposure on lung function over 2 years in a South African birth cohort study.

**Methods:** Mother‐infant pairs enrolled in the Drakenstein Child Health Study (DCHS) were followed from birth through 2 years. IAP exposure (particulate matter, nitrogen dioxide or volatile organic compounds (VOC)) were measured at an antenatal and postnatal home visit. Maternal and infant urine cotinine measured ETS exposure. Lung function measured at 6 weeks (6‐10 weeks), 1 year (11‐14 months) and 2 years (23‐26 months) of age included respiratory rate (RR), lung clearance index (LCI), tidal volume (TV), functional residual capacity (FRC), exhaled nitric oxide (FENO) and expiratory flow ratios (tPTEF/tE ratio). Mixed effect models with random subject effects explored the impact of demographics and postnatal exposures on lung function during the first 2 years of life. Multivariate analysis was adjusted for age, BMI for age Z score, gender, ethnicity, maternal HIV status and socioeconomic status.

**Results:** Between July 2012 and Sept 2017, 910 (female: 48%; HIV‐exposed: 21%, Black African: 76.8%) six‐week, 784 (86%) 1‐year and 744 (82%) 2‐year infants were tested. More than half (53%) of the children had postnatal ETS exposure. Postnatal ETS exposure was associated with an average 3% decrease in RR (0.03 (95%CI ‐0.00, 0.06)), increased LCI (0.09 turnovers (95%CI, 0.01, 0.16)) and decreased TV (‐1.59mL (95% CI‐2.81, ‐0.37)) over 2 years. Of the IAP measures, particulate matter (PM10) was associated with reduced TV (‐4.60 ml (95% CI‐8.51, ‐0.69) at 2 years and benzene (VOC) with a decrease in FENO (‐0.27 (95%CI ‐0.44‐0.11)) over 2 years.

**Conclusion:** Environmental exposures from tobacco smoke and IAP in early life had a significant impact on lung function over 2 years. Reducing early‐life environmental exposures, particularly from tobacco smoke, may improve lung function trajectories.
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**Background:** Real world data on the health care burden of severe asthma in children are limited.

**Aim** To describe exacerbations and health care resource use among children with asthma in England.

**Methods:** We included children aged 6 to 17 years in the Clinical Practice Research Database and linked to Hospital Episode Statistics with at least one asthma record between 2011‐2015. Four hierarchical groups were defined: treated asthma \[with baseline asthma medications\], severe asthma \[above +  Global Initiative for Asthma Step 4/5\], severe refractory asthma \[SRA; above + ≥2 baseline exacerbations\], and eosinophilic SRA \[above +  blood eosinophils \> =150 cells/µL\]. Exacerbations and healthcare resource use during the one‐year follow‐up period were described.

**Results:** The treated asthma group included 32,893 patients, of which 2,711 (8.2%) had severe asthma and 265 (0.8%) had SRA. The mean age in the treated, severe and SRA groups was 12.1 years, 13.4 years and 12.6 years, respectively. The eosinophilic SRA group included only 8 children, likely driven by the fact that only 3% of the SRA group had a valid eosinophil test result, and therefore the eosinophilic SRA group was not analyzed further. During follow‐up, 3.9%, 10.8% and 42.6% of the treated, severe and SRA groups had at least one asthma exacerbation. In the 30 days after the first asthma exacerbation, 4.4% treated, 8.2% severe and 16.8% of the SRA group had \> 1 asthma hospitalization; and 2.4% treated, 3.8% severe and 7.1% of the SRA group had \> 1 record for an asthma accident and emergency department visit. Most children also had \> 1 general physician visit within 30 days after the first asthma exacerbation (73.2%, 77.1%, and 81.4% in the treated, severe, and SRA groups, respectively).

**Conclusions:** This study demonstrates that the burden of asthma exacerbations and health care resource use in children with asthma increases with increased asthma severity, thus highlighting the potential unmet need for specific treatments in subgroups with more severe disease.

**Funding:** GSK \[PRJ3070\].
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**Background:** Polysomnography (PSG) is a gold standard for obstructive sleep apnea (OSA) diagnosis; however it is complex, labor intensive and expensive. Overnight pulse‐oximetry is an alternative diagnostic tool but its feasibility amongst the pediatric age group is debatable. Our study aimed to test the reliability and accuracy of pulse‐oximetry performed by WristOx2 for OSA diagnosis and its severity.

**Method:** A cross‐sectional study was performed in children aged 1 to 18 years with a clinical suspicion of OSA referred to the pediatric sleep lab at the University of Malaya Medical Center between 2014 and 2018. The WristOx2 (Nonin 3150) was simultaneously applied along with PSG (Cadwell, USA). The pulse oximetry studies were scored using a validated McGill Oximetry Score. Using the PSG as the "gold standard", the sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) were calculated for the pulse‐oximetry.

**Results:** 163 patients were recruited with a mean age of 9.3 ± 3.5 years and predominantly male (65%). WristOx2 accurately diagnosed OSA in 139 children (86%) when compared to the PSG (95% CI, 0.72, 0.88). The WristOx2 had a sensitivity of 89% (95% CI= 0.81, 0.94), specificity 95% (95% CI= 0.86, 0.98), PPV 96% and NPV 84%. WristOx2 had 100% sensitivity (95% CI= 0.93, 1.00) for moderate‐to‐severe OSA diagnosis and 76% specificity (95% CI= 0.59, 0.89) for mild OSA diagnosis. The corresponding area under the receiver operator curve for OSA diagnosis was 0.92 (95% CI, 0.86, 0.96). There was also good correlation of SpO2 nadir between PSG and WristOx2 (rS= 0.83). **Conclusion:** Pulse‐oximetry by WristOx is a reliable tool for obstructive sleep apnea (OSA) diagnosis in children.
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**Background:** Acute dyspnea is one of the most common clinical presentations in the emergency department causing a high number of mortalities globally. Lung ultrasound (LUS) is more widely available in the etiologic diagnosis of acute dyspnea. However, it is still a new method in children with lung diseases.

**Objectives:** To describe lung ultrasound characteristics and to evaluate the agreement between LUS and chest X‐ray (CXR) in the diagnosis of four conditions causing almost acute dyspnea in children: pneumonia, pleural effusion, pneumothorax and acute pulmonary edema in children in Viet Nam.

**Methods:** We reviewed the records of the children who presented to the emergency department or pediatric intensive care unit (ICU) at Children hospital 1 with acute dyspnea and had a final diagnosis of one of four etiologies: pneumonia, pleural effusion, pneumothorax and acute pulmonary edema. All patients underwent CXR and LUS at the time of admission.

**Results:** Eighty‐one children were enrolled in the study: 65 cases (80%) of pneumonia, 9 cases (11%) of pleural effusion, 3 cases (4%) of pneumothorax and 4 cases (5%) of acute pulmonary edema. LUS identified 100% cases with pleural effusion and pneumothorax; 92.3% cases with pneumonia and only 75% cases with acute pulmonary edema. When comparing LUS with CRX, we noticed a good agreement between the 2 methods in the diagnosis of pneumonia (kappa = 0.64, *P* \< 0.001). LUS and CRX showed a positive diagnosis for 73.3% of cases with pleural effusion, 50% of cases with pneumothorax and 50% of cases with acute pulmonary edema findings.

**Conclusion:** LUS demonstrated to be a feasible technique which helped clinicians confirm the etiology of acute pulmonary dyspnea.

**Keywords:** acute dyspnea, lung ultrasound, pneumonia, pleural effusion, pneumothorax, acute pulmonary edema.
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**Introduction:** Bronchoalveolar lavage (BAL), an important tool in the assessment of the lower respiratory tract, can be obtained during flexible bronchoscopy as well as non‐bronchoscopically. There are relatively little data in healthy children and no data that compared these techniques. In 100 children without respiratory disease, we described (i) the BAL differential cellular count and its correlation with age, and (ii) compared the differential cytology between non‐bronchoscopic BAL (NB‐BAL) and bronchoscopic BAL (B‐BAL).

**Methods:** Children who underwent B‐BAL or NB‐BAL, with no history of chronic cough and no acute respiratory infection in the preceding 4 weeks were included. BAL was obtained according to European Respiratory Society guidelines. For B‐BAL, a sterile normal saline solution in three aliquots of 1 ml/kg (maximum 20 ml) was instilled into the right middle lobe (first and third aliquots) and lingula (second aliquot) and the return was suctioned into a mucus trap. The first and second aliquots were pooled for microbiological examination, while the third aliquot was used for cytology. For NB‐BAL, with the child's head turned to the left, an 8F catheter was inserted through the endotracheal tube until it was wedged. Sterile normal saline (1 ml/kg, maximum 20 ml) was instilled and collected for microbiology examination. A further 1 ml/kg (maximum 20 ml) was instilled and the second collection was utilized for cytology.

**Results:** The median age of the total cohort (42 B‐BAL and 58 NB‐BAL) was 7.4 years (range 8 days to 16.6 years). However, the NB‐BAL group was significantly older (8.2 years, IQR 5.4‐12.5 years, vs. B‐BAL 3.3 years, IQR 0.9‐9 years). In the pooled grouped, the median total cell count was 10.4 x104 per milliliter (IQR 5.7‐18.2x104), macrophage (89.5%, IQR 82.3‐93%), lymphocytes (5%, IQR 3‐10%) and neutrophils (4%, IQR 2‐7%). The total cell count and lymphocyte percentage were inversely correlated with age while the macrophage percentage was positively correlated with age. In univariate analysis, macrophage percentage was significantly higher in NB‐BAL (91%, IQR 87‐94%) compared to B‐BAL (85%, IQR 78‐90%) with lower lymphocyte percentage (NB‐BAL (4%, IQR 2‐6%) versus B‐BAL (10%, IQR 4‐13%)). However, when adjusted for age using regression statistics, these differences were not significant. There was no significant difference in the total cell count (NB‐BAL 9.3x104/mL, IQR 4.5‐15.3x104/mL versus B‐BAL 11.8x104/mL, IQR 8‐22.1x104/mL) and neutrophil percentage (NB‐BAL 4.5%, IQR 2.8%‐7% versus B‐BAL 3.5%, IQR 1.8‐8%) between the two groups. There was no significant difference in the differential cytology with age in both B‐BAL and NB‐BAL.

**Conclusion:** NB‐BAL provides comparable information on the cellularity components of BAL when compared to B‐BAL and should be considered an alternative. As age influences cellular differential count, age‐matched data are required for comparative studies on BAL in children.
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**Background:** Children with congenital heart disease have impaired pulmonary function whether before or after surgery. Pulmonary function assessment is important and should be performed after open heart surgery. We retrospectively collected the data of spirometry performed after open heart surgery in children with congenital heart disease, analyzed the prevalence of abnormal findings, its relation to the severity of underlying cardiac defect, and its impact on outcome across the spectrum of pediatric congenital heart disease after open heart surgery.

**Methods:** Patients with congenital heart disease, after open heart surgery (all less than 18 years of age) undergoing spirometry as part of routine clinical follow‐up by conventional spirometry at our hospital between 2015 and 2017 were included into our study. The data of vital capacity (FVC), forced expiratory volume in the first second (FEV1), ratio between FEV1 and FVC(FEV1/FVC) were collected.

**Results:** A total of 111 patients (mean age 15.46±5.95, 45 males and 26 females) who underwent spirometry after open heart surgery were enrolled into our study. Their diagnosis of congenital heart diseases included: 29 (26.1%) had TOF, 25 (22.5%) had VSD, 8 (8.1%) had TGA, and another 49 patients had other diagnoses. Normal spirometry was noted in 47 patients (43.7%), obstructive type in 35 patients (28.2%), restrictive type in 23 patients (15.5%), and mixed type in 7 patients (9.8%). In TOF patients, spirometry was normal in 9, obstructive type in 9, restrictive type in 10 and mixed type in 4. In VSD patients, spirometry was normal in 15, obstructive type in 4, restrictive type in 4 and mixed type in 2. In TGA patients, spirometry was normal in 4, obstructive type in 4 and restrictive type in 1. In other patients, spirometry was normal in 19, obstructive type in 16, restrictive type in 8 and other in 1.

**Conclusion:** Spirometry was normal in 17.1% patients after open surgery. In these spirometry assessments, obstructive type was more common than restrictive type (31.5% vs. 20.7%). However, in TOF patients, restrictive type was slightly more common than obstructive type.
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**Background:** Spirometry is an essential tool for assessing patients with lung disease. However, it necessitates cooperation and thus, it cannot be performed in infants. One of the established alternative techniques in infants is the raised‐volume rapid thoraco‐abdominal compression technique (RVTCT) which uses a compression vest to squeeze the chest forcedly after inflating the lungs to near total lung capacity (TLC). Although it is an acceptable method, it is far from being perfect since it is not easy to perform. Obtaining the raised‐volume passive expiration curve (RVPE) from passive deflation of the lungs from TLC is an easier technique (Figure 1). However, to our knowledge, data obtained from the RVPE curve were not assessed for their ability to estimate expiratory airway function in infants.

**Aim:** To compare data collected from the RVPE flow‐volume curves with those of the RVTCT and investigate the ability and ease of creating technically valid curves.

**Methods:** A retrospective study investigating the RVPE and the RVTCT curves in infants that were tested at Hadassah hospital during the years 2011‐2015. Data were gathered for: FVC (Forced Vital Capacity), FEV0.5, FEV0.75 (Forced Expiratory Volume at 0.5 and 0.75 seconds, respectively), and for the following flows: peak flow (PF), and the flows at 50%, 75% and 85% of the FVC (FEF50%, FEF75%, FEF85%) and the respective parameters for all of the above parameters on the RVPE loops (table [1](#ppul24373-tbl-0001){ref-type="table"}).

###### 

Raised‐Volume Forced vs Passive expiration techniques and their correlation

  Parameters                                           RV‐Passive Curve                                        RV‐Forced Curve                                           Pearson Correlation (r)
  ---------------------------------------------------- ------------------------------------------------------- --------------------------------------------------------- -------------------------
  Volumes                                                                                                                                                                
                                                       IC                                                      FVC                                                       0.888
  Volumes Per Second                                                                                                                                                     
                                                       PEV 0.5 sec                                             FEV 0.5 sec                                               0.816
                                                       PEV 0.75 sec                                            FEV 0.75 sec                                              0.844
                                                       PEV 1 sec                                               FEV 1 sec                                                 0.854
  Flow[\*](#ppul24373-tbl1-note-0002){ref-type="fn"}                                                                                                                     
                                                       Passive‐PF                                              Forced‐PF                                                 0.848
                                                       PEF 50%[\*](#ppul24373-tbl1-note-0002){ref-type="fn"}   FEF 50%[\*\*](#ppul24373-tbl1-note-0003){ref-type="fn"}   0.645
                                                       PEF 75%[\*](#ppul24373-tbl1-note-0002){ref-type="fn"}   FEF 75%[\*\*](#ppul24373-tbl1-note-0003){ref-type="fn"}   0.714
                                                       PEF 85%[\*](#ppul24373-tbl1-note-0002){ref-type="fn"}   FEF 85%[\*\*](#ppul24373-tbl1-note-0003){ref-type="fn"}   0.65
  Relations                                                                                                                                                              
                                                       PEV 0.5/IC                                              FEV 0.5/FVC                                               0.646

RV: Raised Volume, IC: Inspiratory Capacity, FVC: Forced Vital Capacity, PEV: Passive Expiratory Volume, FEV: Forced Expiratory Volume, PF: Peak Flow, PEF: Passive Expiratory Flow, FEF: Forced Expiratory Flow

The flow at certain Percentage of Inspiratory Capacity

The flow at certain Percentage of Forced Vital Capacity

John Wiley & Sons, Ltd.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

**Results:** Success rate: Of 166 tests meeting the inclusion criteria, 35% did not have valid RVTCT curves, as opposed to 8.4% of the RVPE group. In 107 tests with valid curves, only a third of the trials ended in a valid RVTCT curve, compared to 70% of RVPE loop trails. Correlations: FVC, FEV0.5, FEV0.75 and FEV0.5/FVC were correlated with their perspective parameters on the RVPE loops. R was equal to 0.888, 0.844, 0.819 and 0.646, respectively (*P* \< 0.05). The correlation between the PF, FEF50%, FEF75%, and FEF85% and their perspective parameters on the RVPE loops were 0848, 0.645, 07.14, 0.65 (table 1).

**Conclusions:** RVPE is easier to perform and correlates reasonably with the RVTCT.

Parameters RV‐ Passive CurveRV‐ Forced CurvePearson Correlation (r) Volumes ICFVC0.888 Volumes Per Second PEV 0.5 secFEV 0.5 sec0.816 PEV 0.75 secFEV 0.75 sec0.844 PEV 1 secFEV 1 sec0.854 Flows\* Passive‐ PFForced‐ PF0.848 PEF 50%\*FEF 50%\*\*0.645 PEF 75%\*FEF 75%\*\*0.714 PEF 85%\*FEF 85%\*\*0.65 Relations PEV0.5 /ICFEV0.5 / FVC0.646. **Figure 1**
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**Objective:** To verify the concordance between tuberculin skin test (TST) and interferon‐gamma release assay (IGRA) results for the diagnosis of latent tuberculosis infection (LTBI) in individuals aged up to 15 years old.

**Methods**: In this cross‐sectional study, we recruited immunocompetent, HIV‐negative subjects exposed to smear‐positive adult index cases with pulmonary TB. TST was performed with the purified protein derivative (PPD) RT23 (Statens Serum institute, Copenhagen, Denmark), whereas IGRA was performed through QuantiFERON® TB Gold in Tube (QFT‐GIT; Qiagen, Hilden, Germany). All procedures were performed according to manufacturers' recommendations by an experienced professional, blinded to clinical and radiological findings. TST was considered positive if induration \> 10 mm and QFT‐GIT when value of the TB antigen minus nil control was \> 0.35 IU / ml and \> 25% of nil value. Agreement between the results of the TST and QFT‐GIT tests were assessed through Kappa statistics.

**Results:** Among the 42 children evaluated, 22 (52.4%) were girls, 15 (35.7%) were under five when exposed to index cases, 26 (61.9%) were children or grandchildren of the index cases and 30 (71.4%) were exposed to the index case more than 1 day per week during the symptomatic period and before treatment with antituberculous drugs. Eleven out of the 42 studied patients (26.2%) had a positive result to TST and/or IGRA; none of them had active TB. Overall, the simple percent agreement between TST and QFT‐GIT was 95.2%, while Kappa value was 0.87 (*P* \< 0.001, 95% CI, 0.57‐1.0). Specifically for under‐fives, agreement between the two tests was slightly lower (simple percent 93.3% and Kappa= 0.84 (*P* = 0.001, 95% CI, 0.34‐1.0).

**Conclusion**: As the level of agreement between TST and IGRA was quite high, both tests might be used for the diagnosis of LTBI in children under fifteen years of age exposed to adults with smear‐positive pulmonary TB.

**Funding:** Supported by a Grant (number 303031/2016‐6, to PC) from the Brazilian Council for Scientific and Technological Development.
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**Objective:** The aim of this study was to evaluate the influence of malocclusion to upper airway volume in children during the mixed dentition period.

**Methods:** From 2014 to 2018, 39 patients in the mixed dentition period (at the age of 8‐10 years) who underwent cone beam computed tomography at our dental clinic were included in the study. Children for whom malocclusion treatment had already been initiated were excluded. The upper airway volume was defined as the total volume of nasopharynx and oropharynx as measured with SICAT AIR. Malocclusion was classified according to the anterior dentition into the following groups: crowding group (n = 7), protrusion group (n = 10), deep bite group (n = 11) and crossbite group (n = 11). The upper airway volume was compared among these groups. Statistical significance of differences among the groups was tested by the Mann--Whitney U‐test.

**Results:** The upper airway volume (mean ± SD) was 13921.7 ± 4037.8 mm3, 11847.8 ±4288.0 mm3, 10654.5 ±3.36.8 and 9617.2 ±2898.5 mm3in the three groups, respectively. The upper airway volume was reduced in the order of simple crowing group\>  protrusion group \>  deep bite group \>  crossbite group. Furthermore, the reversed occlusion group's volume was significantly lesser than the crowing group's volume (*P* \< 0.05).

**Discussion:** Our results indicate that upper airway volume in the protrusion and deep bite and crossbite groups is lesser than in the crowding group. This is probably due to severe malocclusion caused by lowering of the tongue position owing to disturbed nasal respiration in the presence of reduced upper airway volume.

**Conclusion:** We suggest that malocclusion in children is associated with upper airway stenosis.
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**Background:** Upper airway microbiota undergoes rapid evolution during the first 2 years of life, which may alter host susceptibility for respiratory tract infections and airway allergies. In contrast to microbiome in infancy, there is limited data on upper airway microbiota composition of healthy toddlers. This study investigated the profiles and determinants for nasal microbiota in Chinese toddlers.

**Methods:** Flocked nasal swab samples were collected at baseline from subjects who participated in a nutritional intervention study (registration identifier: NTR4779), which were stored at ‐80°C until analysis. DNA isolated by mechanical lysis was subjected to Illumina sequencing of the V4 region of the 16S rRNA gene. Samples with less than 6000 bp reads in amplicon sequencing were excluded from further analysis. Possible associations between host factors and nasal microbiota composition were analyzed using non‐supervised and supervised statistical methods.

**Results:** A random subset of 160 participants aged 18.2 ± 4.9 months, with 72 (45%) being males, were identified for this microbiome analysis. One hundred and forty‐three (89.4%) children were ever breastfed for 4.0 ± 4.7 months. Forty‐five (28.1%) children had passive smoking exposure. Based on DNA quantity and PCR quality, 94.4% of samples were eligible for microbial analysis. Following feature selection by abundance and coefficients of variation, we identified seven dominant bacterial genera that included *Corynebacterium, Dolosigranulum, Moraxella, Streptococcus, Staphylococcus, Haemophilus* and *Helcococcus*. These genera were also observed in deep nasopharyngeal swabs of Dutch children (Biesbroek et al, 2014; Bosch et al, 2016). We observed considerable heterogeneity of these microbes in nasal samples. Subjects' age accounted for 0.72% of the variance seen in microbiota composition (*P* = 0.005). However, none of the following factors significantly explained the variation in microbiota composition: gender, breastfeeding ever, presence of siblings, daycare attendance, history of neonatal problems, occurrence of allergic diseases and passive smoking exposure.

**Conclusion:** Nasal microbiome of healthy Chinese toddlers is dominated by seven bacterial genera, although there is considerable between‐sample heterogeneity. None of the host factors from metadata explained more than 1% of the variance observed in nasal microbiota composition, suggesting that most variation lies among individuals.

**Funding:** FrieslandCampina R&D and Health and Medical Research Fund (reference no. 17161332).
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**Background:** Post‐bronchoscopy fever in children is a commonly described complication (14.2%‐48%). Risk factors for fever are well described and include young age and abnormal BAL findings. However, anesthetic choice as a risk factor for fever has not yet been reported.

**Objectives:** The aim of our study was to explore the role of sedative agents as a risk factor for fever during the 24 hours after the procedure. Additional risk factors were investigated as well.

**Methods:** A retrospective analysis of files of immunocompetent children that underwent elective bronchoscopies during the period of 2013‐2017 in Safra\'s Children\'s Hospital was conducted, and a statistical analysis was performed.

**Results:** One hundred and thirty children were enrolled, 56.15% of patients were treated with Sevoflurane. Post‐bronchoscopy fever occurred in 23.85% of cases, 35.62% of patients receiving Sevoflurane developed post‐bronchoscopy fever compared to 8.77% in the non‐Sevoflurane group (RR= 4.06, CI \[1.66‐9.91\], *P* = 0.05). Multivariate analysis of the data (comorbidities, sedation choice, age, indication for performing the procedure, BAL performed and its findings, post‐prematurity, FTT, and medications) suggested that only Sevoflurane and young age were statistically significant risk factors for fever. Chronic treatment with Montelukast was found to be a protective factor against fever.

**Conclusions:** We conclude that post‐bronchoscopy fever is probably an inflammatory noninfectious process. Sevoflurane is a significant risk factor for developing post‐bronchoscopy fever by generating such inflammation. The same mechanism may also explain why Montelukst has a protective role.
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**Introduction:** Tracheobronchomalacia (TBM) is not a common disease, although several studies have reported that TBM is more prevalent than previously thought. Severe airway malacia is usually recognized and diagnosed in early infancy; on the other hand, cases that are not severe are often misdiagnosed. Flexible bronchoscopy (FB) is the gold standard for the diagnosis of TBM. However, this procedure is invasive and requires sedation and special techniques, thereby limiting its use. Alternatively, dynamic four‐dimensional computed tomography (4D CT) imaging is potentially a noninvasive modality. This study compares the findings of 4D CT with those of FB in the assessment of TBM.

**Aim:** To assess the accuracy of 4D CT in detecting TBM in young children.

**Methods:** Fifteen patients underwent 4D CT and FB at the Department of Pediatric Pulmonology and Allergy of Osaka Women's and Children's Hospital from April 2015 to December 2018.TBM was retrospectively reviewed as present or absent in 3 anatomic segments: trachea and the right and left main stem bronchi. TBM was defined as \> 50% reduction of the airway lumen.

**Results:** The study population comprised 15 patients (8 males and 7 females) with ages ranging from 1 month to 5 years（median: 9 months). The most common presenting symptom was recurrent wheezing. Eleven patients were diagnosed with airway malacia from the FB findings. Among the others, 1 patient had gastroesophageal reflux disease, 2 patients had complete tracheal rings, and 1 was idiopathic. The overall diagnostic accuracy of 4D CT compared to FB was 91% (41/45 possible segments). The agreement was not different between that for the trachea and the left and right bronchi. 4D CT indicated no false‐positive results.

**Conclusions:** 4D CT is a highly accurate and reliable noninvasive imaging modality for evaluating TBM in young children.
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**Background:** Lobar pneumonia is a serious infectious disease and causes severe morbidity and morbidity in children. Conventionally, radiological imaging is the test of choice for diagnosing pneumonia and follow‐up. Our objective was to determine the clinical application of chest sonography in pediatric patients with particular emphasis on sonographic characteristics in consolidation in lobar pneumonia in children.

**Method:** The study was conducted comparing chest sonography in 35 children from birth to 18 years of age suspected of having lobar pneumonia in a tertiary‐teaching hospital. All ultrasound examinations were conducted using a 3 to 8 MHZ probe. Chest sonography was performed by 2 authors (KSH and CWT). Chest sonography was interpreted independent of the radiographic findings. We included 35 patients who had the final diagnosis of lobar pneumonia. All of these patients had conventional clinical examination plus chest radiography and chest sonography.

**Results:** A total of 35 patients were included, ranging between 4 months to 18 years old with a mean and standard deviation of 5.3 ± 3.1 years old. Affected lobes were respectively; 3 on the right upper, 7 on the right middle, 10 on the right lower, 4 on the left upper and 11 on the left lower lobe. Sonographic signs that indicated lobar pneumonia were consolidation in the individual lung lobes. Cases with lobar pneumonia and consolidation showed scattered airbronchogram, There was no air entry with mixed fluid and tissue density, loss of nature curvature of lung surface with shrinkage of lung tissues.

**Conclusion:** Chest ultrasonography is a useful, safe and accurate diagnostic tool for evaluating children with lobar pneumonia and could well delineate consolidated lung in the affected lobes.
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**Aim:** To study the characteristics of pediatric patients who had initiated nocturnal Positive Airway Pressure (PAP) for treatment of OSAS and to assess the outcomes of PAP therapy.

**Methods:** Retrospective review of clinical data of patients aged 1 month to 18 years having initiated PAP for treatment for OSAS in the pediatric unit of a public hospital in Hong Kong. Treatment outcomes of polysomnographic parameters and symptoms pre‐ and post‐ therapy were analyzed and patient's adherence was evaluated.

**Results:** Forty‐five patients having initiated PAP during January 2009 to December 2016 were included. There was an increasing number of patients being initiated on PAP therapy for treatment of OSAS over the years. The study population was predominantly male with two‐thirds over 12 years old. Craniofacial or syndromal conditions were mostly present in young children less than 5 years old while obesity was more common in adolescents. Of the treated patients, 75.6% had allergic rhinitis. Comparing symptoms before and within 6 months after PAP trial, there were significantly less patients with complaints of habitual snoring (95.6% vs. 8.9%, *P* \< 0.01) and excessive daytime sleepiness (42.2% vs. 11.1%, *P* \< 0.01). There was significant improvement in PSG parameters with mean OAHI decreasing from 21.5±18.5/hour TST to 1.6±1.9/hour TST (*P* \< 0.05) and mean SpO2 (oxygen saturation) nadir increasing from 80.6%±10.4% to 90.9%±5.7% (*P* \< 0.05) after PAP therapy. Within 6 months of follow up, 57.8% of the patients adhered to PAP satisfactorily while the adherence dropped to 37.8% at the time of the latest follow‐up. Satisfactory usage established before 6 months was associated with favorable long‐term outcomes of satisfactory usage or cessation of therapy due to improvement at the latest follow‐up (chi square test *P* = 0.008). The commonest reported reason for non‐adherence was due to nasal obstruction.

**Conclusion:** Nocturnal PAP is an effective treatment option for OSAS especially in children with comorbid conditions. Our findings of high prevalence of coexistence of allergic rhinitis and complaints of nasal obstruction warrant further investigations on management strategies to improve adherence in our local population.
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**Background:** Tracheobronchial (TB) lumen narrowing may require prolonged positive‐pressure ventilation, endotracheal tube intubation or even surgical interventions. Therapeutic flexible bronchoscopy (TFB) of balloon‐expandable metallic stent (BEMS) placement and subsequent management with forceps, laser and balloon dilatation are less invasive and may be helpful. This study aimed to analyze the placement, follow‐up management with TFB and long‐term outcomes in small infants with BEMS.

**Methods:** This retrospective study reviewed the medical records and associated TFB videos of infants with a maximum BW of 5.0 kg who had TB BEMS placement from January 2005 to December 2018 at our institution. All these TFB procedures were supported with a novel Noninvasive ventilation of nasopharyngeal oxygen with intermittent nose closure and abdominal compression.

**Results:** Forty‐three BEMSs were placed in 26 infants. The mean BW and mean age were 4.0 ± 0.8 kg and 4.9 ± 2.7 months, respectively. There were 21, 9 and 13 stents located in trachea, carina and main‐stem bronchi, respectively. Seven infants with 13 stents died without obvious stent‐related mortality. Among them, 12 stents in 8 children were successfully retrieved by rigid endoscopy. At placement, the diameters of 30 tracheal and 22 bronchial stents were 7.5 ± 1.1 (4--10) and 5.4 ± 0.9 (4--8) mm, respectively. These implanted BEMSs could be gradually and significantly (*P* \< 0.01) expanded. At the end of this study, all the remaining 18 stents in 12 infants could be kept functional. The diameters of the 11 remaining tracheal and 11 remaining bronchial stents were 9.7 ± 2.0 (8--14) and 7.0 ± 1.4 (4--10) mm, respectively.

**Conclusion:** BEMSs are practical and effective in select small infants with benign TB narrowing and can be safely implanted and managed with TFB, and finally retrieved by rigid endoscopy.

**Keywords:** balloon dilatation; balloon‐expandable metallic stent; flexible bronchoscopy; nasopharyngeal oxygen with intermittent nose closure and abdominal compression.
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**Background:** Primary spontaneous pneumothorax (PSP) is a significant clinical problem in pediatric populations. Patients with recurrent PSP or persistent air leakage require video‐assisted thoracoscopic surgery (VATS) for bullectomy and mechanical pleurodesis. Compared to conventional triple‐port VATS (TP‐VATS), single port‐VATS (SP‐VATS) has become a trend in adult populations owing to a smaller surgical wound, less pain and a more rapid recovery period. The aim of this study is to evaluate the clinical effectiveness of single port VATS for pediatric patients with primary spontaneous pneumothorax.

**Methods:** We retrospectively reviewed pediatric patients (age less than 18 years old) who received VATS for bullectomy and pleurodesis for recurrent PSP between January‐May 2015 to September 2018 at the China Medical University Children's Hospital. The surgical outcome of conventional TP‐VATS and SP‐VATS were compared and analyzed.

**Results**: A total of 63 surgeries were performed in our institute, including 12 cases of TP‐VATS and 51 of SP‐VATS. The patients' median age was 16±1.15 years old, and 92.3% patients were male (Male to Female ratio= 12:1). The site of the pneumothorax was 62.9% at the left side, 32.3% at the right side, and 4.8% at both sides. The operation time (109.3±23.9 for TP‐VATS vs. 100.2 ± 39.2 minutes for SP‐VTAS, *P* = 0.258) and postoperative hospital stay (3.1±0.87 vs. 3.57±1.01 days, *P* = 0.251) were not significantly different between these two groups. The ipsilateral recurrence rate was slightly higher in the TP‐VATS group compared to the SP‐VATS group (33% vs. 13.7%, OR= 2.36, *P* = 0.095) The median recurrence time after surgery was slightly longer in TP‐VATS than in SP‐VATS (188 \[156.3 ‐ 294.8\] vs. 141.5 \[74.5‐245.5\] days, *P* = 0.096). Females were more likely than males to have ipsilateral recurrence in the SP‐VATS group (M:F= 10.4% vs. 40%, OR= 5.73, *P* = 0.124).

**Conclusion:** SP‐VATS is as effective as TP‐VATS for treating pediatric patients with recurrent PSP. Both groups have similar operation time and postoperative hospital stay; nevertheless, SP‐VATS is associated with lower recurrence rate and longer recurrence time.

K‐195. Endobronchial Foreign Body‐ An Important Cause of Respiratory Symptoms in Children and its Management by Flexible Bronchoscopy {#ppul24373-sec-0940}
=====================================================================================================================================

[*Tahura S*.]{.ul} ^1^ *,* Kabir L.^2^, Molla A.^3^

^1^Pediatric Respiratory Medicine, Bangladesh Institute of Child Health (BICH), Dhaka Shishu Children Hospital ‐ Dhaka, Bangladesh; ^2^Pediatrics, Ad‐Din Women Medical College ‐ Dhaka, Bangladesh; ^3^Pediatrics, Ibrahim Medical College ‐ Dhaka, Bangladesh

**Introduction:** Foreign body (FB) aspiration in the airway is a common occurrence in the pediatric age group; however, it is not always diagnosed (especially in radiolucent FB) due to nonspecific symptoms of varying severity. Often the symptoms are subtle and mistaken for other more common conditions such as pneumonia and asthma and does not respond as expected to standard therapy and presents a diagnostic challenge.

**Aim:** This study aimed to emphasize the importance of considering endobronchial foreign body as a cause of persistent or recurrent respiratory symptoms in children and to outline the clinical evidence of the utility and feasibility of flexible bronchoscopy for endobronchial FB management in children.

**Methods:** This prospective study was performed on children (aged 6 months to 6 years) having recurrent or long standing, non‐resolving or partially resolving respiratory complaints who underwent flexible bronchoscopyfor suspected FB from July to December 2018 in a tertiary care hospital in Bangladesh. History, clinical, radiological, bronchoscopic findings and immediate effect after bronchoscopy were analyzed.

**Results:** Among a total of 11 children, only 18.2% (n = 2) had a definite history of FB aspiration. The most frequent symptom was paroxysmal cough (72.7%) followed by wheezing, stridor and recurrent pneumonia. FB was found in 54.5% (n = 6) of children and removed successfully by Dormia basket in 5 children and 1 by grasping forceps. The most common (n = 3) FB was peanut. Other foreign bodies were a plastic Tasbih bead, a pencil torch light filament and a custard apple seed. Respiratory symptoms improved after removal of foreign bodies in all cases. During the procedure, transient hypoxia developed in 2 children which was alleviated by temporary cessation of the procedure.

**Conclusions:** The possibility of foreign body aspiration should be considered in any child who presents with persistent or recurrent respiratory symptoms. Flexible bronchoscopy is documented as a crucial diagnostic and safe therapeutic tool for foreign body management in the pediatric age group.

12. CELLULAR AND MOLECULAR BIOLOGY {#ppul24373-sec-0950}
==================================

L‐81. Role of Biomarker and Effect of FIP‐FVE in an Acute and Chronic Animal Asthma Model {#ppul24373-sec-0960}
=========================================================================================

**Lue K. H.^1^, [*Pan H. H*.]{.ul}^*2*^*,* Sun H. L.^1^, Lee Y. T.^1^**

^1^Department of Pediatrics, Institute of Allergy, Immunology, and Rheumatology, Chung Shan Medical University Hospital ‐ Taichung, Taiwan; ^2^Institute of Medicine, Chung Shan Medical University ‐ Taichung, Taiwan

**Background:** Asthma is a chronic inflammatory airway disease. It is a significant public health issue all over the world. There have been many clinical and experimental studies in past years which have implied that allergic asthma is much more heterogeneous and complex than the Th2 model. Previous studies have also shown that excessive inflammation worsens chronic and allergic inflammatory diseases. Moreover, different stages of asthma and allergic inflammatory diseases might also appear in different immune environments.

**Objective:** In this study, we investigated an immune microenvironment including cytokines and chemokines during acute and chronic stages of an asthma/allergy model and also investigated the effect of FIP‐fve in the immune microenvironment during acute and chronic stages.

**Materials and Methods:** Acute, female BALB/c mice were intraperitoneally sensitized with ovalbumin on days 1, 2 and 3, and received intranasal OVA challenges on days 14, 17, 21, 24 and 27. The sensitized mice were divided into different groups according to the course of designed airway changes. FIP‐fve groups of sensitized mice received 200μg of FIP‐fve on days 1 to 14 (pretreatment) and the other groups of sensitized mice received the same drug on days 14 to 27 (posttreatment). In the chronic model, the mice were intraperitoneally sensitized with ovalbumin on days 1, 2 and 3, and received intranasal OVA challenges on days 14, 17, 21, 24, 27, 60, 69, 71, 73, 74 and 75. However, FIP‐fve groups of OVA‐treated mice were given FIP‐fve. The pretreated groups were given FIP‐fve on days 1 to 14 and days 45 to 60. The post‐treated groups were given FIP‐fve or a corticosteroid on days 14 to 28 and days 60 to 75.

**Results:** According to the results, TGF‐β, TNF‐a, IL‐8, IL‐17, CXCL‐1, CXCL‐10, CCL‐17 and CCL‐22 were highest in the chronic stage compared to the acute stage. However, their difference might be the marker to distinguish between acute or chronic stage in asthma. Moreover, in the FIP‐fve groups, Th2 cytokines and TNF‐a, IL‐8, IL‐17, TGF‐ β, CXCL‐1, CXCL‐10, CCL‐17 and CCL‐22 were decreased significantly while IL‐22 increased significantly in the FIP‐fve groups during the chronic stage.

**Conclusions:** There are many different immune responses in the different stages of asthma. Therefore, our finding could be the marker to distinguish between acute or chronic stage in asthma. However, FIP‐fve can improve asthma through immune regulation not only in acute, but also in chronic stages. Hence, FIP‐fve might be an alternative therapy that can be used in the different stages in allergic airway diseases such as asthma.
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**Background:** Childhood Interstitial Lung Disease (CHILD) is a rare but important cause of DLD. Controlled ventilation high resolution computed tomography (CVHRCT) and bronchoalveolar lavage play limited roles in the diagnosis of CHILD. Genetic testing for the hereditary form of CHILD is expensive and not widely available in low middle‐income countries (LMIC), including South Africa. Thus, lung biopsy is a potentially useful diagnostic tool in diagnosing and directing therapeutic management of CHILD.

**Methods:** We conducted a retrospective cohort study in Cape Town, South Africa, on the role of lung biopsy in diagnosing CHILD and directing therapeutic management in children presenting with DLD.

**Results:** Thirty‐six (36) lung biopsies for DLD were performed between January 1 2013 and June 30 2018. Median age was 52 months (range 1 To 164 months), 15 (42%) females, 19 (53%) \< 2 years age; 8 (22%) were performed via open lung biopsy and 25 (69%) via Video‐Assisted Thoracoscopic Surgery (VATS). A definitive histological diagnosis was reached in 35/36 (97%) patients. In children \< 2 years of age, pulmonary hemorrhage syndrome (7/19, 37%), probable surfactant dysfunction/ chronic pneumonitis of infancy (4/19, 21%), others (7/19, 37%) including lung infections, systemic disease, lipoid pneumonia and congenital pulmonary airway malformation, were the leading causes. One had no histological diagnosis due to suboptimal specimen. In children \> 2 years age, pulmonary hemorrhage syndrome (9/17, 53%) followed by pulmonary infections, pulmonary lymphangiectasia, hypersensitivity pneumonitis and metastatic thyroid carcinoma were the leading causes (8/17, 47%). Complications of lung biopsy were few (4/36,11%) and included pneumothorax, bleeding, emphysema and infection. Intervention involved the increase or addition of immunosuppressive drugs 20/35 (57%), discontinuation of therapy 6/35 (17%), palliation 2/35 (6%) and addition of other treatment 7/35 (20%) such as antibiotics, immunoglobulins, ganciclovir and sirolimus. Thirty (30/36, 83%) children are currently being followed, 5 died (14%) including two post mortem biopsies, and 1 (3%) was lost to follow‐up.

**Conclusion:** Lung biopsy has an important role in diagnosing CHILD and directing therapeutic management in children presenting with DLD in LMIC where genetic testing for hereditary CHILD conditions is not widely available. Pulmonary hemorrhage syndromes with capillaritis is an important cause of CHILD in South Africa.
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**Introduction**: Community‐acquired pneumonia can be complicated by empyema thoracis. Prompt diagnosis and management will influence the outcome. We intend to compare the management of empyema thoracis in Malaysia to local and international guidelines.

**Methods:** Retrospective descriptive study of children diagnosed with community‐acquired pneumonia complicated by empyema thoracis, who were admitted to Penang Hospital (northern regional tertiary hospital with Pediatric Respiratory services), Malaysia from October 2017 to October 2018. Adherence to the standards for diagnosis, investigation and management were analyzed.

**Results:** Fifteen patients were reviewed, of which 86% (13/15) were less than 5 years old. Approximately 53% (8/15) presented before Day 5 of illness and only 40% (6/15) received outpatient antibiotics. Most patients were diagnosed with empyema thoracis based on the chest radiograph during the first week of illness (67%, 10/15 cases, median: Day 5 of illness). All patients were subjected to thoracic ultrasound for confirmation and staging of effusion by the second week of illness (Median: Day 8.5 of illness). Chest drainage was performed in 67% (10/15) of patients, however, first insertion was at median Day 10 of illness due to late presentation. Urokinase was administered in 47% (7/15) of patients with a failure rate of 57% (4/7). They were unsuitable for urokinase intervention due to late presentation and referral or clinically unstable upon diagnosis. Most patients underwent open lateral thoracotomy and decortication (73%, 11/15 cases) with prolonged median hospital stay of 21 days (range 14 ‐ 52 days) while those who had successful urokinase therapy had a median hospital stay of 16 days (range 14 -- 23 days). This may be due to late presentation, unsuccessful urokinase therapy and inaccessibility of Video Assisted Thoracoscopy Surgery (VATS) in Penang Hospital. One patient recovered with only antibiotic therapy (without any urokinase or surgical intervention).

**Conclusion:** Empyema thoracis is associated with high morbidity but rarely mortality. There were various limitations in our center which eventually led to surgical management of empyema thoracis. In the presence of a Malaysian consensus guideline, educational courses need to be reinforced to ensure better understanding, proper implementation and improve outcomes.
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**Objective:** To determine the correlation of Fingertip Portable Pulse Oximetry versus Arterial Oxygen Saturation Result of patients with Pediatric Community‐Acquired Pneumonia ages 2 months to 18 years old seen at the Emergency department of a Tertiary Government Hospital.

**Design:** Cross‐sectional analytical study.

**Setting:** QCGH Medical Center.

**Subjects:** All pediatric patients aged 2 mos. -- 18 years seen at the QCGH ‐ Emergency department presented with PCAP C & D.

**Methods:** O2 saturations of patients with PCAP C & D using only one MD FS20A brand of Fingertip PPO and ABGs were obtained and recorded. O2 saturations by Fingertip PPO and arterial oxygen saturation were then compared using Pearson's correlation coefficient.

**Statistical Analysis:** SPSS version 10 for Windows was used. Descriptive statistics were generated for all variables. For nominal data, frequencies and percentages were computed. For numerical data, mean ± SD were generated. Analysis of the different variables was performed using Pearson's correlation and McNemar test.

**Results:** A total of 168 subjects were included. Mean age was 2.94 years. Mean RR was 58.41. There was a strong positive correlation of 0.72 noted in the comparison of the results of O2 saturation pulse oximeter and arterial blood gas result as proven by the p value of \< 0.001. The oxygen saturation reading of Fingertip PPO was comparable with arterial oxygen saturation. As oxygen saturation in fingertip PPO increased, arterial oxygen saturation result also increased or vice versa.

**Conclusion:** This study showed a direct correlation between the O2 saturation obtained from Fingertip Portable Pulse Oximeter with that of the oxygen saturation in arterial blood gas.

**Keywords:** O2 saturation, portable pulse oximeter (PPO), SaO2.
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**Background:** Routine zinc supplementation is a potential intervention for the prevention of acute lower respiratory infections in developing countries. However discrepant findings from recent randomized trials remain unexplained.

**Methods:** This study was a prospective, open label single arm clinical study. Four hundred and sixty‐five healthy children aged 6 months to 5 years were enrolled in the study. The data on socio‐demographic profile, number and duration of episodes of acute upper and lower respiratory infections in the last 6 months were collected through a pretested structured questionnaire. Anthropometry was performed and all children were assessed for serum zinc levels. The primary outcome was the prevalence of serum zinc deficiency. Children having zinc deficiency were recruited for the study of the effect of oral administration of zinc 20 mg for 2 weeks. The secondary outcomes were incidence and duration of acute upper respiratory and acute lower respiratory infections per child‐year and side effects after giving zinc therapy.

**Results:** There was no significant difference with regard to mean age, weight, height and modified Kuppuswamy classification of family status between zinc deficient and non‐zinc deficient groups. There was a significant difference in mid arm circumference between zinc deficient and non‐zinc deficient groups. Also the number of episodes of acute upper respiratory infections (AURI) and mean duration of acute respiratory infection (ARI) was significantly different in the two groups. There was no significant difference in acute lower respiratory infection (ALRI) episodes in the two groups.

After zinc supplementation in zinc deficient children, there was a significant decrease in the number of episodes of AURI, ALRI and mean duration of ARI at 6 months after supplementation as compared to the preceding 6 months before supplementation.

**Conclusion:** This study sheds light on the efficacy of short course prophylactic zinc supplementation in reducing the burden of ARI among zinc deficient children. Future studies should assess the effectiveness of delivering prophylactic zinc supplementation at scale, comparing the feasibility and cost benefit of short course and continuous regimens.
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**Background:** Acute Respiratory Distress Syndrome (ARDS) is a serious complication of sepsis and septic shock. This syndrome increases the mortality rate of sepsis. The exact diagnosis and treatment of ARDS contribute to a reduction in mortality from hypoxia and from sepsis in general.

**Objectives:** To describe the ARDS characteristics in children with septic shock at a teaching hospital in Viet Nam.

**Methods:** A descriptive prospective study of ARDS in children from 2 months to 15 years old with septic shock between 10/2008 and 4/2011 in the emergency department and intensive care unit at Children\'s Hospital 1 in Ho Chi Minh city, Viet Nam. Septic shock was diagnosed according to criteria of the International Pediatric Sepsis Consensus Conference in 2005. We used the Berlin definition to recruit ARDS cases with at least 2 samples of blood gases separated by 12 to 24 hours showing a ratio of PaO2/FiO2 ≤ 300 mm Hg. We excluded patients with congenital heart disease and heart failure.

**Results:** Eithty ‐three children were included. Males represented 48.5%, average age was 31.7 ± 4 months. The rate of ARDS was 39.8%. The mortality rate in children with this syndrome was 78.8%. Septic shock with ARDS had a higher mortality rate than septic shock without this syndrome (26%). Most children with this syndrome were in the moderate and severity range (78.8%); 81.8% were ventilated. The tidal volume was 8.3 ± 1.6 ml/kg and average PEEP was 8.6 ± 2.2 cmH2O, the medium FiO2 was 90.7 ± 16.4 %; 36.4% of cases had a tidal volume of 8 to 10 ml/kg. There were no differences in tidal volume, PEEP and FiO2 between survivor and non‐survivor cases.

**Conclusions:** ARDS had a high prevalence in pediatric septic shock and the mortality rate among septic shock cases with this syndrome is still very high.

**Keywords:** septic shock, acute respiratory distress syndrome
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**Background:** Flexible bronchoscopy (FB) in children has been widely accepted and applied by pediatric pulmonologists since decades. It is an important procedure for evaluating the pediatric airway as well as therapeutic purposes. In Indonesia, the procedure is still less performed due to less availability of the equipment and the experts as well. It is a great challenge for us as pediatric pulmonologists in Indonesia to start initiating the procedure more widely to our patients.

**Objective:** To describe our 6 years' experience of performing pediatric flexible bronchoscopy in Harapan Kita Women and Children Hospital, Jakarta, Indonesia.

**Method:** All children with varying indications who had undergone a FB procedure from August 2012 to August 2017. Children of age 1‐month to 18‐years were included in this study. The data were collected from medical records and analyzed using SPSS version 22.

**Results:** Of 591 patients, boys were more predominant (n = 354, 59.9%) than girls (n = 237, 40.1%). There were 69.9% (n = 413) children under 12 months old, 17.8% (n = 105) were between 12 to 36 months old, 12.3% (n = 73) more than 36 months old, and the youngest was 10 days of age. There were 32.5% (n = 192) of the patients who were referred from other hospitals. The procedures were performed in the operating theatre and PICU. Sedation was performed by our anesthesiologist or pediatric intensivist colleagues. None of the patients suffered from severe complication after the procedure. The FB findings were laryngomalacia as a single condition (52.8%), normal airway (8.8%), left main bronchus stenosis (8.6%), laryngo‐tracheomalacia (6.9%), foreign body aspiration (2.7%), and other combinations of congenital airway problems. All cases (n = 16) of foreign body aspirations were also successfully retrieved by FB. The number of procedures increased every year, 2 in 2012, 23 in 2103, 62 in year 2014, 96 in 2015, 126 in 2016 to 177 in 2017, and 104 in 2018.

**Conclusion:** Flexible bronchoscopy is a very helpful tool in the management of pediatric airway problems. There is an increasing need for the procedure. We must start and improve the procedure in Indonesia to enhance the comprehensive management of childhood airway problems.

**Keywords:** airway problems, pediatric flexible bronchoscopy, diagnostic, therapeutic tools, complication.
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**Background:** The World Health Organization recommends that bacteriological confirmation of TB should be sought whenever possible as indicated by clinical presentation. This is however not usually possible due to the paucibacilliary nature of childhood TB and the difficulty in getting sputum from young children. In Nigeria at present, the diagnosis of TB in children is made using the TB score chart which is based on clinical findings.

**Objective:** To assess the sociodemographic features and the diagnostic methods of childhood tuberculosis in Nigerian children.

**Methods:** This was a retrospective cross‐sectional study. Data were extracted from the case notes of children managed for tuberculosis in the Pediatric ward and the DOTs clinic of UUTH from January 2013 to December 2017. Information extracted from the case records included the patients' epidemiological data, duration of illness, signs and symptoms, TB score, chest radiograph findings and microbiological diagnosis. Pulmonary tuberculosis was defined as a symptomatic child with: (1) bacteriologically‐confirmed tuberculosis, (2) radiologically‐confirmed tuberculosis, or (3) probable tuberculosis (as defined). Probable TB was defined as a TB score \> 7 and a good clinical response to antituberculosis treatment in the absence of bacteriological confirmation or radiological certainty. Radiologically‐certain TB was defined as agreement between two independent radiologists that the chest X‐ray indicated certain tuberculosis and a TB score 1 to 6 in the absence of bacteriological confirmation and a good clinical response to antituberculosis treatment.

**Results:** Thirty‐three patients met the criteria for TB as defined in this study. The total inpatients from January 2013 to December 2017 were 3276, while the total number of respiratory cases for this period was 1307. Therefore, the prevalence of TB was 1% and 2.5% of the total ward admissions and respiratory admissions respectively for the period studied. Most patients (56%) were in the 0 to 5 year age group, with a predominance of males (72%). Ten patients (31%) had a positive history of contact with an adult with chronic cough and 30 patients (94%) had BCG vaccination. Cough (72%) was the commonest symptom recorded with a mean duration of 13 weeks, followed by weight loss (63%) and fever (63%). Pallor (47%) was the commonest clinical sign, followed by lymphadenopathy (44%). Nine patients (28%) had abnormal chest signs. Two patients (7%) had a positive sputum AAFB result, geneXpert was positive in the gastric aspirate sample of one patient and negative for all the sputum and lymph node aspirate results. The chest radiograph was suggestive of TB in 21 (84%) patients while TB‐HIV coinfection was present in nine (29%) patients. Tuberculin skin test (Mantoux) measurement ranged from 0‐23mm with a mean ± SD of 10±7.8. Nine (53%) of the patients had a Mantoux result of 10mm and above. The TB score ranged from 6 to 17 with 96% of the patients having a TB score of seven and above.

**Conclusions:** The microbiological confirmation of TB in Nigerian children is grossly inadequate and the TB score chart and TB algorithm is still the preferred method of TB diagnosis in Nigerian children.
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There is a paucity of data regarding childhood pneumonia in Asia and this is more so in South Asian countries such as Sri Lanka.

The **objective** of the study was to describe the outcome of the children admitted with acute community‐acquired pneumonia to a tertiary unit in the country.

This is a **retrospective study** conducted in children who presented to the professorial pediatric unit of the Teaching Hospital, Peradeniya from March 1st 2016 to August 30th 2017, fulfilling diagnostic criteria for community‐acquired pneumonia requiring in‐hospital care.

**Results:** The study population included 127 children, aged between 1 month and 14 years; 58% were girls and 42% boys. There were 42, 69 and 15 patients in the age categories of 1 month to 1 year,one to 5 years and more than 5 years respectively. Bronchopneumonia was diagnosed in 47% of patients while 44% had lobar pneumonia. Atypical pneumonia was diagnosed in 3%. The diagnosis of the remaining patients was undetermined lower respiratory tract infection. All patients fulfilled the admission criteria and were treated according to the unit guidelines which are based on British Thoracic Society guidelines and Infectious Diseases Society of America (IDSA) pediatric guidelines. Accordingly, antibiotics had been changed to second line agents if there was no/inadequate response by 48 to 72 hours. This included addition of azithromycin or clarithromycin and addition of vancomycin to cover atypical organisms and resistant pneumococcal infections respectively.

In our sample, 35% (44) of patients responded to first line antibiotics including cefuroxime, cefotaxime, ceftriaxone or co‐amoxiclav according to unit policy, 52% (66) required second line antibiotics and 13% (17) needed treatment beyond second line agents due to complications.

According to the unit policy to transfer to ICU which is based on IDSA guidelines, 2% of the patients needed intensive care. HDU care was given for 38% of patients who required supplemental oxygen to maintain pulse oximetry above 92%.

Analysis of length of hospital stay indicated that 25% of the patients were discharged by the 4th day and 61% were hospitalized for 5 to 9 days. There was no mortality among the patients evaluated.

**Conclusions:** This retrospective analysis revealed that childhood community‐acquired pneumonia is associated with significant morbidity and is an economic burden. The majority (65%) needed therapy beyond first line antibiotics which may indicate significant antibiotic resistance.

**Reflections and proposals:** The study sheds light on indirect evidence of significant antibiotic resistance and the need for surveillance data on drug sensitivity and a national policy on antibiotic use. Moreover, it highlights the importance of introduction of the pneumococcal vaccine to the national program of immunization.
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Wheezing episodes due to viral infections that occur early in life have been identified as risk factors for the development of asthma in childhood. Human Metapneumovirus (hMPV) is one of the most frequently detected viruses in children under 2 years of age in Hospital Nacional de Niños of Costa Rica.

**Objective:** This study aimed to determine the prevalence of recurrent wheezing and asthma in a group of children with a history of hospitalization due to low respiratory tract infection by Metapneumovirus.

**Methods:** We performed a cross‐sectional study that included all patients that were hospitalized before the age of two, and tested positive for hMPV in the immunofluorescence of nasopharyngeal aspirate, between 2008 and 2011. A telephone questionnaire was performed to inquire about the prevalence of wheezing episodes and diagnosis of asthma of these patients at the age of 6 to 11 years.

**Results:** a total of 65 children were reached to complete the questionnaire. The prevalence of asthma in this group was 41.5%, with up to One‐third of the children being male (66%). We found that 66% of the patients reported having at least one other episode of wheezing in the first 12 months after discharge. The mean age of hospitalization was 7.3 months, and 81.4% were younger than 1 year of age. We did not find an association between younger age at the time of hospitalization, prematurity or secondhand smoke exposure and asthma diagnosis at school age. The children who were exclusively breastfed in the first 6 months of life were found to have a lower prevalence of asthma later in childhood (OR= 0.3, CI, 95%, 0.1‐0.9). On the contrary, children that used antibiotics in the first 2 years of age had a higher prevalence of asthma (OR= 3.2, CI, 95%, 1.1‐10.7). We found a high percentage of patients who were exposed to secondhand smoke at home at the time of hospitalization (35.3%) and during pregnancy (47.6%), yet we could not demonstrate an association with the diagnosis of asthma. Up to 32.3% of the patients of school age reported having respiratory symptoms during exercise, and 30.7% had nocturnal symptoms.

**Conclusion:** The prevalence of asthma in children with a previous respiratory infection by hMPV is very high, and twice of that reported nationwide (21.9%). Other associations found were that children who used antibiotics in the first 2 years of life had a higher prevalence of asthma, while breastfeeding resulted in a preventive association. The prevalence of secondhand smoke found in this study exceeds the latest reported prevalence in the country (19.7%).
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**Introduction:** Recurrent and persistent pneumonia is one of the common reasons for referral and continues to be a major challenge. There are limited data on underlying causes of persistence or recurrence of pneumonia in children. This study aimed to ascertain the etiology and clinical profile of recurrent and persistent pneumonia in tertiary level hospitals in Dhaka city.

**Methods:** A descriptive cross‐sectional study conducted in admitted recurrent and persistent pneumonia patients in tertiary level hospitals in Dhaka City during June 2015 to May 2016. Among the enrolled population, 100 recurrent and persistent pneumonia patients were finally studied and analyzed after completing the inclusion criteria. Recurrent pneumonia was defined as 2 or more episodes of pneumonia in a single year or 3 or more episodes ever, with radiographic clearing between occurrences. Persistent pneumonia was defined as features of lower respiratory tract infection with radiological evidence of infiltrates or consolidation in lungs persisting for 30 days or more, despite receiving antibiotics for minimum 10 days. The following investigations such as CXR, CBC with film, TB screening, CRP, blood culture, USG of chest, HRCT, bronchoscopy, contrast swallow of esophagus in T position, stool for fecal fat, sweat chloride test, serum IgG, IgA, IgM level, T‐cell, B‐ cell marker, echocardiography, pleural fluid study, X‐ray PNS, saccharine test were performed according to cases. Patients were followed‐up regularly.

**Results:** Among 100 cases, 66 were male and 34 female, ages ranging from 2 months to 14 years with a mean age of 3.92 ± 3.75 years. Seventy‐six (76%) were recurrent pneumonia and 24 (24%) were persistent pneumonia. Etiology of recurrent and persistent pneumonia was determined in 83 cases. The most common causes of recurrent pneumonia were recurrent aspiration (21%: GIT aspiration ‐18.4% and foreign body aspiration ‐ 2.6%), cystic fibrosis (19.7%), pulmonary tuberculosis (7.9%), congenital heart disease (6.6%) and immunodeficiency (3%). The most common causes of persistent pneumonia were recurrent aspiration (37.5%: GIT aspiration ‐ 20.8% and foreign body aspiration ‐16.7%), pulmonary tuberculosis (12.5%), congenital cystic adenomatous malformation of the lung (4.2%), interstitial lung disease (4.2%) and cystic fibrosis (4.2%). Less common causes were immunodeficiency, cerebral palsy, spinal muscular atrophy, Down syndrome, bronchopulmonary dysplasia, BOOP, bronchial asthma.

**Conclusion:** Aspiration pneumonia, cystic fibrosis, pulmonary tuberculosis, congenital heart disease and immunodeficiency, congenital cystic adenomatous malformation of the lung and interstitial lung disease are common causes of recurrent and persistent pneumonia.
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Central sleep apnea (CSA) and periodic breathing are unusual findings described in pediatric patients with congestive heart failure. However, CSA has not been reported in children with pulmonary hypertension. We hereby report on a 10‐year‐old girl with idiopathic pulmonary arterial hypertension (IPAH) who had frequent central events in a periodic breathing fashion seen in her polysomnography, which was normalized following medical treatment leading to improvement of the pulmonary pressures.

This case supports the importance of PSG in pediatric patients with IPAH, not only to exclude OSA as a potential cause but also to assess for the presence of PB. We also show that the presence of PB might be a sign of disease severity and can be a marker of response to medical treatment. Prompt diagnoses and management of IPAH would improve SDB in this vulnerable population and might lead to a favorable prognosis.
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**Background:** Esophageal duplication cyst (EDC) is a rare developmental aberration arising from the embryonic foregut. It may remain asymptomatic but produces a mass effect on surrounding organs if it rapidly enlarges. Congenital pulmonary airway malformation (CPAM) is a congenital lung malformation with an unknown chance of developing symptoms. Here we report a rare case of a esophageal duplication cyst with CPAM.

**Case summary:** A 16‐month old boy with type 2 CPAM presented progressive stridor and was admitted to our hospital because of pneumonia. The patient responded poorly to antibiotics. A chest X‐ray showed consolidation in the left upper lobe with tracheal right side deviation. Chest computed tomography (CT) revealed a cystic lesion 3.3 cm in size in the superior mediastinum. During the surgery, we found an isolated cystic lesion located between the trachea and bilateral carotid arteries. The cyst was completely removed and some yellowish turbid was exuded when the cyst was incised. Microscopically, the cyst was lined by squamous epithelium (90%) and ciliated columnar epithelium (10%). The cyst wall presented predominantly of smooth muscle, with an absence of mucus gland, cartilage, thyroid follicle, lymphoid tissue, or thymic tissue. Finally, pathological diagnosis was confirmed as an EDC. The postoperative course was uneventful and the patient was discharged as such. One month later, at outpatient clinic follow‐up visit, the patient no longer had stridor.

**Conclusion:** To the best of our knowledge, this is the first case report of EDC with left side type 2 CPAM. Our patient is also the only known case to recover well without lobectomy of CPAM. Despite the rarity of esophageal duplication cyst, a chest CT scan should be considered for children with persistent stridor, as well as CXR findings of the trachea deviated by a mass lesion in the mediastinum, especially for those with CPAM.
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**Introduction:** We report the case of a 2‐year‐old female with suppurative chronic bronchitis associated with esophageal candidiasis revealing a rare genetic disease, recently described: heterozygous STAT1 gain of function.

**Case Report:** E. 2 years old, with no personal or family past history and no inbreeding, was referred for feeding difficulties (anorexia and crying for first 6 months), with failure to thrive associated with persistent wet cough since the age of 6 months and persistent mouth candidiasis (despite prolonged adequate treatment). Clinical examination found crackles in the left inferior lobe with folds candidiasis. Chest radiograph (fig 1) showed left inferior opacity consistent with partial atelectasis. Fiberoptic bronchoscopy showed thick and diffuse secretions, predominantly in left bronchial tree. Bronchoalveolar lavage was inflammatory (79% of neutrophils) with 10(8) *Haemophilus influenzae*. Gastroesophageal endoscopy revealed esophagitis with erythema with white deposits, consistent with candidiasis (confirmed by biopsies). The main etiologies of chronic suppurative bronchitis were ruled out: sweat test, immunological test (NFS, Ig G,A,M; IgG1‐4), barium swallow, pH‐meter were normal. CT scan (fig 2) showed partial atelectasis of the lingula, medial segment of the middle lobe, anterobasal segment of the right inferior lobe and bronchiectasis of the anterior segment of the right upper lobe. Because of the association of bronchiectasis and persistent candidiasis, complementary immunological tests were performed: lymphocytic phenotyping showing mild T and NK lymphopenia, with B lymphocytosis; the search for mutation on the STAT1 gene was positive (heterozygous gain of function C.1154C‐T in exon 4 STAT1 gene).

**Discussion:** Heterozygous STAT1 gain of function mutations was first described in 2011. Since then, over 50 mutations were described. It is responsible for more than 50 % of chronic mucocutaneous candidiasis (CMCD). The largest case series identified 274 patients(1): symptoms started around 12 months and were heterogeneous: bacterial (cutaneous and airways, with mainly *Staphylococcus* and *Pseudomonas*) viral, mycobacterial infections. They touched upper and lower airways, responsible for bronchiectasis in 20% of cases. Autoimmunity can be present in 40% of cases. Morbidity is severe, and mortality is premature (cancer, cerebral aneurysm). In cases of chronic suppurative bronchitis and/or bronchiectasis, heterozygous STAT1 gain of function mutations should be searched (after excluding current etiologies), especially if associated with candidiasis.

\(1\) Toubiana et al Heterozygous STAT1 gain of function mutations underlie an unexpectedly broad clinical phenotype. Blood 2016;127(25):3154‐3164.
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One‐third of the world's population is estimated to be infected with *Mycobacterium tuberculosis*. Tuberculosis (TB) is endemic in many Sub‐Saharan African countries. The burden is further made worse by the HIV scourge. The number of children with TB and its attendant complications, is equally on the rise. TB can mimic many diseases ranging from infections to malignancies. Among pleuro‐pulmonary TB complications, exudative effusion is more common while chylothorax is rare and thus easily missed especially if no classical milky appearance.

We present two children from a TB endemic region, with microbiologically confirmed TB presenting with parapneumonic effusion containing chyle, that were misdiagnosed initially as pleural empyema. Tuberculous pleural effusion occurring with chylothorax is uncommon. The first case is a 12‐ year‐old girl who presented with localized left‐sided chest pain and parapneumonic effusion and a previous liver transplant and long‐term intravenous catheter, who was on chronic immunosuppressive therapy. The second case was a 10‐year‐old boy who was HIV‐exposed but uninfected and presented with symptoms of severe complicated pneumonia with right‐sided pleural effusion. These cases are instructive as they bring to the fore the importance of a full investigation of pleural fluid in suspected TB disease, and thus assist in correct diagnosis and prompt effective management.
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*Pneumocystis jirovecii* causes respiratory infections in patients with cellular immunodeficiency. These infections are severe, with a mortality rate of 100% without treatment. Detecting *P. jirovecii* by bronchoalveolar lavage (BAL) or lung biopsy is the gold standard for PJP diagnosis, but these techniques are not always applicable in children because of their high invasiveness. To date, there are no reports, to our knowledge, on using gastric lavage PCR to diagnose PJP. We report two cases in which *P. jirovecii* was identified by gastric lavage PCR and was treated appropriately.

**Case 1** was a 1‐year‐old preterm, low‐birth‐weight male infant with Down syndrome who had undergone operation for necrotizing enterocolitis and was being administered central venous nutrition. He was started on prednisolone for pericardial effusion because of post‐pericardiotomy syndrome when he was 7 months old and had been in an NICU for a year. On the day of onset of PJP, he required increased oxygen levels, and infiltrative shadows were observed in both lung fields on chest radiography. Further, his (1→3)‐D glucan (BDG) levels were elevated. *P. jirovecii* was detected on gastric lavage polymerase chain reaction (PCR), and trimethoprim‐sulfamethoxazole was administered for 3 weeks, following which his condition improved.

**Case 2** was an 8‐month‐old preterm, very‐low‐birth‐weight male infant who was under central venous nutrition because of digestive tract disease. He was under treatment with hydrocortisone for 5 months because of refractory hypoglycemia and had been in an NICU. On the day of PJP onset, he showed increased oxygen demand, and chest radiography showed infiltration in both lung fields. Further, his BDG level was elevated. *P. jirovecii* was detected on gastric lavage PCR, and trimethoprim‐sulfamethoxazole was administered for 3 weeks, following which his condition improved.

**Discussion:** About 10%‐30% of immunocompetent children carry *P. jirovecii* in their respiratory tract, and this percentage, depending on the underlying disease, is 60%‐70% in immunosuppressed patients. Therefore, when *P. jirovecii* is detected, it is important to distinguish infection from colonization. In these two cases, we suspected PJP on the basis of the clinical symptoms, backgrounds, BDG levels, and observations from image examination, and *P. jirovecii* was detected on gastric lavage PCR analysis. The patients\' condition improved after definitive therapy. To our knowledge, there has been no report of PJP diagnosis by gastric lavage PCR to date, and this diagnostic technique may be useful if it is difficult to collect lower respiratory tract specimens. Both patients had cellular immunodeficiency because of long‐term steroid administration, although prophylactic treatment with trimethoprim‐sulfamethoxazole for PJP had not been administered. This suggests the necessity of prophylaxis.

**Conclusion:** Gastric lavage PCR in suspected cases of PJP helps confirm PJP diagnosis in children with mild‐to‐moderate airway symptoms or in whom invasive examination is difficult. PJP prevention should be considered in long‐term steroid users.
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We are reporting a 7‐month‐old boy, who was previously hospitalized with recurrent monthly pneumonia since birth until presentation to a regional tertiary center with pediatric respiratory services in Penang, Malaysia. He had persistent right middle and lower lobe opacities on chest radiograph which were attributed to collapse consolidation. Right lung hypoplasia was suspected by our unit. Computed tomography of the thorax and pulmonary angiogram demonstrated right lung hypoplasia, hypoplastic right pulmonary artery, partial anomalous left pulmonary artery and possible esophageal bronchus. Bronchoscopy showed absent right bronchus with no fistula while esophagoscopy showed a fistula from the esophagus which was suspicious of right main bronchus. The diagnosis of esophageal lung was secured. Right pneumonectomy was performed due to a short and hypoplastic right bronchus. He was discharged with no respiratory support and was well during subsequent follow‐up. Esophageal lung is a rare cause of congenital pulmonary bronchopulmonary foregut malformation and scarcely reported in the literature. Although rare, children with recurrent pneumonia and persistent opacities on chest radiographs who are unresponsive to conventional medical treatment should be evaluated for congenital bronchopulmonary malformation. Anastomosis of esophageal lung to normal tracheobronchial tree is a treatment option, though lobectomy or pneumonectomy may be considered in severe hypoplasia or abnormal vasculature. Both surgical options offer excellent outcomes.
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Congenital stridor is not a rare condition in infants. Although laryngomalacia accounts for 70%‐80% of congenital stridor in infants, the possibility of other etiologies should be kept in mind. We herein report a case of laryngeal cyst in a 3‐month‐old boy who suffered from stridor breathing sounds since one‐month‐old accompanied with poor feeding and failure to thrive. Bronchoscopy and head and neck CT revealed one 1.1x1.3 cm laryngeal cyst at midline and another 6 mm cyst inferior to the epiglottis. The patient underwent CO2 laser marsupialization and the pathology showed mucocutaneous tissue with cyst lined by stratified squamous epithelium. The breathing pattern was smooth after the operation and his growth curve caught up later. Early flexible bronchoscopy diagnosis can rescue the failure to thrive of this condition. Epidermoid cyst, thyroglossal cyst, and vallecular cyst should be considered in the differential diagnosis of congenital laryngeal cyst.
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**Background:** Pediatric obstructive sleep apnea (OSA) caused by adenotonsillar hypertrophy is common. Adenotonsillectomy (AT) is the first line treatment to improve OSA in most children. However, there is a possibility that compensatory enlargement of other tonsils occurs after AT, and it can cause OSA again. There are few reports evaluating risk factors for OSA relapse after AT. We present the case of a 2‐year‐old girl with congenital myopathy who had relapse of severe OSA caused by compensatory sublingual tonsil hypertrophy a year later after the first AT.

**Case Report:** A 22‐month‐old girl with nemaline myopathy who had been cared with noninvasive ventilation (NIV) at home underwent AT because of OSA caused by adenotonsillar hypertrophy. After the AT, her symptoms of OSA improved. However, when she was 34 months old, she had a relapse of severe OSA. She could not breathe intermittently while sleeping and presented cyanosis with oxygen saturation nadir \< 80% in spite of NIV care. A laryngeal endoscopy revealed sublingual tonsil hypertrophy above the epiglottis, and a tracheotomy was scheduled. However, before the operation, she suffered from aspiration pneumonia and went into cardiopulmonary arrest caused by mucous suffocation in spite of the management with NIV in an intensive care unit. She was recovered with immediate cardiopulmonary resuscitation with tracheal intubation and mechanical ventilation. After this episode, a tracheotomy was performed and symptoms of OSA improved. She was discharged without neurological sequelae and has been cared with all‐day mechanical ventilation at home.

Congenital muscle diseases in young children can be a risk factor of relapse of OSA by compensatory enlargement of other tonsils after AT. High‐risk patients should be evaluated repeatedly with a laryngeal endoscopy after AT to detect compensatory enlargement of other tonsils.
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Mediastinal syndrome has become increasingly recognized as the use of diagnostic imaging increases. A lipoblastoma is a rare, benign, rapidly growing tumor that develops principally (and asymptomatically) on the extremities during infancy. We report a 6‐month‐old male infant with a presentation of acute bronchiolitis with respiratory distress. Sudden onset of cyanosis with respiratory failure and emergent intubation occurred 3 days after admission. X‐ray showed a mediastinal mass unexpectedly. Subsequent chest CT revealed a tumor located in the upper posterior mediastinum, which anteriorly displaced the esophagus and the trachea, and entrapped the descending aorta. Exploratory thoracotomy was performed by pediatric thoracic and cardiovascular surgeons for complete excision. The pathological report revealed lipoblastoma. The patient\'s respiratory condition improved and extubation was performed 4 days after operation. He had no need for further chemotherapy and no recurrence of tumor in the 4 years follow‐up.
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An 8‐month‐old female infant was admitted to our intensive care unit with the initial presentation of acute bronchiolitis with respiratory failure requiring intubation. After extubation, recurrent wheezing and stridor was noticed. Echocardiography showed an abnormal left pulmonary artery arising from the right pulmonary artery. With the impression of pulmonary sling, an esophagogram also showed a narrow esophagus with anterior indentation. Bronchoscopy revealed tracheal stenosis. The chest CT revealed aberrant left pulmonary artery with sling between the trachea and esophagus. In addition, stenosis of the distal trachea and right main bronchus was found due to external compressions by the pulmonary artery, vertebral body and azygos vein. Due to recurrent wheezing and failure to thrive, surgery was performed at the age of 2 years old. Left pulmonary artery reconstruction with sliding tracheoplasty was performed. After operation, the clinical course was uneventful and the patient was discharged 2 weeks after surgery.
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Acute respiratory complications occur frequently during the early phase of leukemia, and the most severe form is acute respiratory distress syndrome (ARDS). Leukemia‐related complications and documented infections are the most frequent etiologies of ARDS. Extracorporeal membrane oxygenation (ECMO) allows for ultraprotective ventilation to minimize ventilator‐associated lung injury and enable injured lung parenchyma to heal. Mesenchymal stem cells (MSCs) have shown promising therapeutic effects in preclinical models of both ARDS and sepsis. Poor outcome is usually accompanied in immunocompromised patients with hematological malignancies, and usually worsens with ECMO‐related major bleeding, cannula infection, and ventilator‐associated pneumonia (VAP).

We herein report a 6‐year‐old girl with immunocompromised status and ARDS. She was rescued by ECMO, exogenous surfactant supplementation, and intratracheal mesenchymal stem cell therapy. Her underlying disease was juvenile myelomonocytic leukemia (JMML). ARDS developed soon after JMML being diagnosed. She was initially rescued by ECMO, but lung conditions did not gain much improvement for months despite aggressive ventilatory care and exogenous surfactant use. Mesenchymal stem cell therapy was then considered after full discussion with the family and obtaining approval from the institutional review board for human trial. We administered intratracheal mesenchymal stem cell therapy via fiberbronchoscopy once per week for three consecutive weeks. After the 3rd course, her oxygen demand decreased from 100% to 50%‐70% to maintain the oxygen saturation higher than 85%. The general perfusion and vital signs showed short‐term improvement after the intratracheal mesenchymal stem cell therapy. However, the patient eventually expired after an episode of irreversible ventilator‐associated pneumonia and septic shock. This therapeutic experience highlights the potentially beneficial effects of intracheal mesenchymal stem cell therapy to treat immunocompromised ARDS cases who are already under ECMO support.
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This very low birth weight premature male baby was born by cesarean section due to twin delivery, premature rupture of membranes, at the gestational age of 26 weeks and 1 day. The patient weighed 1,100 gm, the Apgar score at one and 5 minutes was 6 and 8, respectively. He had respiratory distress since birth, and the initial diagnosis was premature with grade III respiratory distress syndrome (RDS) and neonatal sepsis. RDS persisted after surfactant use, and high frequency oscillatory ventilation (HFOV) was applied since birth for desaturation, subcostal retraction, and grunting. Significant patent ductus arteriosus, 1.9 mm with left to right shunt when the patient was 3 days old, surgical ligation was carried out after 2 days of ibuprofen treatment without proper response. Multiple cystic lesions were well visualized in the left lower lung before and after PDA ligation. Respiratory distress was persistent. The chest radiograph showed progressively prominent multiple cyst lesions in the left lower lung. Congenital pulmonary airway malformation (CPAM) was highly suspected. Because of sudden onset of frequent desaturation and hypotension when the patient was 10 days old, emergent open chest surgery was performed. CPAM was excised by the pediatric surgical team Partial lung lobectomy was carried out. The surgical specimen consisted of multiple lung cysts and confirmed the diagnosis of type 2 CPAM. The postoperation course was uneventful, he was discharged with good condition.

**Conclusion and reflection:** CPAM, previously known as congenital cystic adenomatoid malformation (CCAM) is a congenital disorder of the lung. It occurs in approximately 1 in every 30,000 newborns. Unlike type 1, type 2 congenital pulmonary airway malformation is more difficult to detect prenatally and should be taken into consideration when facing an infant with persistent respiratory distress.
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Tracheal agenesis (TA) is extremely rare and usually fatal. Complete or partial absence of the trachea below the larynx can be found, and a tracheoesophageal fistula may exist. There is usually no prenatal symptom, but other congenital anomalies are commonly found.

We present a low‐birth‐weight male infant (gestational age 36 weeks; birth weight 2100g) born with respiratory distress. Physical and radiological examination disclosed single umbilical artery, bilateral malalignment of thumbs, sacral dimple, and hemi vertebra. Difficult intubation was noted soon after birth. After being transferred to our center with an intubated endotracheal tube, flexible bronchoscopy was performed and found it was an esophageal intubation. A blind pouch at the subglottic level of the trachea without a fistula was observed. Diagnosis by computed tomography (CT) with 3D‐reconstruction revealed TA (Floyd type II) with a small esophago‐bronchial (EB) fistula at the lower esophagus and linked to the right upper bronchus. At the age of 3 days, esophageal ligation and gastrostomy were performed. At the age of 21 days, with the assistance of 3D‐printing simulation and veno‐venous extracorporeal membrane oxygenation (ECMO) support, cervical esophagostomy and tracheoplasty were executed. The cervical esophagus was end‐to‐end anastomosed to the larynx. After dividing and excision of the EB fistula, the proximal end of the lower thoracic esophagus just above the fistula was end‐to‐side anastomosed to the right main bronchus. The distal end of the lower thoracic esophagus was ligated. However, pneumothorax, anastomosis dehiscence and repair, narrowing of anastomosis, collapse of esophageal‐consisted airway, and bilateral pulmonary atelectasis developed in the following 2 weeks. Flexible bronchoscopy aid balloon dilatation and stent implantation were planned. However, massive air‐leak to mediastinum and peritoneum, shock and disseminated intravascular coagulation (DIC) occurred. Finally, this neonate passed away with Do‐Not‐Resuscitate (DNR). The whole clinical course revealed strong interprofessional collaborative practices in pediatric intensive care. In addition to traditional intensive care, the technique of 3D‐printing to assist surgical reconstruction, maintaining ECMO on a 2‐kg neonate, and flexible bronchoscopy for both diagnostic and therapeutic interventions all played important roles in trying to save this infant's life.

In conclusion, TA should be considered during difficult tracheal intubation of a newborn baby with respiratory distress. Flexible bronchoscopy, CT scan and surgical interventions for diagnosis and management are suggested. Further updated techniques for effective therapy are required to improve the outcomes.
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**Introduction:** Surfactant protein deficiency is a rare congenital pulmonary disease in neonates which is difficult to diagnose. It may be caused by different types of gene mutations. Among these, surfactant protein C deficiency shows variable presentation and prognosis.

**Case Presentation:** This neonate presented as a late preterm (gestational age: 36 4/7 weeks) who was transferred to our intensive care unit due to respiratory distress developed after birth. Maternal and birth history were uneventful. Physical examination showed bilateral coarse breathing sounds with subcostal retraction.

Initially, nasal CPAP (continuous positive airway pressure) was provided for respiratory support; however, intubation was finally performed with high‐frequency oscillation use due to fluctuating respiratory condition. Series of chest plain film showed progressive diffused infiltration, while high‐resolution computed tomography showed bilateral ground glass appearance. In combination of her clinical features and image presentation, lung biopsy was performed due to the high suspicion of diffuse lung disease. Oral steroid and azithromycin was administered but her improvement was poor. We did not administer Hydroxychloroquine because of her G6PD (glucose‐6‐phosphate dehydrogenase) deficiency. Recurrent ventilator‐associated pneumonia was noted which needed several types of antibiotics. At 3 months of age, a tracheostomy was performed. Lung transplantation was offered to the family but they decided to proceed with mechanical ventilation use. Due to worsening of clinical condition and resistance to medication treatment, she received palliative extubation after full discussion with her family at the 5th month. A blood sample was collected for genetic testing before the patient passed away.

**Result and Discussion:** The biopsy result showed interstitial widening with type II pneumocyte hyperplasia and pulmonary alveolar proteinosis. Next generation sequencing (NGS) and DNA sequence analysis showed heterozygous mutation of codon 39 (c.115G\>T, p.Val39Leu) on SFTPC gene. Surfactant protein C deficiency was confirmed.

A number of cases have been reported in surfactant protein C deficiency worldwide. Each of them feature different mutation sites, disease onset, clinical presentation, treatment and prognosis. In our patient, she had early onset of respiratory distress with rapid progression which needed maximal ventilation support to maintain her respiration at the end. Also, experimental hydroxychloroquine was held due to her underlying disease. These are the main differences compared with previous literature.
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**Introduction:** Kaposiform lymphangiomatosis (KLA) is an aggressive lymphatic vascular anomaly with morbidity and mortality due to pericardial and pleural effusions. Mean interval between diagnosis and death was 2.75 years in a large case study. Treatments including Sirolimus, Avastin, Corticosteroids and Vincristine have limited success. Magnetic resonance intranodal lymphangiography has revolutionized imaging of the "forgotten third circulation", improving our understanding of lymphatic diseases and paving the way for a new treatment modality, lymphatic embolization. We present a 7‐year‐old girl with KLA whose pleural effusion stabilized following two lymphatic embolization procedures.

**Case Report:** Our patient presented at 2 years with recurrent severe non pulmonary infections. Chest radiographs showed prominent diffuse reticular opacities despite the absence of respiratory symptoms or signs. Comprehensive immunology and rheumatology investigations were normal, as were exhaled and nasal nitric oxide, ciliary biopsy, bronchoscopy and lavage, echocardiography and oxygen saturation at rest, on exertion and overnight. A chest CT showed thickening of interlobular septae with preservation of parenchymal architecture. A bone scan showed reduced uptake at L4, as well as T10 and the left clavicle in keeping with \"vanishing bone disease\".

By 5 years of age, tachypnea had developed with radiographic disease progression. A thoracoscopic lung biopsy showed diffuse proliferation and dilation of lymphatic channels within the pleura and interlobular septa typical of lymphangiomatosis, associated with spindle cell proliferation with admixed red blood cells, typical of the kaposiform variant.

Following the lung biopsy, an ipsilateral pleural effusion developed and progressed over subsequent months despite Propranolol and Sirolimus treatment, to occupy the entire left hemithorax (Figure 1A).

MR lymphangiography showed huge left lymphatic collaterals draining into the left lung and pleural space. Lymphatic embolization resulted in significant reduction in lymphocyte and triglyceride drain output. However, the effusion recurred over the following months. A repeat MR lymphangiogram showed clear improvement in the interstitial changes of the right lung. However, additional lymph vessels draining into the left lung and pleural space were identified. A second lymphatic embolization was performed, following which only a small amount of pleural fluid returned. This has been unchanged for 3 years (figure 1B), with excellent functional status under maintenance treatment with Sirolimus alone.

**Discussion**: In our patient, MR lymphangiography followed by targeted lymphatic embolization procedures aborted aggressive progression of a lymphatic pleural effusion. Although KLA is a systemic proliferative disease, our case demonstrates that this "mechanical approach" might change the natural course of the disease.

A\) Chest x‐ray before lymphatic interventions (May 2015) showing a large pleural effusion with mediastinal shift. B) Chest x‐ray following two lymphatic embolization procedures employing glue and coils. A small left pleural effusion and right sided port‐a‐cath are seen. Prominent interstitial lung markings visible throughout. (June 2018)
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Lung carcinoid tumors start in neuroendocrine cells, a special type of cell found in the lungs or gut. They are sometimes classified by where they form in the lung, central or peripheral. There are 2 types of lung carcinoid tumors: typical and atypical. Rarely, they release sufficient hormone‐like substances into the bloodstream to cause symptoms. The present case is an adolescent Chilean boy, 13 years old. He suffered four obstructive bronchitis episodes during 2017 diagnosed as asthma. He was started with fluticasone +  salmeterol twice a day, salbutamol SOS and desloratadine daily. Despite the treatment, he had weakness, wheezing, cough which was sometimes bloody. No family history of hemorrhagic disease. In August 2017, the patient attended the emergency service because of hemoptysis. He was admitted into the hospital. Pulmonary tuberculosis was suspected. He stayed at the pediatric service for 1 week. He was stabilized; he was sent home to complete the tests as outpatient. TB infection and atypical bacterial infections with Ziehl‐Neelsen tests were negative. The chest X‐rays were reported as normal. PCR in bronchial secretion for atypical and TB mycobacterium were negative. Respiratory viruses were (‐). Bacterial cultures in bronchial secretion (‐). Blood culture was (‐). Blood cell count and Shilling formula were normal. A chest computed tomography with contrast confirmed an endobronchial hypervascular tumor in intermediate bronchi. The fiber‐optic bronchoscopy confirmed the tumor. The biopsy was performed by open lung surgery, there were no lymph nodes involved. The middle lobe and the right lower lobe were excised because of obstruction of the lumen, with failure of re‐expansion. The biopsy was negative for atypical cells, confirming neuroendocrine tumor grade I: Positive immunohistochemical staining for Chromogranin (Cg) and Synaptophysin, (+) TTF1, (+) Ki67, (‐) Keratin AE1/AE3. No possibility for octeocride test before or after surgery. The boy is now under control in oncology, pediatric pulmonology, endocrine unit and continues with respiratory rehabilitation exercises.

O‐128. Chronic Arsenic Poisoning Presenting with Widespread Bronchiectasis -- A Case Report {#ppul24373-sec-1250}
===========================================================================================

Tuazon A. [*Francisco J*.]{.ul}, Garcia R., Ramos M., Ramolete J.

Pediatric Pulmonology, Philippine General Hospital ‐ Manila, Philippines

Chronic arsenic poisoning can cause a variety of symptoms of which the most commonly reported are dermatological and neurological although pulmonary complications have also been seen. Here we present a 17 year‐old male who came from Lubang Pampanga where there are known cases of chronic arsenic poisoning from a previously identified water source. The patient's symptoms included chronic cough, bipedal edema, and worsening difficulty of breathing. On admission, the patient was tachypneic, tachycardic, with O2 saturations as low as 70%‐80% on room air. The patient had digital clubbing, multiple hyperkeratotic papules on the palms and soles, with melanosis more prominent on the lower extremities. Other family members also had the same skin lesions but did not present with respiratory complaints. Arsenic levels were analyzed from urine and bronchoalveolar lavage samples which were both low. Chest CT scan showed extensive bronchiectatic changes in both lungs.
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Surfactant dysfunction disorders can present as severe diffuse lung disease of the newborn, leading to progressive hypoxemic respiratory failure and are often fatal in early infancy. Lung transplantation is the only definitive therapy for these patients however, limited availability of suitable donors and high waitlist mortality often prevent transplantation. One strategy to increase organ availability for infants is to perform ABO‐incompatible (ABO‐i) transplants, a strategy that was previously established in infant heart transplantation. We performed the world\'s first successful ABO‐i lung transplantation in an infant (Grasemann H et al, Am J Transplant. 2012;12:779‐81). We report here on the Hospital for Sick Children experience of three consecutive infant ABO‐i lung transplantations for surfactant dysfunction disorders. All three patients are alive and current follow‐up ranges from 7.5 to 2.5 years.

Of the three patients, two had genetically confirmed surfactant protein‐B deficiency and one had a diagnosis of ATP binding cassette subfamily A member 3 (ABCA3) deficiency. All received a double lung transplant and the surgeries were performed on cardiac bypass. Donor/recipient blood groups were B‐/A1 +  in one, and A+ /O+  in two patients. An intraoperative plasma exchanges of 1.5 times the infant's blood volume was the only preparatory procedure performed. Isohemagglutinins were monitored before transplant and regularly during follow‐up. Immunosuppressive therapy included basiliximab (induction) on day 0 and day 4 post‐op, methylprednisolone, and mycophenolate mofetil. Tacrolimus was added at post‐op day 5 to 7. All patients remained on relatively low‐doses of triple maintenance immunosuppressive therapy. Investigations to monitor lung grafts during follow‐up included surveillance bronchoscopy with bronchoalveolar lavage (BAL) and transbronchial lung biopsies, radiographs and computed tomography of the chest, infant pulmonary function testing (iPFT) and multiple breath washout (MBW) technique to determine the lung clearance index (LCI). None of the three transplant recipients experienced any episode of severe infection, acute cellular rejection (ACR) of the graft or Bronchiolitis Obliterans (BO).

Our experience suggests that ABO‐i lung transplantation for severe surfactant dysfunction disorders is a suitable therapeutic option resulting in long term survival. ABO‐i lung transplantation should also be considered for other fatal diffuse lung diseases in infancy.
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**Background:** Adenotonsillectomy (AT) is the first‐line treatment for obstructive sleep apnea (OSA) due to adenotonsillar hypertrophy (ATH) in children. However, craniofacial abnormality (CA) is also a known cause of OSA in children. AT has no effect on OSA caused by CA, although rapid maxillary expansion (RME) is reported to be useful for it.

**Objectives:** Herein, we report the case of a patient with OSA likely due to CA that was successfully treated with RME.

**Case Report:** A 7‐year and 1‐month‐old boy visited our dental clinic with a chief complaint of malocclusion. Constricted maxilla and mandible with open bite, retruded maxilla, and tongue thrust were the pediatric orthodontic findings observed. An anterior cross‐bite and open bite associated with maxillary hypogrowth was diagnosed. A medical interview revealed the presence of snoring, apnea and chest retraction during sleep. Computed tomography scan indicated the presence of moderate ATH. OSA was suspected and out‐of‐center sleep testing (OCST) was performed on two consecutive nights. Respiratory event index (REI) were 24.2/h and 17.0/h on nights 1 and 2, respectively; nadir SpO2 were 70% and 76%. As a result, severe OSA was diagnosed. Since his family did not wish for AT, RME was performed. Snoring and retractive breathing during sleep disappeared 3 weeks after the start of RME, and 8 months later, OCST was performed again on two consecutive nights. REI had improved to 5.7/h and 3.7/h on nights 1 and 2, respectively, and nadir SpO2 had improved to 81% and 85%.

**Discussion and Conclusion:** No evidence on the usefulness of RME for OSA in children has been established. However, RME was useful for OSA likely due to moderate ATH and CA in this patient, suggesting that tongue space expansion by RME can be a useful therapeutic method for OSA.
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Gorham‐Stout disease is also known as vanishing bone disease. It is a rare disease of unknown etiology characterized by progressive osteolysis and proliferation of lymphatic vessels. We report 2 cases of Gorham‐Stout disease presenting with recurrent chylothorax and lytic bone lesion.

**Case 1:** 12‐year‐old boy presented with recurrent episodes of right chylothorax for 6 weeks needing chest tube drainage. Radiological imaging showed vanishing right scapula with abnormal right clavicle, humerus and ulna. Bone biopsy was performed but unfortunately the result was inconclusive. Lymphoscintigraphy revealed normal finding. Child was treated with total parenteral nutrition, sirolimus and propranolol in which the child responded well to treatment.

**Case 2:** 8‐year‐old boy presented with multiple lytic bone lesion involving the lower cervical and upper thoracic spine and massive left pleural effusion for 3 months. Left chest tube drainage showed presence of chyle. He underwent two bone biopsies, however the result was inconclusive. He was treated with total parenteral nutrition, sirolimus and propranolol but unfortunately response to treatment is poor. He still has persistent left chylothorax despite good adherence to treatment.

In conclusion, diagnosis of Gorham‐Stout disease should be considered in children presenting with recurrent chylothorax and bony abnormalities.
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Pediatric acute respiratory distress syndrome (PARDS) is one of the most challenging conditions in treating critical infants and children. There is still no conclusive recommendation regarding the ideal ventilator mode to treat PARDS. High‐frequency oscillatory ventilation (HFOV) is considered as an alternative ventilator mode for patients with moderate‐to‐severe PARDS. The risk of mortality of PARDS is thought to be more related to underlying disease processes than the ventilator mode. Sepsis due to various infections is a common cause of PARDS. *Pneumocystis jiroveci* pneumonia (PJP) is a life‐threatening opportunistic infection. It is relatively common in immunocompromised patients, including HIV‐infected population, infants born preterm or having poor nutritional status.

We present a 2‐month‐old female infant with fever, cough, and vomit for 4 days. She was transferred to our medical center due to rapid progression to PARDS within 1 day, and her throat swab CMV PCR test revealed positive. Her chest radiograph showed bilateral white‐out, and very high ventilator settings were required to maintain oxygenation. Cardiac disease was excluded by ultrasonography. Intravenous ganciclovir, broad‐spectrum antibiotics, and methylprednisolone were given, but the gas exchanges were still poor (oxygenation index= 31 at 38 hours after hospitalization). HFOV was then applied (FiO2 = 1.0, MAP= 20 cmH2O, amplitude = 30 cmH2O, frequency = 10, I time = 33%). After using HFOV, the lungs were recruited and the settings could be weaned down gradually. Intravenous immunoglobulin was given for suspected viral sepsis. Since tracheal aspirate was positive to toluidine blue O stain, PJP was also highly suspected and intravenous trimethoprim‐sulfamethoxazole was started. Two days later, high CMV viral loads from urine ere detected. In addition, multiple respiratory viral antigen tests from the respiratory aspirates were positive, including parainfluenza virus, rhinovirus, and corona virus. Otherwise, bacteria culture from sputum, tracheal aspirate, urine and blood all revealed negative results. This patient was successfully extubated 72 hours later. Tracing back her history, this infant was under good nutritional status, having negative SCID test and no repeated or opportunistic infection since birth. Maternal anti‐HIV combo was negative. Immune status was examined, but there was no significant finding.

In conclusion, this successful therapeutic experience highlights the potential role of HFOV in infants with severe PARDS when the underlying disease is adequately treated. Furthermore, PJP and CMV infection may be taken into consideration in infants with PARDS.
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**Introduction:** Pulmonary artery (PA) thrombosis in neonates is rare. The true incidence is probably underestimated because of its varying presentations, ranging from mild respiratory distress to acute right‐heart failure and cardiovascular collapse. The standard of management of life‐threatening thrombotic events in neonates is not established. The options include use of anticoagulation therapy alone and addition of thrombolytics. We report a case of a neonate with symptomatic PA thrombosis successfully treated with recombinant tissue plasminogen activator (RTPA).

A full term neonate male was born by normal vaginal delivery and had birth weight of 2,5 kg. Antenatal history was significant for gestational diabetes, arterial hypertension. In 6 hour after birth infant developed *Streptococcus.agalacticae* sepsis successfully treated with combination of ampicillin and gentamicin through the venous umbilical catheter.

![Floating thrombus extending from outflow tract of RV into the trunk of the PA](PPUL-54-S81-g005){#ppul24373-fig-0005}

![Left lower lobe infarction, cardiomegaly](PPUL-54-S81-g003){#ppul24373-fig-0003}

![One day after thrombolysis](PPUL-54-S81-g004){#ppul24373-fig-0004}

On day of life nine, the infant suddenly developed severe respiratory distress with severe hypoxemia (SpO2 37%), acute cyanosis with lethargy and poor perfusion. The patient was reassigned to NICU for high‐frequency oscillation ventilation. Anti‐shock therapy was started according to the accepted protocol. Echocardiography revealed a structurally normal heart. Right ventricle was dilated to 20mm, with the intraventricular septum bowing into the left ventricle. Right ventricular pressure was elevated to 60 mmHg. Floating thrombus was detected in the outflow tract of RV. It extended in the trunk of the PA (21mm x 4mm). (Fig. [1](#ppul24373-fig-0001){ref-type="fig"}). The diagnosis of pulmonary thrombosis was made, and anticoagulation therapy with low‐molecular‐weight heparin (LMWH) was started. Infant's clinical status did not improve. The patient\'s condition was critical. It was decided to start thrombolytic therapy with RTPA (Tenecteplase "Metalyse") 0,2 mg/kg. Dose was repeated after 6 hours. The follow‐up echocardiogram after 6 hours showed thrombus size reduction from 21 mm to 4,5 mm. PA pressure was near normal. Thrombolytic therapy was stopped and replaced with continuous intravenous heparin therapy for 72 hours followed by subcutaneous LMWH.

Thrombolytic therapy complicated with the development of bilateral intraventricular hemorrhage. The formation of occlusive hydrocephaly was excluded by brain MRI.

At the 30 day of life patient was discharged. Echocardiogram demonstrated completely dissolved thrombus with normalization of pulmonary pressure. Cranial ultrasound showed partial lysis of trombotic masses. Daily LMWH heparin was continued for 3 months.

Genetic analysis showed homozygous polymorphisms in genes of inhibitor of the activator of a plazminogen (PAI‐1) and a platelet collagen receptor.

Follow up at the age of two years showed no residual or recurrent thrombus in the PA or other systemic vessels. His neurologic status now is normal.

**Conclusion:** PA thrombosis is a rarely reported complication in neonates. Considering the potentially lethal nature of pulmonary embolism, pediatricians and neonatologists should maintain a high degree of suspicion for thrombotic events in infants with sudden inexplicable deterioration in cardiorespiratory status. In our case thrombolysis was a life‐saving treatment.
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**Introduction:** Recurrent respiratory papillomatosis is rare condition usually caused by human papilloma virus (HPV) types 6 and 11. It occurs in children younger than 5 years. HPV attacks the mucosal basal layer and induces cellular proliferation. Papillomatosis is very often predilected to the larynx but may be present anywhere in the respiratory tract. Purpose of the case was to show the course of the disease after using different therapeutic options.

**Case Report:** 19‐month‐old child, male, admitted to the Institute for Child and Mother Care Belgrade, for dysphonia, stridor, shortness of breath and tachypnea worsening during cry, physical activity and at night. Child was without fever at all times. Two months before onset of symptoms, he often vomited after mA.   eals. Antenatal history was insignificant. This was the second child from the second pregnancy, vaginally delivered on time with birth weight of 3800 grams, birth length 55 cm, vaccinated on time with proper psychomotor development. There were no respiratory symptoms in the neonatal period. Family history was unremarkable. On admission: body weight 10 kg (P5), using auxiliary respiratory muscles, and audible inspiratory stridor, without fever or cyanosis. RF 38/min, SpO2 96%. Remainder of the physical examination was normal. Laboratory analyses (CBC, biochemistry, CRP) were in the reference range. Chest X‐ray: areas of lung consolidation were observed as scattered opacification in the right lower lobe and around the hilum. Barium swallow test showed dilatation of the distal two thirds of the thoracic segment of the esophagus and extended evacuation and retention of contrast. Lymphoid hyperplasia of the hypopharynx with obstruction of supraglottis and glottis with tumor masses were seen on flexible fiberoptic bronchoscopy. Biopsy of the papilloma was performed and HPV type 11 was identified. Esophagoscopy showed papilloma on the anterior wall of the upper esophagus. After admission to hospital, treatment with Acyclovir was started with little success. Several excisions using carbon dioxide laser failed to prevent spread of papilloma to trachea and bronchi. After the episode of severe respiratory distress, urgent tracheostomy was performed and interferon (IFN) 2α was introduced, without significant improvement. Laryngeal microdebrider was then was applied for the treatment of laryngeal and intra‐tracheal lesions. The intervention required simultaneous use of flexible endoscope to visualize the lesions and rigid instrument to introduce the debrider. The "Shaving‐off" of the papillomas reduced their number and dimensions in both trachea and bronchi. Radical improvement was seen only after antiviral Cidofovir had been intralesionally injected into remaining papilloma of larynx, trachea and bronchi with the needle commonly used for aspiration biopsies.

**Conclusion:** The treatment of recurrent juvenile papillomatosis is challenging especially in case of metastatic disease and even more in little child where the dimensions of the airways limit the choice of instruments. We present the successful use of microdebridement and intralesional injection of cidofovir in the treatment of laryngo‐tracheo‐bronchial papillomatosis in a two‐year old.
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Parapneumonic pleural effusion remains a common complication in lung infection. The presence of parapneumonic pleural effusion denotes an increase in morbidity, mortality and also hospital length of stay in pediatric patients. Despite the current development of diagnostic tools and treatment, limited resources countries still find it difficult to provide these modalities.

**Case presentation:** We report four cases of parapneumonic pleural effusion in pediatric patients. The patients' ages (2 male, 2 female) ranged from 1 to 10 years. Three patients presented with dyspnea as their chief complaint and only one patient had chest pain as a chief complaint. The diagnosis of parapneumonic pleural effusion was established from clinical findings and chest radiography. Three patients had necrotizing pneumonia and one of them had already been treated with antituberculosis drugs 2 months before admission. Upon the patients\' arrival in the emergency department, we performed pleural fluid analysis and culture. We managed these patients with antibiotics and nonoperative surgical procedure in most cases. Broad spectrum antibiotics were already administered in all cases before they were referred to our hospital. All of the pleural fluid culture results were sterile due to prior administration of antibiotics. Chest tube insertion was performed on the first day of admission in all cases: two patients had only chest tube drain placement, one patient had chest tube insertion and fiber‐optic bronchoschopy and one patient had chest tube insertion followed by open thoracotomy and decortication.

**Conclusion:** The clinical presentation of parapneumonic pleural effusion may vary in each case. Management of parapneumonic pleural effusion in limited resources country is becoming much more challenging and more patient‐specific. Most cases of parapneumonic pleural effusion that we reported here have favorable outcomes.

**Keywords:** Parapneumonic pleural effusion, pneumonia, limited resources country.
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**Introduction:** Pulmonary artery pseudoaneurysm (PAP) is a rare condition that may occur in association with congenital cardiovascular anomalies, infection, trauma, neoplasm, or vasculitis. Presentations range from a silent lesion incidentally found in imaging studies to severe life‐threatening hemoptysis. We report two cases of PAPs in pediatric infective lung diseases.

**Case Report:** Patient A was an 18‐month‐old girl with Down syndrome, congenital hypothyroidism, small patent ductus arteriosus and anorectal malformation who presented with persistent fever and cough for 2 weeks post stoma closure. On examination, she was tachypneic with a respiratory rate of 50 breaths/minute and subcostal recessions. Her breath sounds were reduced over the right lower zone with stony dullness. Chest X‐ray (CXR) showed right lower lobe consolidation with a loculated parapneumonic effusion. Minimal thick stale blood‐stained fluid was aspirated during an ultrasound guided thoracocentesis and an unusual mass was seen. Hence the chest drainage was aborted and a contrast‐enhanced CT angiography revealed a pulmonary pseudoaneurysm within the consolidated lung, adjacent to the right pleural collection. Blood investigations showed a drop in hemoglobin from 12g/L to 8.8g/L. Embolization 4 days later was abandoned as there was no identifiable feeding vessel. The pseudoaneurysm appeared echogenic and smaller with no color flow, thus it was assumed to be thrombosed. Her nasopharyngeal culture grew *Elizabethkingia meningoseptica*. Her condition improved with a course of ceftriaxone and gentamicin. She was discharged well after 25 days of hospitalization. Serial follow‐up CXRs and ultrasound scans showed spontaneous resolution of the pseudoaneurysm. Patient B was a 17‐year‐old boy with spastic quadriplegic cerebral palsy and epilepsy who presented with five‐month history of cough and intermittent hemoptysis. Clinically, he was cachexic with scoliosis and multiple joint contractures. He was mildly tachypneic with a respiratory rate of 26 breaths/minute. There were reduced breath sounds over his left lung. A CXR showed air space nodular opacities at the left upper lobe and patchy consolidation over both lung fields. He had a positive Mantoux test. His gastric lavage was smear‐positive for acid‐fast bacilli, and a culture later grew *Mycobacterium tuberculosis* confirming the diagnosis of pulmonary tuberculosis. He was commenced on antituberculous medications on day three of admission. However, his hemoptysis persisted and worsened despite over 2 weeks of treatment and his hemoglobin dropped from 8.8g/dL to 6.4g/dL requiring blood transfusion. A CT angiography revealed a pseudoaneurysm and multiple adjacent cavitating lesions over the left upper lobe with no feeding vessel seen. In view of the potential high mortality and morbidity, and increased technical complexity of interventional management due to the underlying comorbidities, he was treated conservatively. The hemoptysis resolved after 4 weeks of anti‐TB treatment and he was subsequently discharged home. A follow‐up CXR 3 months later showed resolving pseudoaneurysm.

**Conclusion:** Although pulmonary artery pseudoaneurysms are uncommon, knowledge of their existence and association with infective lung diseases is important. Recognition of unusual abnormalities on imaging studies can lead to early diagnosis and treatment. Diagnosis is often made by CT angiography and embolization is the treatment of choice.

O‐183. Middle Aortic Syndrome Presenting as Pulmonary Edema, 3‐Month‐Old Boy: Case Report {#ppul24373-sec-1340}
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[*Ikeyama S*.]{.ul}, Kawabe T., Monoi A. Yokoyama S., Takahashi K., Yokoyama Y.

Pediatrics, Oume Municipal General Hospital ‐ Tokyo, Japan

Coarctation of the aorta (CoA) is a congenital malformation of the aorta that is a relatively common defect. However, middle aortic syndrome (MAS), an uncommon condition characterized by segmental narrowing of the distal descending, thoracic or abdominal aorta, is rare. We herein report a case of MAS presenting as seizure and difficult breathing.

A three‐month‐old boy came to the emergency department with seizure clustering and difficult breathing. Although seizures stopped with intravenous administration of Diazepam and Thiamylal, respiratory condition was unstable. Chest X‐ray revealed cardiomegaly and congestive lung. Ultrasound cardiography (UCG) was conducted for assessment of cardiac function. UCG identified a decrease in left ventricular ejection fraction (36%) and moderate atrioventricular valve regurgitation. There was no stenosis in the descending thoracic aorta. However, his echocardiogram identified segmental narrowing of the abdominal aorta, which caused cardiac hypofunction. His upper limb BP was 118/76 mm Hg and lower limb BP was 77/44 mm Hg. The cause of the seizures was considered to be posterior reversible encephalopathy syndrome (PRES). Since surgical operation was necessary, he was transferred to a tertiary referral children's hospital. At 10‐months old, catheter surgery for intravascular stenosis was performed successfully. Vasculitis, such as Takayasu's arteritis, can be stated as a differential diagnosis; however, finding of vasculitis was all negative. One year after initial presentation, the patient was fine.

This report describes a rare case of CoA, MAS. Chest X‐ray and UCG could result in leading to diagnosis, even if it does not appear to be a cardiovascular disease based on symptoms.

O‐184. Primary Empyema Due to *Streptococcus Mitis* Infection: A Common Disease by an Unusual Etiology {#ppul24373-sec-1350}
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**Introduction:** Community‐acquired pneumonia is one of the most common respiratory infections in children. Epidemiology and etiologies have changed among the last decades and new pathogens have emerged recently. Some cases may present with unusual clinical features and evolve to complicated pneumonia. We present the case of an 8‐year‐old boy who presented with chest pain and was diagnosed with empyema caused by *Streptococcus mitis* (*S. mitis*) secondary to an odontogenic infection. This is the first case of empyema caused by this agent in our center.

**Case Report:** An 8‐year‐old boy with no past medical history, presented with 3 weeks of right‐sided chest pain that radiated to right shoulder. No fever, respiratory symptoms or history of trauma were recorded. Initial diagnosis by Orthopedics was a musculoskeletal pain treated with anti‐inflammatory medications without improvement. Subsequently, he was admitted at the emergency department with persistent chest pain for further investigations.

Chest X‐ray showed an extensive right pleural effusion and ultrasound described a right basal consolidation with a pleural effusion of 353ml. Pleural fluid sample obtained by thoracentesis was purulent with exudate characteristics and a chest tube was inserted for drainage.

Due to these findings, a thoracic CT scan was performed and revealed atelectasis of the right lung and severe loculated pleural effusion with fluid‐filled cavities in the right middle and lower lobes.

Since the patient was stable, a conservative management was preferred and empiric IV antibiotics, cefotaxime and clindamycin, were started. After 7 days of treatment, pleural fluid culture was positive for *S. mitis*.

*S. mitis* was sensitive to ampicillin, thus treatment was completed with 10 days of ampicillin and 7 days of cefotaxime and clindamycin with a satisfactory outcome.

Considering that *S. mitis* is an innocuous commensal organism of the oropharynx, skin, and gastrointestinal and genitourinary tracts, we looked for primary infection sites. The origin of the infection was a cavity in the third lower molar that extended to the root. The patient had a history of a dental procedure 4 weeks before diagnosis.

**Discussion:** Empyema in children may develop with different clinical findings. Patients that present without the typical symptoms of fever, cough and shortness of breath, represent a diagnostic challenge. Our patient presented with chest and shoulder pain, and was not diagnosed until several weeks after symptoms started. Currently, the most common pathogens causing complicated pneumonia are *S. pneumoniae* and more recently MRSA. *S. mitis* is a rare etiology and few known cases have been described in the past. *S. mitis* strains may cause endocarditis and bacteremia, and infections have been increasing probably because of acquisition of new virulence factors. Management of empyema in children is controversial, and although fibrinolytic agents and surgical interventions are commonly recommended, our patient improved with drainage and IV antibiotics with no further procedures.

**Conclusion:** Complicated pneumonia and empyema remain common high burden infections in children. Unusual clinical presentations represent a true challenge and changing epidemiology and etiology may interfere with a timely diagnosis. Since the publication of *S. mitis* genome, understanding the rise in cases of infections is currently under investigation.
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Bronchiolitis obliterans organizing pneumonia (BOOP) is characterized histologically by the formation of granulation‐tissue plugs within the lumens of small airways. It was reported in association with various disorders including infection, drug reactions and collagen vascular diseases. However, there are only rare reports of BOOP accompanied with systemic lupus erythematosus (SLE), especially in the pediatric population. Herein, authors report a case of an adolescent with SLE who initially manifested respiratory illnesses due to BOOP.

A 14‐year‐old girl referred to our clinic for a protracted cough with fever, dyspnea and hemoptysis. Her chest X‐ray revealed predominant multifocal consolidations in bilateral lung fields with pleural effusion. Computed tomography (CT) scan showed surrounding ground‐glass opacities with the crazy‐paving appearance with multiple centrilobular nodules suggesting diffuse alveolar hemorrhage. Laboratory tests revealed pancytopenia, elevated blood urea nitrogen and creatinine, low serum levels of complements and positivity for antinuclear antibody, p‐anti‐neutrophil cytoplasmic antibody and anti‐double stranded DNA antibody. To exclude the possibilities of vasculitis and other mixed connective tissue diseases, video‐assisted thoracic surgery biopsy was performed. The pathology confirmed BOOP and systemic steroid therapy including high‐dose methylprednisolone was commenced. Her respiratory symptoms, pulmonary function tests, and radiological findings showed significant improvement following treatment, and the patient is now doing well without a relapse. This pediatric case of BOOP as the initial presentation of SLE brings the need for more attention to the pulmonary manifestations of SLE in children.

O‐194. Cutis Laxa: A Case Report {#ppul24373-sec-1370}
================================
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Department of Child Health Medical School, Sriwijaya University, Dr. Mohammad Hoesin Hospital ‐ Palembang, Indonesia

**Background:** Cutis laxa (CL) is a rare disease, a heterogeneous group of genetic and acquired connective tissue disorders caused by mutations in the elastin and fibulin‐5 genes. Congenital forms of cutis laxa are more common than acquired disease. Autosomal dominant, autosomal recessive and x‐linked recessive patterns have been described, with the recessively inherited form being the most frequent and most severe. Cutis laxa is characterized by a generalized reduction in the amount and size of elastic fibers and fragmentation and disruption of their normal arrangement, progressive looseness of the skin associated with abnormalities of other organs and structures containing elastic tissue such as lung, vasculature or gastrointestinal tract. The most clinical feature is loose and pendulous skin, sagging of the cheeks, or prematurely aged appearance. This disease is often associated with severe internal complications such as emphysema leading to cor pulmonale and death in the first few years of life. Emphysema in autosomal dominant CL is caused by heterozygous elastin gene mutations. Cutis laxa shows increased lung compliance and decreased stiffness of lung tissue. Combined effects of these processes lead to the development of an emphysematous pulmonary phenotype in CL.

**Case:** An 8‐month‐old girl presented with cough and shortness of breath, inguinal lump, weight loss, sagging in almost entire part of the body. There had a history of recurrent episodes of cough and breathlessness since age of 4 months, with an increase in the frequency and severity of the episodes in the last weeks. The patient has a sister with the same condition who already passed away. On examination, the child had fever, tachypnea, dyspnea with intercostal and subcostal retractions. The respiratory rate was 55x/min, heart rate 105/min, and SaO2 was 95% using 2l% of oxygen supplementation. Weight and height were 5.7 kg (\< ‐2DS) and 66 cm (0--(‐2)DS), the nutritional status was malnourished. The face had a senile appearance with sagging cheek, pendulous ear lobes and lax skin. There were rales and retractions on chest examinations; the cardiovascular system was normal. There were umbilical hernia and inguinal hernia. The laboratory findings showed an anemia, leukocytosis and increase in C‐reactive protein. Other examinations such as electrolyte, thyroid hormone, renal and liver function were within normal limits. A chest X‐ray showed bilateral emphysema, pneumomediastinum. Echocardiography showed normal limits. The child was treated with antibiotics, malnourish management, herniorrhaphy.

**Keywords:** emphysema, cutis laxa, children.
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**Introduction:** Magnetic resonance imaging (MRI) is an ideal tool for assessing many diseases in the neonatal brain including neurodevelopment disorder and congenital airway disease and modality for defining extrinsic airway abnormalities.

Bronchopulmonary dysplasia (BPD) infants with ventilator dependency (VD) are at risk for undergoing MRI, especially those receiving anesthetic care with noninvasive ventilation (NIV) support. There are technical issues that need to be overcome before using the MRI‐ventilator as NIV support in the MRI room. The aim of this case report is to share an experience of practice in NIV support on infants with VD during MRI.

**Case Report:** A nine‐month‐old male preterm BPD infant with maternal premature rupture of membranes delivered by emergency caesarean section at 28 +  weeks gestation due to fetal distress. Apgar score was 4 at 1‐minute and 7 at 5‐minutes and birth weight was 1500 g. Because of respiratory distress syndrome, endotracheal intubation was performed and the patient was transferred to the neonatal intensive care unit. After 3 months of mechanical ventilation support, the endotracheal tube was removed and the patient was treated under NIV support. After 9 months of mechanical ventilation support since birth, we decided to make an assessment of the neurodevelopment of the patient by brain MRI. The MRI‐ventilator (ServoI‐MRI, Maquet, Sweden) was set and placed outside the Safety Line (20 mT) from the MRI machine (Figure 1). Before connecting the patient to the MRI‐ventilator, there were a few steps that needed to be performed, (1) Use of Tubing Compensation to minimize the deadspace from the longer ventilator circuit; (2) Increase of ventilation parameters due to MRI anesthetic care; (3) Repositioning of the nasal prong and ventilator circuit appropriately to avoid dislocation. The patient completed the MRI successfully and safely (Figure 2).

**Conclusion:** Most of the time, preterm BPD infants with VD who are receiving NIV support will be considered as high risk and follow‐up for MRI delayed because of two reasons: (1) need of oral intubation with endotracheal tube to guarantee the safety of the respiratory system; (2) The neonatal MRI‐ventilator which includes NIV mode is too expensive and requires a well‐trained respiratory therapist to operate the MRI‐ventilator. We believed that once we well‐prepared the MRI‐ventilator, infants with VD who are receiving NIV support could undergo MRI more safely. By sharing this case experience, we hope the profession of neonatal respiratory therapy could receive more attention.

**Keywords:** neonatal magnetic resonance imaging; bronchopulmonary dysplasia; ventilator dependency; noninvasive ventilation.
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**Introduction:** Osler‐Weber‐Rendu syndrome or hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by epistaxis, mucocutaneous telangiectasia with systemic manifestations due to visceral telangiectasia and arterio‐venous malformations (AVM). Pulmonary arteriovenous malformations (PAVMs) are found in up to half of patients, commonly presenting with hypoxia, and can lead to fatal embolic and hemorrhagic complications.

We present two cases that were diagnosed after multiple consultations:

**Case 1.** A 2‐year‐old girl presented with a history of recurrent episodes of cyanosis during her first months of life, worsening respiratory symptoms and poor exercise tolerance. She was assessed on several occasions by a general practitioner (GP) who did not consider that further investigations were necessary. She also had recurrent epistaxis and was being followed by the local ENT specialist who considered the episodes as normal. At the age of two, she was admitted to her local hospital with a LRTI, cyanosis and persistent low oxygen saturation levels (70%). She was treated with antibiotics, but given her slow improvement she was referred to our center for further workup. On examination, she presented with failure to thrive, general cyanosis, multiple telangiectasia in oral cavity and nostrils, and clubbing fingers. Initial chest X‐ray showed opacity in the left upper lobe with no air bronchogram. Bubble echocardiogram revealed a right‐to‐left intrapulmonary shunt, with normal heart structure and function. Chest CT showed multiple small bilateral PAVMs. She underwent cardiac catheterism finding diffuse bilateral abnormalities in pulmonary vascularity; embolization of the lesions was not possible. With the history of epistaxis, cutaneous telangectasias, central nervous system AVM and diffuse PAVMs, diagnosis of HHT was made. Because of the extensive involvement of the condition, she was given a conservative management and was discharged home with supplementary oxygen.

**Case 2.** A 10 year‐old‐boy was referred to the Pulmonology Department with a two‐year history of hypoxia with no respiratory distress. He had recurrent epistaxis and headaches since he was 5 years old. He was seen by his local GP, pediatrician and ENT in the previous years who did not consider further studies for his recurrent symptoms. On physical examination, he presented digital clubbing, desaturations to Spo2 \< 80% and three cutaneous telangiectasia. Due to the clinical findings, Osler‐Weber‐Rendu disease was suspected and diagnostic workup started.

CT Angiography revealed an arteriovenous malformation (AVM) in the middle segment of the right lower pulmonary lobe, multiple intraparenchymal small AVMs in both lungs and an aberrant artery from the descending aorta that irrigated the right upper lobe. Embolization of the main PAVM was proposed, however, it was not possible due to its large extension since there was no embolic device according to its size. Further discussion in several international forums, a thoracotomy and pulmonary segmentectomy of the right lower lobe was suggested and then performed 7 months after presentation. Since then, the patient has been asymptomatic, despite the fact that SpO2 levels have not improved as expected.

**Discussion:** These cases highlight the importance of investigating persistent symptoms reported by parents and underline the high index of suspicion needed to diagnose this condition.
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**Background:** Children with cystic fibrosis (CF) have frequent respiratory exacerbations, therefore the occurrence of cough and fever in a CF child raises the suspicion of an acute infectious event, while in a non‐CF child this fever/cough association would suggest a pneumonia. What about the presence of tachycardia, which would suggest a different diagnosis, from myocarditis or hyperthyroidism. We herein present the case of a 3‐year‐old girl with cystic fibrosis with frequent acute cough, persistent fever and tachycardia attacks.

**Methods:** A 3‐year‐old girl was diagnosed with cystic fibrosis in infancy, because of a Pseudo‐Barterr syndrome. The child\'s evolution was very good, with good clinical and biological status, normal pulmonary lung function described by a normal lung clearance index and germ‐free cough swab and negative induced sputum. She was monitored according to the national Romanian guidelines every 3 months in the regional CF center and annually at the national center, by clinical and biological investigation. No CT or broncho‐alveolar lavage was performed until age of 3 years.

**Results:** In evolution, her mother noticed episodes of tachycardia 5 months before the actual admission, supposed secondary to play or hospital anxiety, without any electrical ECG alteration. Four months before admission, she had a mild exacerbation associated with insignificant chest X‐ray findings and she received intravenous cephalosporin. After 1 month, she started to productively cough and fever, with a relatively strong persistence despite AINS. Her first CT scan showed left lower lobe pneumonia with pleural effusion and antipseudomonal with anti‐MRSA antibiotics were initiated. The evolution was initially good, with fever reduction and reduced cough intensity and frequency. After 2 weeks, the biochemistry showed the persistence of an elevated ESR and CRP; she was referred to the national CF center. At admission, she was started on vancomycine with the suspicion of a resistant *Streptococcus pneumoniae* and inflammatory indices decreased and the 'wait and see' attitude was adopted, without the repetition of CT. Another cardiology evaluation was performed for a new tachycardia episode and a reduced cardiac partial movement was noticed. The lung ultrasound revealed the presence of a large vascularized tumor located in the left lower lobe, without signs of consolidation or pleural effusion. The biopsy revealed an Askin tumor with costal debut.

**Conclusion:** Not every cough or fever in a child with cystic fibrosis signifies an exacerbation; likewise, not every apparent consolidation with pleural effusion is a pneumonia. A more incisive investigational approach should be considered in a CF child with persistent inflammation.

15. MISCELLANEOUS {#ppul24373-sec-1410}
=================
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**Background and significance:** It is estimated that 4800 children living in the USA are currently supported by mechanical ventilation at home. In spite of advances in technology, the mortality rate of 27.5% and 21% remains high. Previous studies identified a knowledge gap in the responses to emergencies in the home. Therefore care providers need to know the types of home emergencies and how to respond appropriately in the home setting.

**Purpose / aims of the study:** The Children's Hospital of Los Angeles (CHLA) approached regional home clinicians and formed an advisory panel to address HMV emergency management.

**Methods:** We consulted 28 clinicians who are HMV clinical experts: 9 home respiratory care practitioners, 9 home health clinical nurses, 3 parents, 2 pulmonologists, 4 hospital nurse clinicians and 1 inpatient respiratory care practitioner. Phase I: the experts participated in an online survey, recalling the emergencies they had encountered in their career. Phase II: the expert advisory panel gathered for a one‐day focus group workshop to discern all the emergency scenarios and responses in detail.

**Data collection procedures:** The final curriculum is a summation of the most commonly encountered home emergencies recalled by this expert panel with 412 years of experience. Home emergencies were recalled; they were categorized according to the type of emergency scenarios. In post data analysis, the expert panel shared clinical experience on each scenario via the modified Delfi method

**Results:** Ninety‐two HMV emergency scenarios were recalled. Data were categorized into 16 emergency situations. The expert panel deliberated on 1) the emergency situation 2) the immediate response 3) the possible causes and 4) pearls -- the collective sharing of experiences on these encounters. Tracheostomy Related IssuesVentilator Related IssuesMucous plugging High‐pressure alarmTube slipped out of the stomaLow pressure alarmTube is disconnectedHigh minute volume alarmInability to suctionLow minute volume alarmLarge volume of secretionsHigh respiratory rate alarmBleeding from the trachDisconnect alarmVentilator disconnectedVentilator stopped with no warningWater in the circuitVentilator power resourcesJohn Wiley & Sons, Ltd.This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

An example of the presentation of the emergency scenario:

SituationPossible CausesImmediate ResponsesClinical PearlsInability to suction through the trach tube.Trach tube is ill‐fitted. Trach tube is too short or too long. Trach tube is blocked by mucous plugs. Granulation tissue below the end of the tube. Abnormal anatomy (tracheal shelf, severe scoliosis).Assess the child. Assess the reason for the alarm. Suction the trach tube. Reposition the child and suction again. Re‐assess the child. Secure the trach tube snugly Change the trach tube.If an inline suction catheter is used, switch to the open suctioning method. Generous amount of normal saline if mucous plug is suspected. Ready to change trach tube. Make sure the trach size is correct: neonatal vs. pediatrics. Reposition trach tube and attempt to suction again if positional tube is suspected. Be ready to go to ED or call 911 for advanced management. Knowing patient's volume baseline will help in determining a possible plug due to a much lower read‐out on the ventilator screen.John Wiley & Sons, Ltd.This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

Sixteen emergency situations will be presented in detail using the above format.

**Conclusion:** A training module for care providers (especially home health nurses and parents) on HMV emergencies is now available; we have the type of home emergencies and the proper responses. This study study is a creative approach to developing the HMV emergency curriculum and implementing the training program in Southern California. We hope to share our experience with the CIPP participants.
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**Background and significance:** Of the more than 9.4 million children in the United States with special health care needs, few present with more challenges than those faced by children requiring home mechanical ventilation (HMV). It is estimated that 4800 children living in the USA are currently supported by mechanical ventilation at home.

In spite of advances in technology, the mortality rate of 27.5 % and 21% remains high. Home health nurses did not perform well in studies related to emergency‐based scenarios on tracheostomy management and ventilator alarms. Inpatient care providers do not have complete data of emergency reports at home.

**Purpose/aims of the study:** We recognized that a curriculum developed by stakeholders at all levels was needed to address the types of emergencies encountered outside the hospital setting and what the response should be. As each state/hospital might have a different approach to the type of tracheostomy tube and ventilator for their HMV patients, we implemented a regional approach to collect data from local experts to create a curriculum for home care providers.

**Methods:** We invited 28 experts who are HMV home clinical experts from inside and outside the hospital: 9 home respiratory care practitioners, 9 home health clinical nurses, 3 parents, 2 pulmonologists, 4 hospital nurse clinicians and 1 inpatient respiratory care practitioner to participate. These experts were asked to recall the emergencies they had encountered in their career and consensus was reached via the modified Delfi method.

**Data collection procedures:** The final curriculum is a summation of the most commonly encountered home emergencies recalled by this expert panel with 412 years of experience. Home emergencies were categorized according to the type of emergency scenarios. In post data analysis, the advisory expert panel discussed the home emergencies in detail.

**Results:** Ninety‐two HMV emergency scenarios were recalled. Data categorized into 16 emergency situations. The expert panel deliberated on 1) the emergency situation 2) the immediate response 3) the possible causes and 4) pearls -- the collective sharing of experiences on these encounters. The tracheostomy and ventilator home emergency curriculum for home health nurses was finalized.

Mucous plugging

Tube slipped out of the stoma

Tube is disconnected

Inability to suction

Large volume of secretions

Bleeding from the trach

High pressure alarm

Low pressure alarm

High minute volume alarm

Low minute volume alarm

High respiratory rate alarm

Disconnect alarm

Ventilator disconnected

Ventilator stopped with no warning

Water in the circuit.

Ventilator power resources ScenarioPossible CausesImmediate ResponsesClinical PearlsBleeding from the trachDryness. Irritation from aggressive suctioning. Infection. Ill‐positioned trach tube. Granulation tissue beyond the end of the tube.Assess the child. Suction the trach tube gently. Use cold normal saline drops to clear aiway. Change the trach tube. Call 911 if airway is still not patent.Distinguish between blood‐tinged mucus vs. frank bleeding from the trach tube. Bleeding non‐stop necessitates ED visit. Clear coagulated blood by trach tube or circuit change. Seek advice of physician for possible antibiotics or flexible endoscopy. For bleeding from dryness: switch to a heated wire circuit. Check room temperature for condensation/rain out phenomenon.John Wiley & Sons, Ltd.This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

**Dissemination of information:** To animate participation, we will provide an incentivized program by offering the first 150 home health nurses a gift card of \$20 for their participation with 1 unit of CEU. We will perform a pre and posttest to capture the knowledge gain from this educational opportunity.

**Conclusion:** We have created a curriculum for HMV emergencies. An innovative training module for HMV emergencies in Southern California is underway to train home health nurses and parents. This curriculum represents all major stakeholders addressing home emergencies for pediatric HMV patients outside the hospital settings.
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**Purpose:** Obstructive sleep apnea (OSA) is a common disorder estimated at 1%‐5% in school‐aged children. With the obesity prevalence reaching staggering rates globally, OSA in obese adolescents is estimated to be 4 to 5 fold higher than their lean peers. There is a paucity of data regarding obesity‐related OSA in children 6 years and less. This is particularly relevant as OSA is associated with neurocognitive deficits. The aim of this study is to evaluate the prevalence of OSA among obese toddlers and preschool children and further to determine what other factors may be associated with the presence of OSA.

**Methods:** A retrospective study involving children \< 6 years, identified from two Canadian pediatric tertiary care centers who had an in‐lab polysomnography (PSG). Obesity was defined by a BMI of \> 95th percentile for age and gender or a z‐score of \> 2. OSA was diagnosed if the obstructive apnea‐hypopnea index (OAHI) was greater than 2 events per hour.

**Results:** There were 60 participants included; the mean age was 4.4 years (standard deviation \[SD\] + 1.7), mean BMI z‐score was 3.0 (SD + 1.2). Of these, 22/60 (36.6%) had OSA. Compared with the non‐OSA group, the OSA group had a higher Epworth sleepiness score (*P* = 0.03) and were more likely to snore (*P* = 0.01).

**Conclusions:** Young obese children should be assessed for OSA. A history of snoring and daytime sleepiness may be useful indicators to facilitate triage for a PSG, especially in resource‐limited settings.

Clinical Implications: Early identification and targeted interventions for OSA in this vulnerable group will likely improve downstream health including neurocognition.
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The present study "Comparative study of nebulized beta 2 agonist, nebulized adrenaline and any added advantage of 3 % hypertonic saline in bronchiolitis" was undertaken to assess the efficacy. A total number of 150 patients (50 patients in each group) were examined below 24 months of age. Group A was nebulized with salbutamol, group B was nebulized with adrenaline and similarly, group C was nebulized with 3% hypertonic saline. Comparison of mean ± S.D. of RDAI score before and after nebulization was performed in all 3 groups. In each patient from all groups (ie A, B and C), RDAI scores were recorded at the time of admission (ie at 0 minutes), at 20 minutes and 40 minutes (after nebulization) and on subsequent days. The mean value of RDAI score at admission and discharge was 10.78± 1.03 and 6.58±1.54 respectively in group A. In group B, RDAI score at the time of admission and discharge was 11.20 ± 1.05 and 5.9 ± 1.61, respectively. Similarly in group C, RDAI score at the time of admission and discharge was 8.14 ± 1.80 and 3.18 ± 0.94, respectively. All the parameters before treatment had a *P* value \> 0.05 (not significant at 0 minutes.) and at the time of discharge, the p value became \< 0.0001 (extremely significant). Mean differences in HR, RR, RDAI SCORE and SpO2 were assessed after subsequent nebulization in all 3 groups. The post treatment values for group A (Salbutamol), group B (Adrenaline) and group C (3% Hypertonic Saline) were compared. All groups showed an increase in HR, but group B (mean difference of 14.80) showed a more increasing trend than group A (mean difference of 4.84) and group C (mean difference of 7.04) and had a *P* \< 0.05. Regarding RR, all 3 groups showed decreased RR, but group B (mean difference of 15.96) was more significant than group A (mean difference of 14.80) and group C (mean difference of 12.20) and had a *P* \< 0.05. Regarding RDAI score, all 3 groups showed improved score, but group B (mean difference of 5.3) was more significant than group A (mean difference of 4.2) and group C (mean difference of 4.96) and had a *P* \< 0.05. Similarly, all 3 groups showed improved SpO2 %, but group B (mean difference of 10.24) showed more improvement than group A (mean difference of 9.26) and group C (mean difference of 6.38) and had a *P* \< 0.05.

**Summary and Conclusion:** Clinical parameters (heart rate, respiratory rate, RDAI score and SpO2 %) in both groups were comparable before nebulization.

Nebulized salbutamol was given to group A, nebulized adrenaline to group B and nebulized hypertonic saline to group C. Different clinical parameters in the groups were compared before and after subsequent nebulization. Mean respiratory rates, RDAI scores and SpO2 (%) significantly improved in all 3 groups. However, improvement was more significant in the adrenaline group. Shorter length of hospitalization was noted in group C (Hypertonic saline).

No undesirable side effects were noted in all 3 groups.

All 3 groups showed a transient increase in heart rate, although more so in the adrenaline group.
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**Introduction/Aim:** Primary ciliary dyskinesia (PCD) is a hereditary and potentially life‐threatening disease. The clinical course is heterogeneous and characterized by progressive destructive airway disease and chronic ear, nose and throat problems; other organ systems, for example the cardiovascular and reproductive system can also be affected. The estimated incidence of PCD is 1:20.000, thus, the availability of longitudinal lung function data needed to characterize the course of pulmonary disease is poor.

**Methods:** We analyzed lung function data from a European PCD registry (BESTCILIA project). The lung function course (forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) was analyzed by linear mixed model analyses for repeated measures (SPSS, V24.0).

**Results:** Three hundred and six spirometries in 127 patients (463.4 patient‐years) with a confirmed diagnosis of PCD were evaluated. Fifty‐nine patients (47.2 %) were male, 61 (48.8%) had situs inversus. 45 (35.4%) patients had a defect of the outer and/or inner dynein arms, in 69 patients (54.3%) the diagnosis was confirmed genetically. Mean FEV1‐z‐score and FVC‐z‐score were ‐1.93 (SD 1.75) and ‐1.39 (SD 1.94), respectively. The mean annual decline of FEV1‐z‐score and FVC‐z‐score was 0.041 (SD 0.01) and 0.044 (SD 0.01), and for the subgroup of PCD with microtubular defects, the mean annual decline was 0.054 (SD 0.05) and 0.027 (SD 0.07), respectively.

**Conclusions:** The annual decline in FEV1 and FVC in PCD is substantial and comparable to the lung function decline in patients with cystic fibrosis. PCD variants with microtubular defects have an increased annual decline in FEV1‐z‐score and a decreased annual decline in FVC‐z‐score. This suggests that PCD subgroups have different patterns of lung function course. PCD registries are a useful tool to characterize the clinical course of PCD and PCD variants.
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**Objectives:** Endothelial dysfunction (ED) is one of the initial pathological changes ultimately leading to atherosclerosis and consequent cardiovascular disease. Children with endothelial dysfunction are at higher risk of developing systemic and pulmonary hypertension, atherosclerosis and cardiac remodeling, with potential long‐term adverse outcomes into adulthood. Obstructive sleep apnea syndrome (OSAS) has been found to cause impaired endothelial function in adults. However, the evidence in pediatric OSAS is limited. The aim of the study is to evaluate endothelial function in a large cohort of children clinically referred for suspected OSAS, and to identify risk factors contributing to the presence of ED.

**Methods:** Children aged 3 to 11 years old with habitual snoring (snoring ≥ 3 nights per week) were recruited to this study between June 1st 2015 ‐ March 1st 2016. All subjects underwent an overnight polysomnography (PSG), as well as endothelial function testing using peripheral arterial tonometry (PAT) to derive the reactive hyperemic index (RHI). Subjects were then divided into OSAS and primary snorers (PS) groups according to their obstructive apnea‐hypopnea index (OAHI).

**Results:** A total of 355 cases completed the study, with 248 children being diagnosed as OSAS, and 107 children assigned to the PS group. There were no differences in age, gender and BMI Z‐score between the two groups (all *P* \> 0.05). The OSA group had lower RHI than that of PS (*P* \< 0.05). Univariate correlation analysis showed that RHI was linearly correlated with age, gender, OAHI, oxygen desaturation index, respiratory related arousal index, and oxygen saturation nadir. The relationship between BMI Z‐sore and RHI was quadratic. RHI and BMI Z‐sore were positively correlated when BMI Z‐score\< 1.67 while negative correlated when BMI Z‐score≥ 1.67 \[RHI = 1.1286 + 0.0338\*BMI Z‐score ‐ 0.0147\*(BMI Z‐score)\^2\]. Multivariate correlation analysis showed that age was independently positively correlated with RHI(*P* = 0.006), while BMI Z‐score\^2 and respiratory related arousal index were negatively correlated with RHI (*P* = 0.03 and *P* = 0.004 respectively).

**Conclusion:** Children with OSAS have significant endothelial dysfunction compared with PS. Frequent arousals due to obstructive apneas and hypopneas during sleep may be a candidate risk factor for endothelial dysfunction in children with OSAS. In addition, age and BMI are also factors influencing the endothelial function in children.
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**Background:** Eisenmenger syndrome (ES) refers to any congenital cardiac defect (CHD) with intracardiac communication that leads to pulmonary arterial hypertension, reversal of flow, and cyanosis. The previous left‐to‐right shunt is converted into a right‐to‐left shunt secondary to elevated pulmonary artery pressures and associated pulmonary vascular disease. It is only suggested to treat functional class (FC) III patients with ES with bosentan. In this study, we retrospectively reassessed the clinical outcome, cardiac hemodynamics, quality of life and complications in ES patients by advanced vasodilators during the long‐term follow up.

**Methods:** Since 2005, we have treated adult patients with ES by utilizing add‐on combination of advanced therapy including Sildenafil, Bosentan and Ventavis except traditional therapies used. During the 14‐year follow‐up, we regularly performed EKG, cardiac echogram, 6 minute walk testing (SMWT) and monitoring of serum BUN, BNP and creatinine. Also, cardiac catheterization and hemodynamic studies, PET study with uptake of glucose analog 2‐deoxy‐2‐﹝18F﹞fluoroglucose (18F‐FDG) and pulmonary perfusion‐ventilation scan were performed.

**Results:** We enrolled six patients with ES including atrial septal defect type II (3 cases), atrial septal defect type I (1case), right atrial isomerism after total cavopulmonary connection (TCPC) (1case) and ventricular septal defect (1case); the male:female ratio was 3:3. Hemodynamic studies revealed that mean pulmonary arterial pressure was 52±7.3 mm Hg; pulmonary vascular resistance index was 26.1±7.9 WU\*m2, except the case receiving TCPC. In addition, three cases of intrapulmonary thrombus in right pulmonary artery, three cases of cerebral stroke and three cases of atrial fibrillation were found. The lung scan revealed that there were nonspecific findings noted in the ES patients with or without intrapulmonary thrombus. Very interestingly, an increased uptake of 18F‐FDG in the right ventricle was noted in three cases. Subsequently, there were two mortalities because of right ventricular failure.

**Conclusion:** Pulmonary scintigraphy did not delineate the intrapulmonary thrombus in ES. There is a relationship between metabolic changes and ventricular dysfunction in the right ventricle, compared with the left ventricle, in ES. Some of the AT agents (eg, bosentan, inhaled prostacyclin and oral sildenafil) have yielded improvements in exercise tolerance, and/or systemic arterial oxygen saturation in limited cases with ES. The beneficial data on specific‐target pharmacologic interventions in CHD with significant PAH are still quite preliminary, and large trials are warranted. Specifically, the extrapolation of ES from adult patients should be made carefully.
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**Statement:** *In vitro* drug delivery by nebulization and with a pressurized metered dose inhaler of a new prototype spacer was investigated as a function of the position of this device in an adult and a pediatric mechanical ventilation circuit.

**Material and methods:** *In vitro* Salbutamol delivery from a pressurized metered dose inhaler (Ventolin, GlaxoSmithKline, France) and a vibrating mesh nebulizer (Aeroneb Solo, Aerogen, Ireland) with the spacer were investigated in invasive mechanical ventilation circuits. The prototype was inserted in the circuit in two different positions: between the inspiratory limb and the Y piece and between the Y piece and the endotracheal tube (7 mm inner diameter for adult model and 4.5 mm inner diameter for the pediatric model). The ventilator (Evita 2 Dura, Dräger, France) was used in volume‐controlled mode with adult settings (tidal volume 450mL, 15 breaths/min, ratio between inspiratory and expiratory 40/60 and Positive end‐expiratory pressure (PEEP) 5 cmH2O) and pediatric settings which corresponds to a child of 15kg weight (tidal volume 150 ml, 25 breaths/min, ratio between inspiratory and expiratory 50/50 and PEEP 5 cm H2O). A filter was placed between the endotracheal tube and the test lung model (SmartLung Adult, IMT medical, Switzerland) to collect the drug. All components were tested for drug deposition. Deposited doses were quantified by spectrophotometry. All measurements were performed five times.

**Results:** The percentages of the nominal dose of salbutamol deposited on the filter with the adult model after nebulization and aerosolization, were similar when the device was located before or after the Y piece (31.87 ± 3.83 % vs. 27.03 ± 3.05 % and 30.71 ± 4.33 % vs. 27.80 ± 3.16 %). The same observations were made with the pediatric model (19.85 ± 3.82 % vs. 20.12 ± 2.36 % and 8.54 ± 2.00 % vs. 8.67 ± 2.16 %).

**Conclusion:** There is no influence of the position of this prototype in the breathing circuit on the *in vitro* drug delivery when using with a vibrating mesh nebulizer or with a pressurized metered dose inhaler for adult and pediatric mechanical ventilation models.

**Reflection:** A clear understanding of the different parameters which could affect drug delivery during mechanical ventilation is important to optimize drug delivery. The position of the inhalation device in a circuit is a key parameter which could significantly affect drug delivery.
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**Statement:** Using a system for improved *In Vitro ‐ In Vivo* Correlations (IVIVCs) of Inhaled Drug Products, the ability of the Annubar probe (AP) to properly analyze respiratory flow and its impact on valved holding chamber (VHC) performance were checked.

**Methods:** Aerodynamic particle size distribution (APSD) and emitted mass (EM) were measured during simulated tidal breathing using IVIVC testing systems. USP throat was connected to a Breath Simulator (BS2000, Copley) and the next generation impactor (NGI) by means of a T‐piece. A constant flow through the NGI cascade impactor was balanced with a pressurized air source, resulting in simulated tidal breathing through the VHC and constant air flow through the cascade impactor. The pressurized metered‐dose inhaler (pMDI) was shaken for 5 seconds and then fired into the spacer at the beginning of the inspiration. Five actuations were performed with 7 full breathing cycle intervals between puffs. Each experiment was performed five times. Respiratory flow analysis was measured during all the experiments using AP inserted into the mouthpiece of the VHC and a differential pressure sensor (SDP610, Sensirion). An electronic card linked to the sensor converted the pressure variation into a flow rate (Bernoulli's Principle).

**Results:** Flow analysis. During inhalation, the pressure differential (y)/flow rate (x) relationship was y = 0.1015x2 + 0.8343x (R2 = 0,9985). During exhalation, the pressure differential (y)/flow rate (x) relationship was y = ‐0.0106x2 + 0.0155x (R2 = 0,9873). This indicated that the flow rate closely followed the pressure differential (n = 5). Furthermore, the AP was able to measure flow rate with great stability and reproducibility during all the experiments.

**IVIVC measurement:** APSD analysis of Ventolin (Salbutamol 100µg/dose, GSK) was assessed *in vitro* using in vivo ‐ in vitro correlation methods. For VHCs including AP, MMADs decreased slightly compared to VHC alone. No significant change in GSDs, FPD5µm and FPF (P values\< 0.05) were noticed. According to these results, the mass distribution of Salbutamol remained stable with or without AP.

**Conclusion:** Results show that within the scope of our *in vitro* experiment, insertion of an Annubar Probe directly into the mouthpiece of the valve holding chamber allows a precise, instantaneous and reproducible measurement of the respiratory flow during the use of the inhalation chamber. Using the IVIVC technique, we were able to test this probe in conditions close to normal use. It was therefore pointed out that the pMDI actuation did not disturb flow measurement, and that presence of the pitot probe inside the mouthpiece did neither affect the VHC characteristics (ASPD) nor treatment delivery (EM).

**Reflection:** Annubar Probe inserted into a VHC mouthpiece could potentially lead to the development of new devices capable of analyzing patients' respiratory cycles during VHC use (inspiratory and expiratory phases, inhalation flow rate, etc.). This information could instruct the patient, leading to an improvement of his/her inhalation technique over time (Kamps 2007).
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**Statement:** The following experiments were aimed at characterizing valve operation and its impact on drug delivery, by measuring valve resistance, ability to close and emitted mass of drug.

**Methods:** Because different valve configurations require different mouthpiece shapes and volumes (ranging from 10.5 to 21.5 ml), six custom‐built VHCs were developed differing only by their inspiratory valves and mouthpieces. The six inspiratory valves had different weights, materials and shapes. Valve resistance (cmH20/L/s) was measured by differential pressure analysis at different flow rates (from 5 to 60 L/min). The ability of the inspiratory valve to close was determined by measuring flow rates with flowmeters placed on both mouthpiece and backpiece of the VHC for different breathing patterns (Child, Adult USP). Delivery of fluticasone propionate (Flixotide 50 µg, GSK) to a filter (emitted dose, ED) was assessed for each custom‐built chamber using a breathing simulator (Copley Scientific) simulating coordinated and uncoordinated pediatric use (Child USP pattern).

**Results:** Valve resistance generated at low inspiratory flow rate (5 L/min) varied greatly between the different valves ranging from 9.5 to 0.27 cmH2O/L/s; however as the flow rate increased, variations were reduced (3.98 to 0.43 cmH2O/L/s at 60 L/min).

The ability to close varied strongly from one valve to another: for some valves, expiratory flow did not pass through the inspiratory valve while for others, only partial closing could be achieved (85% of expiratory flow passed through the inspiratory valve). These results were confirmed by measuring the flow through the expiratory valve, maximum (100% of the initial flow rate) when inspiratory valves were completely closed. Tilting the chamber did not seem to affect this result.

ED measured with pediatric breathing parameters in coordinated and uncoordinated use was similar for four of the custom VHCs while with the other two VHCs, ED was lower.

**Conclusion:** Four of the six custom VHCs showed high ED even when simulating uncoordinated use. Three showed average resistance and one little resistance to low flow inhalation flow rate. All blocked exhaled air properly except one. The other two VHCs showed lower ED compared to the others. One showed little resistance to low inhalation flow rates and could only partially block exhaled air, while the other could close completely but showed high resistance to inspiration at low flow rate. Lower drug output can be explained by high resistance to low flow rate, causing poor opening of the valve at the beginning of the inspiration, and the valve not closing during expiration, causing exhalation inside the chamber.

**Reflection:** The main role of a VHC is to improve inhaled drug delivery. Given the preponderant role of inspiratory valves in the proper functioning of VHCs, it is essential to properly analyze their characteristics, especially at low flow rates. Inspiratory valves must function effectively To not compromise drug delivery. Therefore, it is important to consider it properly when choosing a VHC, especially for children.
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Endotracheal suctioning is considered as one of the invasive nursing techniques which has a risk of hemorrhage, tracheal spasm, bradycardia and so forth; however, research regarding the effective motion of endotracheal suctioning catheter is limited. The aim of this study is to unveil the relationship between effective motion of an endotracheal suctioning catheter and viscosity of secretion.

An electric suctioning machine (Power smile, SHINEI KOGYO), a suctioning catheter (10Fr., NIPRO), two viscosities of simulated secretion (666 poise, SAKAMOTO MODEL, 0.22 poise KYOTO KAGAKU), and a high‐speed camera (HXLink64,nac) and two different shapes of membrane models were used in this study. Five catheter motions: 1) quiescent technique, 2) piston technique, 3) rolling technique, 4) twist technique, and 5) dynamic pressure technique, were performed 10 times each and the weight of secretion was measured by a digital scale. The negative pressure was set at 20kPa, suctioning time was counted 10 seconds. One‐way ANOVA and Tukey test were used to analyze the obtained data.

In experiment 1, the mean amount of secretion for 1) to 5) were 0.31, 0.48, 0.32, 0.43, and 0.45, respectively. There were significant differences between 1) quiescent technique and 2) piston technique (*P* = 0.025), 2) piston technique and 3) rolling technique(*P* = 0.039) on a flat membrane model with high viscous sputum. The high‐speed camera showed that absorption was started when a catheter tip aperture and two side apertures were sealed with the high viscous sputum. As dynamic pressure technique, sputum was quickly absorbed right after the researcher released her thumb which bent the suctioning catheter.

In experiment 2 with high viscous sputum on a tracheal membrane model, mean secretion weight 1) to 5) were 0.36, 0.31, 0.30, 0.42, and 0.43 respectively. There were no significant differences between these five techniques. In experiment 3 with low viscous secretion on a tracheal membrane model, mean amounts of suctioned secretion were 0.97, 0.76, 0.98, 1.01, and 1.15 respectively. There were significant differences between 2) piston technique and 4) twist technique (*P* = 0.042), 2) piston technique and 5) dynamic pressure technique (*P* = 0.000).

In conclusion, the piston technique could absorb the most amount of secretion when a catheter tip was visible on a flat membrane model, however, the catheter motion which suctioned the most secretion was the dynamic pressure technique in a tracheal model despite the viscosity of the secretion. Even though nurses had to carefully apply the level of negative pressure before their procedure, this result indicated that dynamic pressure technique is the most effective catheter motion to remove secretion on a tracheal model.

Further research is needed to clarify the relationship among the nurses' sense of catheter tip to find out the location of secretions, the variety of catheter manipulations, and the amount of suctioned secretion.
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The objective of this study was to determine the prognostic factors related with mortality in pediatric hemato‐oncology patients admitted for pulmonary complications on the ICU.

This was a retrospective cohort study of patients below 21 years old with underlying hemato‐oncologic diseases admitted for pulmonary complications at the ICU of a tertiary referral hospital in Korea between April 2009 and March 2017. Patients admitted for perioperative management or non‐pulmonary complications were excluded. Demographics, laboratory parameters and clinical parameters such as Glasgow Coma Scale (GCS), the pediatric version of the Sequential Organ Failure Assessment (pSOFA) score and the Pediatric Logistic Organ Dysfunction (PELOD) score, etc., were extensively reviewed.

A total of 110 pediatric hemato‐oncology patients were admitted at the ICU for pulmonary complications. The median age was 13 (IQR, 8--16) years old, and 62 (56.3%) were boys. The median duration of ICU hospitalization was 8 (IQR, 4.25--16) days, and 45 patients (40.9%) were applied mechanical ventilation. The mortality rate was 59.1% (65/110 patients). Factors with a significant association with increased mortality in a multivariable logistic regression analysis were as follows: low GCS scores, low SpO2/FiO2 ratio, low hematocrit levels, and increasing total bilirubin levels. The pSOFA score and PELOD score assessed on the third day of admission had significant discrimination for in‐ICU mortality with an area under the curve of 0.87 (95% CI, 0.80‐0.95) and 0.83 (95% CI, 0.74‐0.92), respectively.

The GCS score, SpO2/FiO2 ratio, hematocrit level, total bilirubin level, pSOFA scores and PELOD scores are useful factors for the prediction of an increased risk of mortality in pediatric hemato‐oncology patients with pulmonary complication.
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**Background:** Respiratory syncytial virus (RSV) infection is the main cause leading to acute bronchiolitis in infants or children less than 2 years of age. Children are more susceptible to RSV infection than adults, especially those who have hemodynamic‐significant congenital heart disease or heart failure. In this study, we aimed to evaluate the possible risk factors leading to prolonged stay in the pediatric intensive care unit (PICU) or hospital stay for CHD children with RSV infection.

**Methods:** Data were retrospectively retrieved of patients who had CHD from Jan 2011 to Dec 2013. Those patients who had concurrent RSV infections and underwent computed tomography imaging study were included as the study group. Clinical presentations were recorded and classified. Statistics used descriptive analysis and *P* \< 0.05 was taken as significant.

**Results:** A total of 286 patients with associated congenital heart disease were included. The mortality rate was about 3% due to pulmonary edema, dysfunction or cyanosis. The total number of subjects whose age was below 1 year old was similar to those whose age was between 1 and 2 years old. There were 68 CHD children with airway problems, including trachea‐bronchomalacia, stenosis of the trachea or bronchus. Patients aged less than 1 year old had longer hospital stay than those whose age was above 1 year old. The mean PICU stay and the intubation period had a similar trend. In the comparison of groups without airway anomalies, the hospital stay in children who had hemodynamic‐significant CHD or heart failure (without associated airway anomalies) was 46.6 days compared to 11.6 days in children who did not have hemodynamic‐significant CHD or heart failure(without airway anomalies) (*P* \< 0.05). In children with airway anomalies but did not fulfill the criteria of hemodynamic‐significant CHD or heart failure had longer hospital stay (22.8 days) than those without airway anomalies but with hemodynamic‐significant CHD or heart failure (10.6 days) (*P* \< 0.05).

**Conclusions:** Patients with airway anomalies are not rare in children with CHD, although the severity varies. Lower airway anomalies were associated with longer hospital stay in CHD children who were not hemodynamic‐significant or heart failure. We found that airway problem is a risk factor for prolonged hospital or PICU stay in CHD children with RSV bronchiolitis. To achieve successful and sustainable outcome in CHD children with RSV bronchiolitis, it is crucial to have early identification of concomitant airway anomalies in these children.
